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A B S T R A C T
Background
Two types of implants used for the surgical fixation of extracapsular hip fractures are cephalocondylic intramedullary nails, which are
inserted into the femoral canal proximally to distally across the fracture, and extramedullary implants (e.g. the sliding hip screw).
Objectives
To compare cephalocondylic intramedullary nails with extramedullary implants for extracapsular hip fractures in adults.
Search strategy
We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (June 2007), the Cochrane Central Register of
Controlled Trials (The Cochrane Library 2007, Issue 2), MEDLINE (1966 to June week 3 2007), EMBASE (1988 to 2007 Week 27),
the UK National Research Register, orthopaedic journals, conference proceedings and reference lists of articles.
Selection criteria
All randomised and quasi-randomised controlled trials comparing cephalocondylic nails with extramedullary implants for extracapsular
hip fractures.
Data collection and analysis
Both authors independently assessed trial quality and extracted data. Wherever appropriate, results were pooled.
Main results
Predominantly older people with mainly trochanteric fractures were treated in the 36 included trials.
Twenty-two trials (3871 participants) compared the Gamma nail with the sliding hip screw (SHS). The Gamma nail was associated
with an increased risk of operative and later fracture of the femur and an increased reoperation rate. There were no major differences
between implants in the wound infection, mortality or medical complications.
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Five trials (623 participants) compared the intramedullary hip screw (IMHS) with the SHS. Fracture fixation complications were more
common in the IMHS group; all cases of operative and later fracture of the femur occurred in this group. Results for post-operative
complications, mortality and functional outcomes were similar in the two groups.
Three trials (394 participants) showed no difference in fracture fixation complications, reoperation, wound infection and length of
hospital stay for proximal femoral nail (PFN) compared with the SHS.
Single trials compared the Targon PF nail versus SHS (60 participants); experimental mini-invasive static intramedullary nail versus
SHS (60 participants); Kuntscher-Y nail versus SHS (230 participants); Gamma nail versus Medoff sliding plate (217 participants);
and PFN versus Medoff sliding plate (203 participants). These trials provided insufficient evidence to establish differences between
these implants.
Two trials (65 participants with reverse and transverse fractures at the level of the lesser trochanter) found intramedullary nails (Gamma
nail or PFN) were associated with better intra-operative results and fewer fracture fixation complications than extramedullary implants
(a 90-degree blade plate or dynamic condylar screw) for these fractures.
Authors’ conclusions
Given the lower complication rate of the SHS in comparison with intramedullary nails, SHS appears superior for trochanteric fractures.
Further studies are required to determine if different types of intramedullary nail produce similar results, or if intramedullary nails have
advantages for selected fracture types (for example, subtrochanteric fractures).
P L A I N L A N G U A G E S U M M A R Y
Cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Hip fractures located outside the hip joint capsule (extracapsular hip fractures) may be surgically fixed using a variety of implants. One
particular type of implant is the sliding hip screw. This consists of a screw that is inserted into the upper part of the thigh bone (femur)
to bridge (fix) the fracture. This screw can move within a metal barrel connected to a plate that is screwed to the outside of the femur
(extramedullary). Other implants take the form of intramedullary nails. The nails considered here are inserted from the top of the
femur into the inner cavity of the femur bone (intramedullary) and held in place with screws. This review compared these two types
of implants in predominantly older populations.
The main results were for the comparisons of four types of intramedullary nails with the sliding hip screw. Twenty-two trials, involving
3871 participants, tested the Gamma nail. Five trials, involving 623 participants, tested the intramedullary hip screw (IMHS). Three
trials, involving 394 participants, tested the proximal femoral nail. One trial of 60 participants tested the Targon PF nail. Pooled results
from these trials showed that nails are associated with an increased risk of fracture of the thigh bone both during and after the operation.
The review found that using cephalocondylic nails resulted in one extra reoperation in every 50 people. Mortality and other long-term
outcomes were similar between the implants.
The review concluded that, given the lower complication rate of the sliding hip screw in comparison with intramedullary nails, the
sliding hip screw appears to be a better implant for fixing the more common types of extracapsular hip fractures.
B A C K G R O U N D
Hip fracture is the general term for fracture of the proximal (upper)
femur. These fractures can be subdivided into intracapsular frac-
tures (those occurring within or proximal to the attachment of the
hip joint capsule to the femur) and extracapsular (those occurring
outside or distal to the hip joint capsule). Extracapsular fractures
are further defined as those fractures that traverse the femur within
the area of bone bounded by the intertrochanteric line proximally
up to a distance of five centimetres below the distal part of the
lesser trochanter. Numerous subdivisions and classification meth-
ods exist for these fractures. Other terms used to describe these
fractures include trochanteric, subtrochanteric, pertrochanteric,
intertrochanteric, basal and lateral femoral fractures (Parker 2002).
The most practical classification and that used for this review is
the division into stable trochanteric fractures (AO classification
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type A1), unstable trochanteric (AO classification type A2), and
transtrochanteric which includes those fracture lines at the level of
the lesser trochanter and reversed fracture lines (AO classification
type A3) (Muller 1991).
Operative treatment of extracapsular hip fractures was introduced
in the 1950s using a variety of different implants. Implants may
be either extramedullary or intramedullary in nature. The most
commonly used extramedullary implant is the sliding hip screw
(SHS) which is synonymous with the term compression hip screw
and equivalent models such as the Dynamic, Richards or Ambi
hip screws. The SHS consists of a lag screw passed up the femoral
neck to the femoral head. This lag screw is then attached to a plate
on the side of the femur. These are considered ’dynamic’ implants
as they have the capacity for sliding at the plate/screw junction to
allow for collapse at the fracture site. The Medoff plate (Medoff
1991) is a modification of the sliding hip screw. The difference
is that the plate has an inner and outer sleeve, which can slide
between each other. This creates an additional capacity for sliding
to occur at the level of the lesser trochanter as well as at the lag
screw. Sliding at the lag screw can be prevented with a locking
screw to create a ’one way’ sliding Medoff instead of a ’two way’
sliding Medoff. At a later date the locking device on the lag screw
can be removed to ’dynamise’ the fracture.
Static implants include the fixed nail plates such as the Jewett and
the McLaughlin nail plates. The 90-degree blade plate is also a
static implant of a more recent design. Though, theoretically, the
Dynamic condylar screw plate has the capacity for sliding at the
screw plate junction, it is more likely to act as a fixed device when
used at the hip, with no slide occurring.
Intramedullary nails used for internal fixation of extracapsular
fractures can either be inserted from distal to proximal (condylo-
cephalic nails) or from proximal to distal (cephalocondylic nails).
Condylocephalic nails are inserted at the level of the femoral
condyle above the knee and passed across the trochanteric fracture
and up into the femoral head. These are the subject of another re-
view (Parker 1998).Cephalocondylic nails are inserted through the
greater trochanter of the femur and secured by a cross pin or screw
which is passed up the femoral neck into the femoral head. Theo-
retical biomechanical advantages of these intramedullary nails over
screw and plate fixation are attributed to a reduced distance be-
tween the hip joint and the implant, which diminishes the bend-
ing moment across the implant/fracture construct. Examples of
these intramedullary nails are the Gamma nail, the intramedullary
hip screw (IMHS), the proximal femoral nail (PFN), the Targon
PF (proximal femoral) nail and the Kuntscher-Y nail (Cuthbert
1976). These nails plus an experimental nail tested in Dujardin
2001 are described in Table 1.
Table 1. Intramedullary nails evaluated by the included trials
Name Description
Gamma nail The Gamma nail (Howmedica Ltd) was introduced in the late 1980s for the treat-
ment of extracapsular hip fractures. The implant consists of a sliding lag screw
which passes through a short intramedullary nail. One or two screws may be passed
through the nail tip to secure it to the femoral shaft (distal locking). Theoretical
advantages of this implant are due to a percutaneous insertion technique and in-
clude reduced blood loss, reduced sepsis, minimal tissue trauma and short operat-
ing time. Modifications to the design of the Gamma nail and its instrumentation
have occurred since its introduction. The trochanteric Gamma nail is referred to as
a third generation Gamma nail. It is shorter in length than the standard Gamma
nail (200 mm versus 180 mm), has a lower mediolateral curvature (4 degrees) and
has a diameter of 17 mm proximally and 11 mm distally.
Intramedullary hip screw (IMHS) The IMHS (Richards Medical Ltd) - length 210 mm - was introduced in 1995 for
the treatment of extracapsular femoral fractures. Like the Gamma nail, it consists of
a nail inserted via the greater trochanter into the medullary cavity and a lag screw,
which is passed up the femoral neck to the head.
Proximal femoral nail (PFN) The PFN (Synthes Ltd) - length 240mm -was introduced in 1998 for the treatment
of extracapsular fractures. Like the Gamma and IMHS, it consists of a nail inserted
via the greater trochanter in to the medullary cavity. Two proximal lag screws are
passed up the femoral neck to the head.
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Table 1. Intramedullary nails evaluated by the included trials (Continued)
Targon PF (proximal femoral) nail The Targon PF nail - length 220 mm - is also inserted in a similar fashion into the
intramedullary cavity. Proximally, this nail has a sliding lag screw and an antirotation
pin.
Experimental nail (reported in Dujardin 2001) An experimentalmini-invasive static intramedullary nail, which is not commercially
available, is reported in Dujardin 2001. This consists of an intramedullary nail
which is 170millimetres longwith a distal diameter of 12millimetres and a proximal
diameter of 13 millimetres. There are two five millimetre distal locking holes. The
proximal hold of the femur is with two seven millimetre cannulated screws which
diverge at a 30 degrees angle. Unlike the other proximal femoral nails, there is no
sliding mechanism within the nail construct.
Kuntscher-Y nail The Kuntscher-Y nail (Cuthbert 1976) is an early design of an intramedullary nail.
It consists of a side arm and a separate slotted Kuntscher nail. The side arm is passed
up the femoral neck, and then attached to an alignment jig to enable a slotted
Kuntscher nail to be passed via the greater trochanter through a hole in the side arm
and distally within the medullary cavity. The assembled implant construct has no
capacity for sliding at the side arm and neither has it the capacity for distal locking.
This review compares different types of cephalocondylic nails
with extramedullary implants: a review comparing different in-
tramedullary nails for these fractures is now available (Parker
2006).
O B J E C T I V E S
To compare the relative effects (operative details, fracture fixation
complications, post-operative complications, anatomical restora-
tion, final outcome measures) of cephalocondylic intramedullary
nails versus extramedullary fixation implants for treating extracap-
sular proximal femoral (hip) fractures in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised or quasi-randomised (e.g. alternation) controlled
trials comparing all types of cephalocondylic intramedullary nails
with extramedullary implants.
Types of participants
Skeletally mature patients with an extracapsular proximal femoral
fracture. In presenting trial details and results, consideration is
given to the type of fractures (e.g. stable or unstable trochanteric
fractures, subtrochanteric fracture) were included and what frac-
tures (e.g. pathological fractures due tomalignancy) were excluded
from individual trial populations.
Types of interventions
Surgical fixation of the fracture with a cephalocondylic nail or
extramedullary implants.
Types of outcome measures
The following outcomes were sought.
(1) Operative details
• length of surgery (in minutes)
• operative blood loss (in millilitres)
• number of patients transfused
• radiographic screening time (in seconds or minutes)
(2) Fracture fixation complications
• operative fracture of the femur (around or below the
implant, but excluding comminution of the fracture site)
• later fracture of the femur (around or below the implant)
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• cut-out of the implant from the femoral head
• non-union of the fracture
• detachment of the implant from the femur
• breakage of the implant
• all technical complications of fixation (sum of above six
outcomes with the addition of any other major complications of
fracture healing as specified in each study. Major complications
were defined as those which generally required revision surgery
or a change of surgical procedure during the primary operation,
such as using a longer nail. Excluded from this are minor
operative complications, such as comminution of the fracture site
during surgery, and minor fracture healing complications such as
breakage of the locking screws or backing out of pins or screws)
• reoperation (within the follow-up period of the study)
• wound infection: any (i.e. deep or superficial) or all deep
wound infection (i.e. infection beneath the deep fascia)
• wound haematoma
(3) Post-operative complications
• pressure sores
• pneumonia
• thromboembolic complications (deep vein thrombosis or
pulmonary embolism)
• any medical complication (as detailed in each individual
study, excluding wound infections)
• length of hospital stay (in days)
(4) Anatomical restoration
• leg shortening (preferably using the criterion of a >2 cm
reduction)
• varus deformity
• external rotation deformity (preferably using the criterion
of a >20 degrees deformity)
(5) Final outcome measures
• mortality (within the follow-up period of the study)
• pain (persistent pain at the final follow-up assessment)
• mobility and use of walking aids
• failure to return to pre-fracture residential status
• functional activities of daily living
• composite function and hip scores
In ourmethodology quality assessment tool (seeMethods) we have
specified six-months follow up for all surviving trial participants
as being acceptable. However, longer-term follow up of at least
one year or, better still, two years is preferable to get a full view on
mortality, function and reoperation resulting from complications
and implant failure.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Bone, Joint andMuscle Trauma Group
Specialised Register (June 2007), the Cochrane Central Regis-
ter of Controlled Trials (The Cochrane Library 2007, Issue 2),
MEDLINE (1966 to June week 3 2007) and EMBASE (1988 to
2007 Week 27). We searched the UK National Research Regis-
ter Issue 2, 2007 (http://www.update-software.com/National/nrr-
frame.html) and Current Controlled Trials at www.controlled-tri-
als.com (accessed June 2007) for ongoing and recently completed
trials. No language restriction was applied.
The generic search strategies for hip fracture trials in The Cochrane
Library (Wiley Interscience) and MEDLINE (2002 onwards) are
shown in Appendix 1. ThisMEDLINE search was combined with
all three stages of the optimal trial search strategy (Higgins 2005).
The general search strategy for hip fracture trials in EMBASE
(2002 onwards) is shown in Appendix 2.
Searching other resources
We searched reference lists of articles and our own reference
databases. We included the findings from handsearches of the
British Volume of the Journal of Bone and Joint Surgery sup-
plements (1996 onwards) and abstracts of the American Or-
thopaedic Trauma Association annual meetings (1996 to 2006:
http://www.hwbf.org/ota/am/) and American Academy of Or-
thopaedic Surgeons annualmeeting (2004 to2007:www.aaos.org/
wordhtml/libscip.htm). We also included handsearch results from
the final programmes of SICOT (1996 & 1999) and SICOT/
SIROT (2003), EFFORT (2007) and the British Orthopaedic As-
sociationCongress (2000, 2001, 2002, 2003, 2005 and 2006).We
scrutinised weekly downloads of “Fracture” articles in new issues
of 15 journals (Acta Orthop Scand; Am J Orthop; Arch Orthop
Trauma Surg; Clin J Sport Med; Clin Orthop; Foot Ankle Int;
Injury; J Am Acad Orthop Surg; J Arthroplasty; J Bone Joint Surg
Am; J Bone Joint Surg Br; J Foot Ankle Surg; J Orthop Trauma; J
Trauma; Orthopedics) from AMEDEO (www.amedeo.com). We
contacted Howmedica Ltd UK (manufacturers of the Gamma
nail) and Richards Ltd (manufacturers of the Intramedullary Hip
Screw) and corresponded with colleagues.
Details of other searches conducted prior to 2000 are documented
in Appendix 3.
Data collection and analysis
Selection of studies
Both review authors independently assessed potentially eligible
trials for inclusion. Any disagreement was resolved by discussion.
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Data extraction and management
Data for the outcomes listed above were independently extracted
by both review authors and any differences resolved by discussion.
Where necessary and practical, we contacted trialists for additional
data and clarification.
Assessment of risk of bias in included studies
Each trial was assessed independently without masking by both
authors for its quality of methodology and a consensus reached
where there were differences. The main assessment was by the
method of randomisation, which was also separately graded A, B
or C according to the scheme within the Cochrane Handbook.
In total, 11 aspects of methodology were rated (see Table 2). The
scores of the individual items were no longer summed from 2007
onwards.
Table 2. Methodological quality assessment scheme
Items Scores
1. Was there clear concealment of allocation? Score 3 (and code A) if allocation was concealed (e.g. numbered
sealed opaque envelopes drawn consecutively). Score 2 (and code
B) if there was a possible chance of disclosure before allocation.
Score 1 (and code B) if the method of allocation concealment or
randomisation was not stated or was unclear. Score 0 (and code C)
if allocation concealment was clearly not concealed such as those
trials using quasi-randomisation (e.g. even or odd date of birth).
2. Were the inclusion and exclusion criteria clearly defined? Score 1 if text states the type of fracture and which patients were
included and/or excluded. Otherwise score 0.
3. Were the outcomes of trial participants who withdrew or ex-
cluded after allocation described and included in an intention-to-
treat analysis?
Score 1 if yes or text states that no withdrawals occurred, or data
are presented that, by clearly showing ’participant flow’, allow this
to be inferred. Otherwise score 0.
4. Were the treatment and control groups adequately described at
entry and if so were the groups well matched or appropriate co-
variate adjustment made?
Score 1 if at least four admission details given (e.g. age, sex, mo-
bility, function score, mental test score, fracture type) with no
significant difference between groups or appropriate adjustment
made. Otherwise score 0.
5. Did the surgeons have prior experience of the operations they
performed in the trial, prior to its commencement?
Score 1 if text states there was an introductory period or that
surgeons were experienced. Otherwise score 0.
6. Were the care programmes other than trial options identical? Score 1 if text states they were or if this can be inferred. Otherwise
score 0.
7. Were the outcome measures clearly defined in the text with a
definition of any ambiguous terms encountered?
Score 1 if yes. Otherwise score 0.
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Table 2. Methodological quality assessment scheme (Continued)
8. Were the outcome assessors blind to assignment status? Score 1 if assessors of pain and function at follow up were blinded
to treatment outcome. Otherwise score 0.
9. Was the timing of outcome measures appropriate?A minimum
of six-months follow up for all surviving trial participants.
Score 1 if yes. Otherwise score 0.
10. Was loss to follow up reported and if so were less than five per
cent of trial participants lost to follow up?
Score 1 if yes. Otherwise score 0.
11. Were the authors able to provide supplementary details of the
trial in addition to published data?
Score 1 if yes. Otherwise score 0.
Data synthesis
For dichotomous outcomes, we report relative risks (RR) with
95% confidence intervals and for continuous outcomes, weighted
mean differences (WMD) and 95% confidence intervals. Results
of comparable groups of trials were pooled using both the fixed-
effect and random-effects models. Heterogeneity between compa-
rable trials was tested using a standard chi² test, with additional
consideration of the I² statistic (Higgins 2003). The results for the
random-effects model are presented when there is significant het-
erogeneity (P < 0.10; I² > 50%) in the results of individual trials.
Sensitivity analysis
Some exploratory sensitivity analyses, based on allocation conceal-
ment and the reportage of surgical experience, were performed to
test potential bias.
The choice of denominators for post-operative outcomes such as
non-union and cut-out often presented difficulties as it was often
unclear if these outcomesweremeasured or reported in all patients,
especially those who eventually died. Some studies clearly stated
when and to whom the results for a specific outcome applied and
we have used these data here. In those studies for which it was
unclear, we have selected the denominators which seemed themost
appropriate based on the reported data. These have usually been
the numbers randomised or alive at follow up. Sensitivity analyses
using numbers randomised were done for all outcomes where such
choices had been made in order to check for significant changes
in results.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
In all, 60 trials were identified of which 36 were included, 19
excluded, one is ongoing, and four are awaiting assessment.
Four newly reported trialswere included in this update. Thesewere
Ovesen 2006 which compared the Gamma nail with the sliding
hip screw (SHS); Ekstrom 2007 which compared the proximal
femoral nail (PFN) with the SHS; Giraud 2005 which compared
the Targon PF nail with the SHS; and Papasimos 2005 which
compared three implants: the Gamma nail, the PFN and the SHS
(see the ’Characteristics of included studies’ for details). Further
unpublished details were obtained for an already included trial (
Mehdi 2000).
Of the six other newly identified studies, five were excluded
(Azzoni 2004; Bienkowski 2006; Kafer 2005; Klinger 2005;
Tarantino 2005) (see the ’Characteristics of excluded studies’ for
details).
The remaining newly identified study (Harris 2005), is awaiting
assessment as it is only available as a conference abstract. A trial
previously listed as ongoing is now awaiting assessment after iden-
tifying a conference abstract (Fernando 2006 formerly Khaleel).
Details of the ongoing trials are presented in the ’Characteristics
of ongoing studies’.
The trial populations for the various implant comparisons in the
included trials are summarised below.
Gamma nail versus SHS
Twenty-two trials (Adams 2001; Ahrengart 1994; Benum 1994;
Bridle 1991; Butt 1995; Goldhagen 1994; Guyer 1991; Haynes
1996; Hoffman 1996; Kukla 1997; Kuwabara 1998; Leung
1992; Marques Lopez 2002; Michos 2001; Mott 1993; O’Brien
1995; Ovesen 2006; Pahlpatz 1993; Papasimos 2005; Park 1998;
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Radford 1993; Utrilla 2005) compared the Gamma nail with
the SHS in 3871, predominantly older, people. However, Benum
1994 was a multi-centre study for which data were only available
for a subgroup of hospitals. Ahrengart 2002 was the other multi-
centre study (Ahrengart 1994), which was based in Scandinavian
countries. Since the results for participants with subtrochanteric
fractures and 66 others who were lost to follow up were not pub-
lished in the full report of the trial (Ahrengart 2002), we con-
tinue to present the results from two centres reported in Fornander
1994. This means that the results for only 3080 trial participants,
with 3082 fractures, are included in this review.
Eight trials (Ahrengart 1994; Benum1994; Butt 1995;Goldhagen
1994; Guyer 1991; Haynes 1996; Michos 2001; Mott 1993) in-
cluded subtrochanteric fractures as well as trochanteric fractures.
Where recorded, the mean ages of trial participants ranged be-
tween 73 and 84 years and the proportion of male patients varied
from 15% to 40% in individual studies.
Intramedullary hip screw (IMHS) versus SHS
The five trials (Baumgaertner 1998; Hardy 1998: Harrington
2002; Hoffmann 1999, Mehdi 2000) comparing the IMHS with
the SHS involved a total of 623 people with 627 stable or unstable
trochanteric fractures. The mean ages of the participants of indi-
vidual trials were between 76 and 83 years and, where reported,
proportion of males varied from 20% to 34%.
Full published reports were available for four trials (Baumgaertner
1998; Hardy 1998; Harrington 2002, Hoffmann 1999). A lim-
ited translation from German was obtained for Hoffmann 1999.
A conference abstract (Hardy 1999) presenting the results of 160
people at 18 months follow up is available for Hardy 1998 but,
pending clarification of the limited results presented in the ab-
stract, so far we have not included the results for the extra 60
participants. Mehdi 2000 has only been reported as a conference
abstract, however unpublished material for this trial indicate that
the limited results in the abstract applied to the whole trial popu-
lation.
Proximal femoral nail
Three trials (Pajarinen 2005; Papasimos 2005; Saudan 2002),
compared the proximal femoral nail (PFN) with the SHS in 394
people with trochanteric hip fractures. The mean ages of partici-
pants of the three trials ranged between 81 and 83 years, and the
proportion of males varied between 22% to 39%.
Targon PF (proximal femoral) nail
One trial (Giraud 2005) compared a Targon PF intramedullary
nail with the SHS in 60 people with stable or unstable trochanteric
fractures. The mean age of trial participants was 82 years and 23%
were male.
Mini-invasive static intramedullary nail
One trial (Dujardin 2001) compared an experimental mini-inva-
sive static intramedullary nail with the SHS in 60 people with
stable or unstable trochanteric fractures. The mean age of trial
participants was 83.5 years and 20% were male.
Kuntscher-Y nail
One trial (Davis 1988) compared the Kuntscher-Y nail with the
SHS. The 230 participants with intertrochanteric fractures had a
mean age of 81 years and 17% were male.
Intramedullary nails (various types) versus Medoff sliding
plate
One trial (Miedel 2005) compared the Gamma nail with aMedoff
sliding plate in 217 people with either an unstable trochanteric
fracture (189 cases) or a subtrochanteric fracture (28 cases). The
mean age of participants was 84 years and 19%weremale. Another
trial (Ekstrom 2007) compared the proximal femoral nail (PFN)
with a Medoff sliding plate in 203 people (out of 210 recruited)
with either an unstable trochanteric fracture (172 cases) or a sub-
trochanteric fracture (31 cases). The mean age of participants was
82 years and 24% were male.
Intramedullary nails (various types) versus fixed (static) ex-
tramedullary plates
One trial (Pelet 2001) compared the Gamma nail with a blade
plate in 26 people (mean age 71 years; 35% male) with a com-
minuted trochanteric fracture, classified as Kyle type IV. These
fracture patterns approximate to those of type 31A3 fractures in
the AO classification of fractures with reversed fracture pattern
or transverse fracture lines at the level of the lesser trochanter (
Muller 1991). Sadowski 2002 compared the PFN with the dy-
namic condylar screw in 39 people (mean age 79 years; 31%male)
with type 31A3 fractures.
Risk of bias in included studies
The results of the methodological assessment for individual trials
are given below. (Note that Papasimos 2005 appears in two cate-
gories.) Further details of allocation concealment and randomisa-
tion (item 1), surgeon’s experience (item 5) and assessor blinding
(item 8) are also presented.
Table of the individual methodological quality scores (seeTable
2 for criteria)
1 2 3 4 5 6 7 8 9 10 11 Trial name
Gamma nail versus sliding hip screw
2 1 1 1 1 1 1 1 1 1 1 Adams 2001
2 1 0 1 1 0 0 0 1 0 1 Ahrengart 1994
1 0 0 1 0 0 0 0 1 0 0 Benum 1994
1 1 0 1 1 0 0 0 1 0 0 Bridle 1991
0 1 0 1 0 0 0 0 0 1 0 Butt 1995
0 1 0 1 0 0 1 0 1 1 0 Goldhagen 1994
0 0 0 0 0 1 0 0 0 0 0 Guyer 1991
0 1 0 1 0 0 0 0 1 1 0 Haynes 1996
3 1 1 1 0 1 1 1 1 1 1 Hoffman 1996
2 1 1 1 1 0 1 0 1 1 1 Kukla 1997
1 0 0 1 0 0 0 0 1 0 0 Kuwabara 1998
0 0 0 0 0 0 0 0 1 1 1 Leung 1992
0 1 0 1 0 0 0 0 1 0 0 Marques Lopez 2002
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1 0 0 0 0 0 0 0 0 0 0 Michos 2001
2 1 0 0 0 0 1 0 0 0 1 Mott 1993
3 1 0 1 0 0 1 0 0 0 1 O’Brien 1995
3 1 1 1 0 1 0 0 1 0 1 Ovesen 2006
1 0 0 0 0 0 0 0 1 0 0 Pahlpatz 1993
1 1 0 1 0 1 0 0 1 0 0 Papasimos 2005
0 1 1 1 0 0 1 0 0 1 0 Park 1998
1 0 0 1 1 0 0 0 1 0 0 Radford 1993
2 1 1 0 0 1 1 0 1 1 0 Utrilla 2005
Intramedullary hip screw (IMHS) versus sliding hip screw
3 1 0 0 0 1 1 0 1 1 1 Baumgaertner 1998
0 1 1 1 0 1 1 1 1 1 0 Hardy 1998
2 1 0 1 0 1 1 1 1 1 1 Harrington 2002
3 1 1 1 0 1 1 0 0 1 0 Hoffmann 1999
2 0 0 0 0 0 0 0 1 0 1 Mehdi 2000
Proximal femoral nail (PFN) versus sliding hip screw
3 1 1 1 1 1 1 0 0 0 1 Pajarinen 2005
1 1 0 1 0 1 0 0 1 0 0 Papasimos 2005
2 1 1 1 1 1 1 0 1 1 1 Saudan 2002
Targon PF (proximal femoral) nail versus sliding hip screw
2 1 1 1 0 0 1 0 0 0 1 Giraud 2005
Mini-invasive static intramedullary nail versus sliding hip
screw
1 1 0 1 1 1 1 0 1 0 0 Dujardin 2001
Kuntscher-Y nail versus sliding hip screw
3 1 0 1 0 0 1 0 0 1 1 Davis 1988
Intramedullary nails (various types) versus Medoff sliding
plate
2 1 0 1 0 1 1 0 1 0 0 Ekstrom 2007
2 1 1 1 0 1 1 0 1 1 0 Miedel 2005
Intramedullary nails (various types) versus fixed (static) ex-
tramedullary plates
2 1 1 1 0 1 1 0 1 1 1 Pelet 2001
2 1 1 1 1 1 1 0 1 1 1 Sadowski 2002
Sixteen trials randomised using envelopes; these were described as
sealed in 14 trials (Adams 2001; Ahrengart 1994; Baumgaertner
1998; Davis 1988; Ekstrom 2007; Harrington 2002; Hoffman
1996; Hoffmann 1999; Kukla 1997; Mehdi 2000; Miedel 2005;
O’Brien 1995; Ovesen 2006; Pajarinen 2005; Utrilla 2005) and
mixed in Benum 1994. Seven trials (Baumgaertner 1998; Davis
1988; Hoffman 1996; Hoffmann 1999; O’Brien 1995; Ovesen
2006; Pajarinen 2005) indicated that the randomisation was
blinded. Blinded randomisation was also claimed for Pelet 2001,
which used the drawing of lots, but safeguards were not described.
Computer generated randomised numbers were used for Mott
1993, Sadowski 2002 and Saudan 2002. Giraud 2005 used a ran-
dom numbers table. A further seven trials were quasi-randomised
in which the treatment allocation was inadequately concealed
using either alternating patient admission (Guyer 1991; Leung
1992), medical record numbers (Goldhagen 1994; Hardy 1998;
Marques Lopez 2002; Park 1998), or an even or odd week of ad-
mission (Butt 1995). Though Haynes 1996 used randomisation
cards, allocation concealment was deemed unlikely as the imbal-
ance in the treatment group numbers was attributed to surgeons
withdrawing a patient from the trial when they considered them-
selves unfamiliar with the Gamma nail. The remaining trials did
not specify their method of randomisation.
Brief details of surgical experience (item 5) as reported for indi-
vidual trials are given in the ’Characteristics of included studies’
table. For several trials, surgeons may have been more experienced
with the SHS than the newer implant (the intramedullary nail).
This disparity of experience was certainly true for Baumgaertner
1998 and Harrington 2002 where the participating surgeons had
experience with using sliding hip screws but not specifically with
the IMHS despite being familiar with the techniques involved.
Conversely in Leung 1992, most of the Gamma nail operations
were performed by one senior surgeon with a special interest in in-
tramedullary nailingwhilst the SHS operationswere performed by
a variety of often less experienced surgeons. Similarly in Marques
Lopez 2002, the majority of Gamma nail operations were per-
formed by specialists and conversely the majority of SHS opera-
tions were done by junior or senior residents. In addition, surgeons
were more experienced with the Gamma nail than with the blade
plate in Pelet 2001.
Only four trials (Adams 2001; Harrington 2002; Hardy 1998;
Hoffman 1996) included blinded assessment of some outcomes
(item 8).
Effects of interventions
These are presented by the type of cephalocondylic nail being
compared with the extramedullary plate device (sliding hip screw
or the Medoff plate) and, for two studies, the dynamic condylar
screw and the 90 degree blade plate. The outcome measures listed
earlier were sought for all studies and, where available, results are
summarised in the analyses. Reported outcomes are also listed
in the ’Characteristics of included studies’ table. The key pooled
outcomes for four of the femoral nails (Gamma, IMHS, PFN
and the Targon PF) versus the sliding hip screw are given first,
followed by the results for each type of nail. The experimental
nature, including the lack of commercial availability, of the mini-
invasive intramedullary nail should be noted when viewing the
results of this trial and was the reason for not including it at present
in the pooled femoral nail analysis. The results for the Kuntscher-
Y nail were also not pooled with the other nails because this earlier
version of a cephalocondylic nail does not have the capacity for
distal locking.
The included trials generally used similar outcome measures with
regard to surgical fixation failure and operative details. Wound in-
fection was usually more difficult to quantify and it was not possi-
ble to differentiate between superficial and deep wound infection
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for many of the trials. Mortality was taken as that which occurred
within the follow-up period for each study. The outcomemeasures
of residual pain, change inmobility and function are more difficult
to quantify and were recorded in fewer trials. Moreover, because
no standardised assessment was used for all trials, only a limited
evaluation was possible for these outcomes. Data from each trial
which could be pooled are presented graphically. As reported in
Methods, we performed sensitivity analyses to explore the effects
of our choice for denominators when these were not clearly stated
in trial reports. No significant changes in the pooled results were
encountered (e.g. see Analyses 2.8 and 2.10).
Four types of femoral nails (Gamma, IMHS, PFN and Targon
PF) versus the sliding hip screw (SHS)
To avoid double counting of the participants of the SHS group, the
combined data for the Gamma nail and PFN groups of Papasimos
2005 are presented in a separate sub-category (5 in Analyses 1.2
to 1.7). Thus the results for Papasimos 2005 do not appear in
the Gamma nail (sub-category 1) or PFN (sub-category 3) anal-
yses. The pooled results for these four types of nail demonstrate
a significantly lower incidence of the complications for operative
fracture of the femur (see Analysis 1.2: 35/1804 versus 6/1799;
RR 3.25, 95% CI 1.74 to 6.08), later fracture of the femur (see
Analysis 1.3: 39/1683 versus 2/1645; RR 5.22, 95% CI 2.56 to
10.64) and overall technical complications of fixation (see Anal-
ysis 1.6: 150/1871 versus 74/1861; RR 1.97, 95% CI 1.51 to
2.58) in favour of the SHS. There was remarkable homogeneity
in the results of the trials within and between the separate cate-
gories for these outcomes. These complications contribute to the
significantly greater reoperation rate for femoral nails (see Analysis
1.7: 105/1698 versus 64/1690; RR 1.58, 95% CI 1.17 to 2.12).
Pooled results for cut-out (seeAnalysis 1.4), nonunion (seeAnalysis
1.5), deep wound infection (see Analysis 1.8) and mortality (see
Analysis 1.9) showno difference between the two types of implant,
and again show uniformity. Far fewer data were available for the
three other outcomes (length of surgery, pain and non return to
previous residence or dead) presented graphically (seeAnalyses 1.1,
1.10 and 1.11 respectively); none showed a statistically significant
difference between the twogroups. The heterogeneity in the length
of surgery results continues to be striking.
Gamma nail versus the sliding hip screw (SHS)
Data for 3080 people were available from the 22 randomised
controlled trials (Adams 2001; Ahrengart 1994; Benum 1994;
Bridle 1991; Butt 1995; Goldhagen 1994; Guyer 1991; Haynes
1996; Hoffman 1996; Kukla 1997; Kuwabara 1998; Leung
1992; Marques Lopez 2002; Michos 2001; Mott 1993; O’Brien
1995; Ovesen 2006; Pahlpatz 1993; Papasimos 2005; Park 1998;
Radford 1993; Utrilla 2005) comparing the Gamma nail with
the SHS. Eight trials (Ahrengart 1994; Benum 1994; Butt 1995;
Goldhagen 1994; Guyer 1991; Haynes 1996; Michos 2001; Mott
1993) included subtrochanteric fractures as well as trochanteric
fractures. It is important to note that data are unavailable and may
be lost for over 1000 trial participants from either those trials ap-
parently completed but for which complete trial data have nei-
ther been published nor made available (Ahrengart 1994; Benum
1994; Hogh 1992) or trials which may not have been completed
(Pahlpatz 1993; Prinz 1996). Different versions of the Gamma
nail were used: the early studies used the ’Gamma 1’ nail and
the later studies used the trochanteric Gamma nail (Ovesen 2006;
Papasimos 2005; Utrilla 2005). The results of all these trials have
been pooled in this review. Inspection of the analyses for various
fracture fixation complications and reoperation shows no indica-
tion of a marked difference in results in the two groups of trials;
overall, there was no statistical heterogeneity in any of the pooled
results (I² = 0% in all analyses). We subgrouped these trials by
Gamma nail design for reoperation (see Analysis 2.28), and found
the results of the two groups were not statistically significantly dif-
ferent from each other (test for interaction: two tail z-test = 0.347).
Operative details
Most trials reporting length of surgery indicated that there was no
difference or no significant difference between the two implants for
this outcome (Bridle 1991; Butt 1995;Goldhagen 1994;Hoffman
1996; Leung 1992; Kukla 1997; Kuwabara 1998; Marques Lopez
2002; Mott 1993; Radford 1993). Five trials, however, found in-
creased operating times for the Gamma nail (Ahrengart 1994;
Benum 1994; Haynes 1996; O’Brien 1995; Ovesen 2006). Con-
versely, Adams 2001 and Park 1998 reported a significant reduc-
tion in operating times for the Gamma nail. This probably ap-
plied also to Papasimos 2005. Data for Leung 1992 which also
showed a significant reduction in operating times for the Gamma
nail were removed from the analysis as they were inconsistent
with the statements in the text. In two studies (Ahrengart 1994;
Goldhagen 1994) the results were split up by intertrochanteric,
where the mean operation time was greater in the Gamma nail
group, and subtrochanteric fractures, where it was less. In expla-
nation, Goldhagen 1994 referred to a significant learning curve
for the Gamma nail in contrast to the extensive experience with
the SHS. It is unclear whether this effect of fracture type applies
generally but, irrespective of this observation, the meta-analysis of
length of surgery is limited because of the lack of data. Results of
the six trials (see Analysis 2.1) providing data for length of surgery
show considerable heterogeneity (chi² = 34.80, P < 0.00001; I² =
85.6%). It is also likely that the individual patient data for this out-
come, and indeed for other continuous outcome measures given
below, do not conform to a normal distribution. Although the
data from Kukla 1997 have been presented, Kukla 1997 consid-
ered the distribution pattern warranted a log transformation be-
fore analysis and then found no statistically significant difference
in the results of the two groups.
There were no significant differences for blood loss or for transfu-
sion requirements reported in 12 studies (Adams 2001; Ahrengart
1994; Benum 1994; Bridle 1991; Butt 1995; Goldhagen 1994;
Guyer 1991; Kukla 1997; Kuwabara 1998; Mott 1993; O’Brien
1995; Papasimos 2005). Others (Haynes 1996; Leung 1992; Park
1998; Radford 1993) found a significantly lower blood loss for
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the Gamma nail, as did Fornander (Fornander 1994) in the two-
centre analysis for Ahrengart 1994. Michos 2001 also reported a
lower blood loss for the Gamma nail group but did not indicate
if this was a statistically significant result. One study (Hoffman
1996) found an increased blood loss for the Gamma nail. Whilst
data from five studies (Adams 2001; Kukla 1997; Leung 1992;
O’Brien 1995;Ovesen 2006) are shown in Analysis 2.2, the lack of
available data from other trials means that no firm conclusion can
be drawn. The significant heterogeneity of the pooled results (chi²
= 8.31, P = 0.08; I² = 51.9%) can be attributed to the inclusion
of the more extreme results of Leung 1992; removal of these re-
veals the more homogenous results of the other three trials (chi² =
0.71, P = 0.87; analysis not shown). The three trials (Adams 2001;
Ovesen 2006; Utrilla 2005) reporting the numbers of people re-
ceiving blood transfusion had significantly heterogeneous results
(chi² = 9.77, P = 0.008); when pooled these showed no significant
difference between the two groups (see Analysis 2.3).
Seven studies reported radiographic screening times. Goldhagen
1994, Marques Lopez 2002 and Papasimos 2005 reported that
the increased time for the Gamma nail did not reach statistical
significance, whereas Leung 1992 and Utrilla 2005 reported a
significant decrease for the Gamma nail and two studies (Hoffman
1996;O’Brien1995) showed a significant increase. Again, drawing
conclusions from the pooling of the limited data available is not
possible (see Analysis 2.4) and not done in view of the very major
heterogeneity (chi² = 130.84, P < 0.00001; I² = 97.7%), with
Leung 1992 and Utrilla 2005 reporting a different effect direction
than the other two studies. While we conjecture that the results for
Leung 1992 may reflect the disparate experience of the surgeons
performing the two operations in this trial, this probably does not
apply to Utrilla 2005.
Fracture fixation complications
The outcomes shown are direct complications regarding the im-
plant. Pooled data from 18 trials shows the incidence of operative
fracture of the femoral diaphysis is significantly increased when
the Gamma nail is used (see Analyses 2.5: 27/1351 versus 6/1379;
RR 3.02, 95% CI 1.51 to 6.03). No trend in the incidence of this
outcome was observed when the trials were arranged by date of
publication. When the trials were subgrouped (see Analysis 2.6)
according to the trial report of surgeon’s experience with the de-
vices used, the test of interaction showed no statistically significant
difference (two tail z-test = 0.662) in results of the trials where
the surgeons were reported to be experienced with the devices and
those trials where either no information was provided or a lack of
prior experience was reported.
Subsequent fracture of the femur around the implant occurred in
35 cases of Gamma nailing but in only two cases of SHS fixation
(see Analysis 2.7: 35/1332 versus 2/1341; RR 5.23, 95% CI 2.46
to 11.14).
Pooled data for cut-out of the implant from the femoral head
from 20 trials showed no difference between implants (seeAnalysis
2.8: 46/1334 versus 41/1361; RR 1.15, 95% CI 0.76 to 1.72).
Analysis 2.9 shows the trials subgrouped by reported experience
of surgeons with the devices: there was no statistical significant
difference between the two subgroups (test for interaction: two
tail z-test = 0.745). The next analysis (2.10) shows the very similar
pooled results when the overall denominators are applied. Where
reported, there was also no difference in the incidence of non-
union (or non healed fractures) (see Analysis 2.11), or time to
union or for fracture healing (no analyses shown).
The outcome ’all technical complications of fixation’ comprised
the complications detailed above and any additional major com-
plications of fracture healing such as detachment of the plate from
the femur, re-fracture proximal to the implant, non-union of the
fracture or avascular necrosis. Data for this outcome were avail-
able for all studies except Pahlpatz 1993. This result confirmed
the greater risk of fracture healing complications for the Gamma
nail with overall figures of 118/1420 for the Gamma nail versus
60/1451 for the sliding hip screw (seeAnalysis 2.13: RR 2.00, 95%
CI 1.48 to 2.69; 21 trials).
Fracture of the femur was the main reason for a significantly in-
creased reoperation rate for the Gamma nail (see Analysis 2.14,
pooled results from 18 studies: 86/1320 versus 52/1345; RR 1.66,
95% CI 1.19 to 2.31).
Wound infection (presented as either any infection or deep wound
infection) and, when reported, wound haematoma showed no sig-
nificant difference between the two implants as shown in Analysis
2.16.
Post-operative complications
From the data available, there is not a statistically significant differ-
ence between implants for the complications of pneumonia (nine
studies: see Analysis 2.17), pressure sores (five studies: see Analy-
sis 2.18), thromboembolic complications (12 studies: see Analysis
2.19), and any medical complications other than wound infection
or haematoma (six studies: see Analysis 2.20).
With the exception of Michos 2001, all studies reporting hospital
stay stated that there were no differences or no significant differ-
ences in this outcome between the two implants (Ahrengart 1994;
Benum 1994; Bridle 1991; Butt 1995; Goldhagen 1994; Haynes
1996; Hoffman 1996; Kukla 1997; Leung 1992; Marques Lopez
2002; O’Brien 1995; Ovesen 2006; Papasimos 2005; Radford
1993). This is supported by the limited data available (Hoffman
1996; Kukla 1997; Leung 1992; O’Brien 1995; Ovesen 2006) for
pooling (see Analysis 2.21). Michos 2001 reported a shorter hospi-
talisation time for the Gamma nail group (mean value: 12 versus
14.5 days) but did not indicate if their finding was statistically
significant.
Anatomical restoration (see Analysis 2.22)
Six studies reported on limb shortening. Ahrengart 1994 and
Hoffman 1996 reported that there was no overall difference, and
two studies (Kukla 1997; Leung 1992) reported the same for the
numbers of people with over two centimetres of shortening. Guyer
1991 reported the numbers of patients with more than one cen-
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timetre of shortening. The results in favour of the Gamma nail
group are dominated by the results of the latter trial in the pooled
results of data from just three of the five trials.Utrilla2005 reported
no statistically significant difference between the twogroups (mean
shortening: 4.5 mm versus 3.2 mm; P = 0.35).
Data for varus deformity (expressed as angulation greater than 10
degrees, malunion or deformity) provided by five studies report-
ing this outcome, showed no statistically significant difference be-
tween the two groups.
External rotation deformity was reported by two studies (
Kuwabara 1998; Leung 1992), which found no difference between
the two groups.
Final outcome measures
Mortality data measured from between 3 and 12 months were
presented in 16 studies. No data were available in Benum 1994
who reported a 16% mortality at six months with no difference
between the two groups, nor for Kuwabara 1998 and Park 1998
which did not refer to this outcome. Michos 2001 andMott 1993
only reported on peri-operative mortality. Papasimos 2005 only
reported on hospital mortality (2 versus 1). The values for indi-
vidual studies which seemed independent of the length of follow
up ranged from 4% (Goldhagen 1994; Ovesen 2006) to 34% (
Bridle 1991; Marques Lopez 2002). Analysis 2.23 clearly shows
no significant difference in mortality between the two implants
(209/1136 versus 228/1170; RR 0.95, 95%CI 0.81 to 1.12). The
potential effect of selection bias (testing a post-hoc hypothesis that
there would be a tendency to place more frail and ill patients in the
SHS group) was investigated by subgrouping the data according
to allocation concealment. Analyses based on Cochrane grades (A,
B or C) have been presented (see Analysis: 2.24). While there was
a trend to a higher mortality in the trials with adequate allocation
concealment, a test of interaction between these trials and those
with no concealment of allocation was not statistically significant
(two tail z-test = 0.071). Thus, more evidence is required to prove
the selection bias proposed above.
Of the seven studies reporting post-operative pain (Ahrengart
1994; Goldhagen 1994; Guyer 1991; Hoffman 1996; Leung
1992; O’Brien 1995; Utrilla 2005), only Ahrengart 1994 reported
a significant difference between the two implants. In an abstract
report including participants at all five centres in Ahrengart 1994,
19%ofGammanail group participants comparedwith 6%of SHS
group participants complained of pain at the top of the greater
trochanter (P value reported as < 0.001). Pooling of pain outcome
data is hampered by the differentmethods of assessing residual pain
performed at different time intervals from injury. The numbers at
final follow up shown in the analyses were reported as persisting
lateral hip pain (Ahrengart 1994: two centre data), pain on walk-
ing (Guyer 1991), pain in hip and pain in thigh (Leung 1992),
thigh pain (Utrilla 2005) and unresolved pain in the subgroup of
patients with intertrochanteric fractures (Hoffman 1996). When
pooled, these data showed no significant difference between the
two implants in patients with residual pain (see Analysis 2.25).
The return to pre-fracture residential status, expressed in various
ways such as transfer to long-term care and stay in institutions,
as well as return to pre-fracture residence, was stated or implied
as being no different in nine trials (Ahrengart 1994 (two centre
data); Adams 2001; Benum 1994; Bridle 1991; Goldhagen 1994;
Hoffman 1996; O’Brien 1995; Pahlpatz 1993; Radford 1993).
Of the four trials providing data for pooling, Ahrengart 1994 re-
ported the numbers discharged to their pre-fracture residence for
two centres, whereas the results for the other three applied to resi-
dential status at six months. Data for Haynes 1996 were deduced
from pre-fracture and six-month follow-up residence (home or in-
stitutional). Kukla 1997 reported that eight out of 89 patients in
the study were in specialised nursing homes at the end of the study,
but did not split by treatment group. Neither the analysis for non-
return to previous residence for survivors nor that for overall non-
return including deaths showed a significant difference between
the two implants (see Analysis 2.26).
Measures of mobility varied between studies and were broadly
based on the numbers able to walk independently, the numbers re-
quiringwalking aids and those whowere bed or chair bound. Some
studies (Hoffman 1996;Marques Lopez 2002) further refined this
by ranking or scoring systems and recorded the difference in lev-
els of attainment between pre-fracture and post-fracture mobility.
Utrilla 2005 also presented a walking ability score. Pre-fracture
mobility was probably assessed in all studies and when reported,
was said to be comparable between implants groupswith the excep-
tion of Hoffman 1996 where the pre-fracture status was noted as
being better in the Ambi (SHS) group. Eleven studies (Ahrengart
1994; Benum 1994; Bridle 1991; Goldhagen 1994; Kukla 1997;
Kuwabara 1998; Marques Lopez 2002; O’Brien 1995; Ovesen
2006; Radford 1993; Utrilla 2005) found no difference in post-
operative mobility or changes in mobility. Hoffman 1996 was the
only study to use blinded assessment of mobility and reported
better mobility with the SHS in the early stages, but no difference
at 12 weeks. Although loss of mobility data were presented by a
histogram in Bridle 1991, these differed from results given in text.
The only data available for pooling were the numbers of trial par-
ticipants who could walk without, or with only limited, aids (or,
as presented in Analysis 2.27, the numbers with impaired walk-
ing) from seven studies (Adams 2001; Ahrengart 1994 (two centre
data); Guyer 1991; Kukla 1997; Leung 1992; Ovesen 2006; Park
1998), and a reduction in numbers attaining pre-fracture mobility
status (independent or aided) in Haynes 1996. This provides an
incomplete picture of mobility and no conclusion can be drawn
save the general impression that there is no difference in mobility
between the two implants.
Adams 2001 reported on the Harris hip score for the survivors at
one year, for which there was no difference between the groups.
Papasimos 2005 reported a higher Salvati andWilson score (based
on pain, walking, muscle power and motion, function; 0: worst
to 40: best) at one year for the nail group (mean: 33 versus 27; P
value not reported).
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None of the included trials reported costs or attempted an eco-
nomic evaluation.
Intramedullary hip screw (IMHS) versus the sliding hip screw
(SHS)
Five randomised trials (Baumgaertner 1998; Hardy 1998;
Harrington 2002; Hoffmann 1999; Mehdi 2000) compared the
IMHS with the SHS in 623 people with trochanteric fractures.
Very limited results were available for Mehdi 2000, which was
only reported in a conference abstract.
Operative details
Mean operating times in the IMHS group relative to those for
SHS group were less in two trials (Baumgaertner 1998; Hoffmann
1999), but greater in the other three. Pooled results from three
trials (Baumgaertner 1998; Hardy 1998; Harrington 2002) show
highly significant heterogeneity (P = 0.001; I² = 85.1%), and a
statistically non significant result when the random-effects model
is applied (see Analysis 3.1). The variation in the results may in
part reflect different definitions of this outcome. For instance,
Hoffmann 1999 reported the IMHS took on average six minutes
less operative time (72 versus 78 minutes) but the total anaesthetic
time was on average eight minutes longer for the IMHS (123
versus 115 minutes); neither of these differences were reported as
being statistically significant.
Pooled data from two studies (Baumgaertner 1998; Hardy 1998)
for operative blood loss were homogeneous and showed a statisti-
cally significant reduction (see Analysis 3.2: weighted mean differ-
ence -62.42 ml, 95%CI -98.56 to -26.28 ml) in the IMHS group.
Hoffmann 1999 andMehdi 2000 also reported lower mean values
for the IMHSgroup (380ml versus 400ml; 247ml versus 270ml);
the difference between the IMHS and SHS groups was indicated
as not being statistically significant for either trial. Themean num-
ber of units of red cells transfused was greater in the IMHS group
in Baumgaertner 1998, and less in Hardy 1998; pooled data us-
ing the random-effects model showed no significant difference be-
tween the two groups (seeAnalysis 3.3). Harrington 2002 reported
no statistically significant difference between groups in the pro-
portion of patients receiving transfusion (see Analysis 3.4: 18/50
versus 22/52; RR 0.85, 95% CI 0.52 to 1.39). Hoffmann 1999
reported a mean difference in pre and post-operative haemoglobin
of 1.95 gm/dl for the IMHS and 2.20 gm/dl for the SHS; the dif-
ference between the two groups was reported to be not statistically
significant.
Pooled data from two trials (Baumgaertner 1998; Harrington
2002) showed themean radiographic screening timewas about one
minute longer in the IMHSgroup (seeAnalysis 3.5: weightedmean
difference 1.15minutes, 95%CI 0.83 to 1.47minutes). Screening
time was slightly greater for the IHMS group in Hoffmann 1999,
but the difference was reported not to be statistically significant
(5.7 versus 5.4 minutes).
Fracture fixation complications
Pooled data as available for operative fracture of the femur, later
fracture of the femur, cut-out, non-union, plate detachment and
total fixation failure rate are shown in Analysis 3.6. Although twice
as many people with the IMHS had fracture fixation complica-
tions, including all of the intra-operative and later femur fractures,
the difference between the two groups did not reach statistical sig-
nificance (18/223 versus 9/224; RR 2.02, 95% CI 0.93 to 4.39).
Baumgaertner 1998 also reported an incorrectly assembled IMHS
aswell as two cases of delayed union, one in each group.Hoffmann
1999 reported that two cases in the SHS had loss of fracture reduc-
tion requiring re-fixation. These were the only reoperations within
this study and the complication of cut-out was not mentioned.
Mehdi 2000 referred to one peri-operative complication in the
IMHSgroup and three in the SHS group thatwere “directly related
to the procedure” but did not specify what these were. Complete
data for reoperation were unavailable for Baumgaertner 1998 but
there was mention of two SHS group participants who required
removal of painful hardware. Similar numbers of people (3 ver-
sus 4) had reoperations in Hardy 1998, mostly to remove painful
hardware (3 versus 2). Neither Harrington 2002 nor Mehdi 2000
reported reoperations.
Of the three trials (Hardy 1998; Hoffman 1996; Mehdi 2000)
reporting on wound infection, the only cases occurred in Mehdi
2000 (see Analysis 3.7). Antibiotic prophylaxis was used in all tri-
als except Mehdi 2000. Five wound haematomas, all in IMHS
patients, were reported for the trials of Baumgaertner 1998 and
Hardy 1998. Hoffmann 1999 reported eight wound haematomas
requiring puncture, three in the IMHS group and five in the SHS
group. Pooled data for haematoma showed no statistically signif-
icant difference between the two groups (see Analysis 3.7: 8/173
versus 5/172; RR 1.47, 95% CI 0.54 to 4.02).
Post-operative complications
These outcomeswere not reported inHarrington 2002 andMehdi
2000. Baumgaertner 1998 reported similar numbers of people in
the two groups who had a major medical complication but did
not provide separate data for specific medical complications. Both
Hardy 1998 and Hoffmann 1999 also observed similar numbers
of complications, with data for pneumonia, cardiac failure, urinary
tract infection, and thromboembolic complications, in each group.
Separate and combined outcome data presented in Analysis 3.8 are
consistent with these reports. There was no statistically significant
difference in the length of hospital stay between the two groups
in the three trials reporting this outcome (Baumgaertner 1998;
Harrington 2002;Hoffmann 1999): data were only available from
two trials (see Analysis 3.9).
Anatomical restoration
These outcomes were only reported in two trials (Hardy 1998;
Hoffmann 1999). Hardy 1998 reported that, for a subgroup of
64 patients who underwent radiographic evaluation at fracture
consolidation, there was a significantly reduced mean shortening
of the fractured leg in the IMHS group (see Analysis 3.10: mean
difference -0.70 cm, 95% CI -1.13 to -0.27 cm). Hoffmann 1999
reported that shortening of more than one centimetre occurred in
one person of each group. This study also stated that one IMHS
13Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
groupparticipant had a “relevant” rotational deformity of the limb.
Final outcome measures (see Analysis 3.11)
Mortality at one year (Baumgaertner 1998; Hardy 1998;
Harrington 2002) and around four months (Hoffmann 1999)
showed no significant difference between the two groups (54/221
versus 60/222; RR 0.91, 95% CI 0.67 to 1.24). In Baumgaertner
1998, both people with two fractures at different times who had
been allocated different implants for their second fracture died.
These people have been only counted once in the analysis.
Pain data at final follow up were given for hip and mid-thigh pain
for survivors at one year in Hardy 1998, and at final follow up
between four and 54 months for 105 trial participants (17 peo-
ple who died by three months, seven people with hardware fail-
ure and the two people with different implants were excluded) in
Baumgaertner 1998. Hoffmann 1999 reported on those with pain
on walking at the final follow up of a mean of 3.7 months. Pooled
results from these three trials showed no statistically significant
difference between the two groups (see Analysis 3.11: 38/132 ver-
sus 32/131; RR 1.17, 95% CI 0.79 to 1.75). Harrington 2002
and Mehdi 2000 did not report pain.
Data for failure to return to pre-fracture residential status were
available for three trials (Baumgaertner 1998; Harrington 2002;
Hoffmann 1999). Pooled results from these three trials showed no
difference between the two groups in survivors failing to return
home (36/127 versus 32/129; RR 1.16, 95% CI 0.78 to 1.73).
A similar result emerges for the combined outcome of failure to
return home and death (see Analysis 3.11). Hardy 1998 included
residential status in an assessment of social functioning mostly
based on the patient’s level of independence. Similar numbers of
people in both groups (10/26 versus 12/24) had dropped at least
one level of social function in results for the subgroup of 50 people
who had not returned to their pre-fracture nursing home.
Baumgaertner 1998 reported on those returning to pre-fracture
mobility with no difference between groups (see Analysis 3.11).
At around four months, Hoffmann 1999 found no difference be-
tween the two groups in the use of walking aids, or in the num-
bers unable to walk for one hour, with no statistically significant
difference between the two groups (16/45 versus 19/43; RR 0.80,
95% CI 0.48 to 1.35). However, before discharge most (51/56)
of the IMHS patients were fully weight bearing whereas under
half of the SHS patients were (22/54). Blindly assessed mobility
scores and use of assistive devices were reported in Hardy 1998.
Mobility scores for the IMHS group were significantly better at
one and threemonths, and although the differences betweenmean
mobility scores did not achieve statistical significance at 6 or 12
months, walking ability outside the home remained better in the
IMHS group. Hardy 1998 noted that while this could relate to the
lower amount of leg shortening in the IMHS group, the enhanced
mobility had not had a major impact on other functional out-
comes. Hoffmann 1999 also used the Merle d’Aubigne score with
no significant difference found between groups; an unsatisfactory
score was attained by two IMHS patients and three SHS patients.
Mehdi 2000 considered that their study showed that functional
outcome of the IMHS is as good as the SHS but provided no
supporting data.
Baumgaertner 1998 provided data for hospital charges which
showed that on average those for the IMHS group were $6000
(USA) more. This difference was reported not to be statistically
significant. It was unclear how the hospital charges were derived.
Proximal femoral nail (PFN) versus sliding hip screw (SHS)
This comparison was evaluated by three trials (Pajarinen 2005;
Papasimos 2005; Saudan 2002) in 394 people with trochanteric
hip fractures.
Operative details
Both Pajarinen 2005 and Papasimos 2005 reported a statistically
significantly higher median length of surgery for the PFN group
(respectively: 55 versus 45 minutes, reported P = 0.011; 71 versus
59 minutes, reported P < 0.05), whilst Saudan 2002 found no dif-
ference between the two groups (see Analysis 4.1: mean difference
-1.00 minute, 95% CI -9.14 to 7.14 minutes). Blood losses and
transfusion were similar for both groups of Pajarinen 2005 (see
Analysis 4.2). Papasimos 2005 reported no statistically significant
difference between groups for operative blood loss (265 ml ver-
sus 282.4 ml; reported P > 0.05). Though fewer people received
transfusion in the PFN group of Saudan 2002 (see Analysis 4.3:
55/100 versus 72/106; RR 0.81, 95% CI 0.65 to 1.01), there was
no difference between the two groups in themean number of units
of blood transfused (1.5 versus 1.7 units). Saudan 2002 found the
mean radiographic screening time was about one minute longer
in the PFN group (see Analysis 4.4), while Papasimos 2005 found
no significant difference (0.26 versus 0.21 minutes; reported P >
0.05).
Fracture fixation complications (see Analysis 4.5)
There were no intra-operative or later fractures of the femur. Sim-
ilar numbers of cut-out occurred in the two groups (see Analysis
4.5) and there was one case of non-union in the SHS group of
Papasimos 2005. The mean times to fracture “consolidation” were
similar in the two groups: Papasimos 2005 (3.2 versus 3.4months)
and Saudan 2002 (4.6 versus 4.8 months). There was a statisti-
cally non-significant tendency for an increased fixation failure rate
(11/194 versus 6/200; RR 1.86, 95% CI 0.71 to 4.85) and reop-
eration rate (13/194 versus 7/200; RR 1.90, 95%CI 0.78 to 4.62)
for the PFN.No details of the reoperations were given in Pajarinen
2005. In Papasimos 2005, re-operation entailed implant removal
in 5 cases (4 versus 1), a hip prothesis in two cases (1 versus 1) and
replacement by a Gamma nail and bone graft for the single case
of non-union in the SHS group. Those of Saudan 2002 involved
implant removal and debridement in four cases (3 versus 1) and a
hip prosthesis in the other four cases (3 versus 1).
There were no significant differences in the reported incidences of
wound infections and haematomas (see Analysis 4.6). Papasimos
2005 also reported that one person in the SHS group had delayed
wound healing, and Saudan 2002 reported that wound healing
complications occurred in similar numbers in the two groups (10
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versus 11).
Post-operative complications (see Analysis 4.7)
As shown in Analysis 4.7, there were no differences between the
two groups in the incidence of pneumonia, pressure sores, deep
vein thrombosis or pulmonary embolism.Over a quarter of partic-
ipants had an urinary tract infection in Sadowski 2002. Although,
there were more people in the PFN group of Saudan 2002 with
urinary tract infection (34/100 versus 23/106; RR 1.57, 95% CI
1.00 to 2.47), there was no statistically significant difference in the
overall numbers of people with any medical complication (52/100
versus 49/106; RR 1.12, 95% CI 0.85 to 1.49) in this trial. There
were no statistically significant differences between the two devices
in the mean lengths of hospital stay for all three trials (see Analysis
4.8; for Papasimos 2005, the mean times were 8.8 versus 9.9 days,
reported P > 0.05).
Anatomical restoration
Clinical measures such as limb shortening were not reported by
any of the trials. Papasimos 2005 reported two cases ofmalrotation
and two cases of varus or valgus deformity in each of the nail and
SHS groups. Based on X-ray results, Pajarinen 2005 reported no
difference in the femoral neck-shaft angles or themean shortening
of the femoral shaft (2.5 mm versus 4.7 mm; reported P = 0.081),
but greater mean shortening of the femoral neck for the SHS cases
(1.3 mm versus 6.1 mm; reported P = 0.003).
Final outcome measures (see Analysis 4.9)
Papasimos 2005 only reported on hospital mortality, with one in
each group. Pajarinen 2005 reported morality at four months and
Saudan 2002 at one year with no statistically significant difference
between the two groups in either trial. Neither Pajarinen 2005
nor Saudan 2002 found a statistically significant difference in res-
idential status at final follow up, either in terms of the numbers of
people in institutional care (Saudan 2002) or failing to return to
the same residential status (Pajarinen 2005). The combined out-
comes of nursing home or dead by one year, and failure to regain
previous residential status, seriously ill or dead by four months
also showed no significant differences between the two groups (see
Analysis 4.9). Papasimos 2005 reported there was no difference
between the two groups in return to pre-fracture level of indepen-
dence or ambulation.
Pajarinen 2005 found that significantly fewer PFN group partic-
ipants failed to recover their pre-fracture mobility (10/42 versus
19/41, RR 0.51, 95% CI 0.27 to 0.97); however, this result is
not robust as shown by the combined outcome of failure to re-
cover previous mobility or dead at four months (RR 0.67, 95%
0.38 to 1.17). For survivors available at one year in Saudan 2002,
there were no statistically significant differences noted between
groups for pain (mean scores: 1.36 versus 1.31), mobility (mean
scores: 4.94 versus 5.07) or social function (mean scores: 2.88 ver-
sus 2.65). Papasimos 2005 reported the mean Salvati and Wilson
scores (based on pain, walking, muscle power and motion, func-
tion; 0: worst to 40: best) at one year were comparable for the two
groups (30 versus 27; P value not reported).
Targon PF nail versus the sliding hip screw (SHS)
One study (Giraud 2005) compared the Targon PF nail with the
sliding hip screw in 60 people with intertrochanteric fractures.
Operative details
The mean length of surgery was 34 minutes for the nail versus 42
minutes for the SHS. The mean operative blood loss was 410 ml
for the nail versus 325 ml for the SHS (reported P = 0.07; not
significant).
Fracture fixation complications (see Analysis 5.1)
Giraud 2005 reported three cases of cut-out in the Targon PF
group against two in the SHS group. All cases of cut-out were
reoperated.No other fracture fixation complicationswere reported
and there were no wound infections.
Anatomical restoration
This was not reported in Giraud 2005.
Post-operative complications (see Analysis 5.3).
There was one person with deep vein thrombosis and one with
pneumonia (pulmonary congestion) in the Targon PF group. No
medical complications were recorded in the SHS group. Mean
hospital stay was 11 days for both groups.
Final outcome measures
Mortality at three months was similar for both groups in Giraud
2005 (see Analysis 5.4).
Giraud 2005 reported the mean time to walking was 20 days
for the nail versus 25 days for the SHS (statistical significance
not reported). The mean Harris hip scores (0: worst to 100: best
function) were similar in the two groups (60 versus 59).
Mini-invasive intramedullary nail versus the sliding hip screw
(SHS)
One study (Dujardin 2001) compared this experimental implant
with the sliding hip screw in 60 people with intertrochanteric
fractures.
Operative details (see Analysis 6.1)
The mean length of surgery, operative and total blood loss (in-
cluding the blood loss into wound drains) were all significantly
less in the nail group. No participants of the nail group required
transfusion, whilst on average 1.5 units of blood per participant
were transfused in the SHS group (reported P < 0.001). Radio-
graphic screening time was equal in both groups.
Fracture fixation complications
Dujardin 2001 reported an absence of early post-operative compli-
cations but did not explicitly indicate if this included cut-out and
other fracture fixation complications aside from further surgery.
All fractures eventually united with no difference between the two
implants in the time taken for fracture healing (see Analysis 6.2).
Post-operative complications
As stated above, Dujardin 2001 reported an absence, in the initial
post-operative period, of early post-operative complications which
included thromboembolism and sepsis. Hospital stay averaged 10
days in both groups but, when the length of stay in convalescence
was included, participants of the nail group returned home earlier
(46 versus 68 days; reported P < 0.05) than those in the SHS
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group. The numbers of participants in each group returning home
were not given.
Anatomical restoration
Though some measures of anatomical restoration were presented,
leg shortening results and full data for varus deformity were not
provided by Dujardin 2001.
Final outcome measures
Mortality at one and six months was the same for both groups,
being two and six participants of each group at the two time periods
(see Analysis 6.3 for the six-months mortality data).
The intermediate functional outcomes of the time to painless mo-
bilisation and the time to effective weight bearing (see Analysis
6.4) were both statistically significantly reduced for the nail group.
Various aspects of hip function, including pain, power and mobil-
ity, were measured using the Salvati and Wilson score. The mean
pain score was better for the nail group at six weeks (reported P
< 0.01) but similar thereafter. No significant difference was noted
for functional deficit at follow up. However, the hip power and
motion score was reported to be significantly better in the nail
group at six months (reported P < 0.05). Early knee mobility was
more reduced in the nail group at six weeks (27 versus 10 degrees;
reported P < 0.05), but at six months there was no residual deficit
in either group.
Kuntscher-Y nail versus the sliding hip screw (SHS)
The only randomised trial identified (Davis 1988) compared the
Kuntscher-Y nail with the sliding hip screw (SHS) in 230 people
with intertrochanteric fractures.
Operative details
No data for these outcomes were reported.
Fracture fixation complications (see Analysis 7.1)
The most common complication reported was cut-out (12/116
versus 17/114; RR 0.69, 95% CI 0.35 to 1.39). In addition there
was breakage or bending of the implant for two Kuntscher nails
and one SHS, implant uncoupling for one Kuntscher nail, and
“implant loosening” for one Kuntscher nail and four sliding hip
screws. The overall fracture fixation complication rate was not sta-
tistically different between the two groups (16/116 versus 22/114;
RR 0.71, 95% CI 0.40 to 1.29). Four participants of each group
required a reoperation. There were no statistically significant dif-
ferences between the two groups in superficial or deep wound in-
fection (see Analysis 7.2).
Post-operative complications (see Analysis 7.3)
The complications reported in Davis 1988 were urinary infec-
tion, chest infections, thromboembolic complications and pres-
sure sores. There was no significant difference in incidence of these
complications between the two implants, although pressure sores
tended to be more prevalent after the SHS.
Anatomical restoration (see Analysis 7.4)
There was a significant increase in the number of trial partici-
pants with more than 2.5 cm of shortening after Kuntscher nailing
(17/48 versus 9/54; RR 2.13, 95% CI 1.05 to 4.31). There was
no significant difference between the two groups in the incidence
of varus angulation (defined as >15 degrees) or external rotation
deformity (defined as >15 degrees).
Final outcome measures (see Analysis 7.5)
There was no statistically significant difference between the two
groups in one yearmortality (48/116 versus 41/114;RR1.15, 95%
CI 0.83 to 1.60) nor, for the survivors, in the numbers who failed
to regain their pre-fracture level of mobility (40/68 versus 37/73;
RR 1.16, 95% CI 0.86 to 1.57). The combined outcome (failure
to regain mobility or death) again showed no significant difference
between the two groups. However, for survivors with a good pre-
fracture mobility, more people in the SHS group regained their
mobility (loss in mobility: 20/32 versus 10/28; RR 1.75, 95% CI
0.99 to 3.08; subgroup analysis not shown). Davis 1988 reported
without data that there were no differences between the groups in
hip pain or loss of hip movement at one year.
Intramedullary nails (Gamma or PFN) versus the Medoff slid-
ing plate
Miedel 2005 compared the Gamma nail with the Medoff sliding
plate in 217 people and Ekstrom 2007 compared the proximal
femoral nail (PFN) with the Medoff sliding plate in 203 people.
Both studies included people with either an unstable trochanteric
fracture or a subtrochanteric fracture.
Operative details
Neither trial found a statistically significant difference between the
two groups in the mean length of surgery: Miedel 2005 reported
61 minutes for the Gamma nail versus 65 minutes for the Medoff
plate; the data for Ekstrom 2007 are shown in Analysis 8.1. Both
trials reported statistically significantly lower blood losses in the
intramedullary nail groups: Miedel 2005 reported 276 ml for the
Gamma nail versus 402 ml for the Medoff plate (reported P <
0.01); the data for Ekstrom 2007 are shown in Analysis 8.2 (mean
difference -297.00 ml, 95% CI -414.33 to -179.67 ml). Miedel
2005 reported no statistically significant difference in the mean
volume of blood transfused (864 ml versus 800 ml), and Ekstrom
2007 reported, without confirmatory data, no difference between
the two groups in the numbers of blood transfusions. The mean
radiographic screening time was two minutes greater in the PFN
group of Ekstrom 2007 (see Analysis 8.3).
Fracture fixation complications
All four cases of operative fracture of the femur occurred in the
nail groups of the two trials (see Analysis 8.4). There were no later
fractures of the femur in either study. There were no statistical
significant difference between groups for cut-out (see Analysis 8.6:
9/214 versus 6/206; RR 1.44, 95% CI 0.52 to 4.01), non-union
(see Analysis 8.7) or technical complications of fixation (see Anal-
ysis 8.8: 14/214 versus 11/206; RR 1.23, 95% CI 0.57 to 2.65).
Not included in Analysis 8.8 was the late diagnosis of a stress
fracture in the femoral neck resulting in revision to a total hip
replacement for one person in the Medoff plate group of Miedel
2005. Miedel 2005 also reported three cases of excessive medial
displacement of the femur requiring revision surgery in theMedoff
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group. These cases contributed to the greater, but not statistically
significantly greater, number of reoperations in the Medoff group
in Miedel 2005 (see Analysis 8.9: 3/109 versus 9/108; RR 0.33,
95% CI 0.09 to 1.19). Conversely, Ekstrom 2007 reported a sig-
nificantly higher reoperation rate in the PFN group (see Analysis
8.9: 9/105 versus 1/98; RR 8.40, 95% CI 1.08 to 65.09).
Data for any type of wound infection from the two trials were
not pooled due to significant heterogeneity (I² = 83.9%); there
was a trend to less infection in the Gamma nail group of Miedel
2005, and conversely a trend to greater infection in the PFN group
of Ekstrom 2007 (see Analysis 8.10). There was no statistically
significant differences between the two groups in deep wound
infection (data from Miedel 2005; see Analysis 8.11) or wound
haematoma (data from Ekstrom 2007; see Analysis 8.12).
Post-operative complications
Miedel 2005 reported similar numbers of survivors in the two
groups with severe general complications (cardiac, pulmonary,
thromboembolic or cerebrovascular) at four months (see Anal-
ysis 8.13). There was no mention of medical complications in
Ekstrom 2007. Miedel 2005 reported mean length of stay in the
orthopaedic ward was six days for both groups. Ekstrom 2007
reported the mean length of hospital stay was 12 days with no
difference between the two groups.
Anatomical restoration
This was not reported in either Miedel 2005 or Ekstrom 2007.
Final outcome measures
Both studies found no statistical difference between groups in
mortality at one year (see Analysis 8.14: 39/214 versus 49/206;
RR 0.77, 95% CI 0.53 to 1.12).
Miedel 2005 reported there were no significant differences be-
tween the two groups in pain, hip movement or walking ability
scores assessed in the Charnley score for hip function, nor in ac-
tivities in daily living (Katz) or health related quality of life scores
(EuroQol) in those participants without severe cognitive dysfunc-
tion. Ekstrom 2007 reported, without supporting data, there was
no statistically significant difference between the two groups in
pain or return home at one year from injury. Similarly, there were
no statistically significant differences between the two groups of
Ekstrom 2007 for four measures of mobility at one year: inability
to walk 15metres, inability to rise unassisted from a chair, inability
to climb a curb, and need for walking aids other than one crutch
(see Analyses 8.15 to 8.19).
Femoral nails versus condylar screw or blade plates
Two trials compared a femoral nail with either a dynamic condylar
screw (DSC) plate (Sadowski 2002) or a 90-degree blade plate (
Pelet 2001) for specific types of lower trochanteric fracture, in-
cluding reversed fracture lines and transverse fractures at the level
of the lesser trochanter. Since the fracture types, as well as the im-
plants being compared, are similar these two trials are considered
together, though presented as separate subcategories in the anal-
yses. These fractures are uncommon and the trial populations in
the two trials were small with 39 participants in Sadowski 2002
and 26 participants in Pelet 2001.
Operative details
In Sadowski 2002, the mean length of surgery for the proximal
femoral nail (PFN) group was under half that of the DSC group
(see Analysis 9.1: 82 versus 166 minutes; mean difference -84.00
minutes, 95%CI -115.71 to -52.29 minutes). A similar difference
in mean operation times between the Gamma nail and blade plate
groups was found in Pelet 2001 (86 versus 169 minutes, reported
P < 0.05).
Significantly fewer participants of the PFN group of Sadowski
2002 received blood transfusion (see Analysis 9.2: 11/20 versus
18/19; RR 0.58, 95% CI 0.39 to 0.88). The mean number of
units of blood transfusedwas also less in the PFNgroup (1.5 versus
3.0 units). Pelet 2001 reported the mean operative blood loss was
lower in the Gamma nail (550 ml versus 1150 ml, reported P <
0.05).
The mean radiographic screening time was around four minutes
for both implants of Sadowski 2002 (see Analysis 8.3).
Fracture fixation complications
In Sadowski 2002, no cases of implant failure were reported in
the PFN group, whereas five cases of cut-out of the implant from
the femoral head and one breakage of the implant occurred in the
DSC group. There was one case of non-union in each group. Six
reoperations were undertaken in the DSC group; these involved
implant removal and debridement in five cases and a hip prosthesis
in one case. The two “minor” reoperations undertaken to remove
the distal locking screw in order to change the PFN to a dynamic
construct are not counted in the analysis. This is because of the
minimal nature of these operations, which are often undertaken
under local anaesthesia as a day case.
One cut-out and one operative fracture of the femur occurred in
the Gamma nail group of Pelet 2001. In the blade plate group,
there was one operative fracture of the femoral neck, two non-
unions, three cases of avascular necrosis and one plate breakage.No
one in either group had a reoperation because of “low functional
demand”.
Overall, there were significantly fewer fracture healing complica-
tions in the nail group (see Analysis 9.7: 3/31 versus 13/30; RR
0.23, 95% CI 0.07 to 0.71). The pooled results for reoperations
were not statistically significant (seeAnalysis 9.8: 0/33 versus 6/32;
RR 0.07, 95% CI 0.00 to 1.22).
Deep wound infection was reported in one case in the DSC group
of Sadowski 2002.Wound healing complications occurred in sim-
ilar numbers in the two groups (3 versus 2) for this trial. Pelet
2001 did not report this outcome.
The mean time to fracture “consolidation” was longer in the PFN
group of Sadowski 2002 (6.5 versus 5.0 months); this difference
was reported as not statistically significant. Conversely, Pelet 2001
reported that the mean time to fracture consolidation was 4.2
months in the Gamma nail group versus 6.3 months in the plate
group (reported P < 0.05).
Post-operative complications
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For both studies, there were no significant differences between the
two groups in the numbers of participants with medical compli-
cations, either overall (see Analysis 9.14: 16/33 versus 13/32; RR
1.20, 95% CI 0.69 to 2.06) or, where these occurred, for specific
complications (see Analyses 9.10 to 9.13).
In Sadowski 2002, PFN group participants stayed on average five
fewer days in hospital (see Analysis 9.15: 13 versus 18 days; mean
difference -5.00 days, 95% CI -8.60 to -1.40). The average stay in
acute hospital was also reported as less for the nail group of Pelet
2001: 33 versus 44 days.
Anatomical restoration
This outcome was not reported in Sadowski 2002. Pelet 2001
reported that themean external rotation deformity was the same in
both groups. Flexion was 112 degrees in the nail group compared
with 96 degrees in the blade plate group (reported P = 0.05).
Final outcome measures
Both trials found no difference between the two groups in mor-
tality at one year (see Analysis 9.16). Sadowski 2002 also found no
difference in nursing home residence.
Functional scores (for pain, mobility and social function) at one
year were only provided for survivors without fracture healing
complications in Sadowski 2002; no statistically significant differ-
ences between the two groups were reported for these outcomes.
There were no statistically significant differences between the two
groups of Pelet 2001 in the numbers of people with residual pain
(3/13 versus 5/13) or requiring walking aids (6/13 versus 10/13)
at one year (see Analyses 9.17 and 9.20 respectively).
D I S C U S S I O N
Four types of femoral nails (Gamma, IMHS, PFN and Targon
PF) versus the sliding hip screw (SHS)
Pooling of the results of the comparisons of four nails (Gamma,
IMHS, PFN and Targon PF) versus the SHS showed a consistent
picture of higher rates of operative and later fracture of the femur,
and technical complications of fixation for femoral nails. In the
absence of evidence showing a superiority in functional and longer
term outcomes (follow up was generally 12 months or less) for
these nails, the increased risk of later femur fracture and reopera-
tion are key findings. Pooled results show that using these nails re-
sults in one extra later femur fracture in every 50 trial participants
(95% CI 1 in 33 to 1 in 100) and one extra reoperation in every
50 trial participants (95% CI 1 in 25 to 1 in 100). These results
are dominated by the weight of evidence available for the Gamma
nail.
Gamma nail versus the sliding hip screw
The initial reports of the use of the Gamma nail were simple re-
views of the implant that suggested its potential value. However,
these studies observed that femoral fracture was the main compli-
cation and this has been confirmed by results from randomised
trials in both the original version of this review and subsequent
updates. This complication is themain difference between the two
implants. Inadequate reaming and the use of excessive force on nail
insertion have been implicated as the cause of femoral fracture.
More recent reports of the Gamma nail have emphasised the need
to over-ream the femur by 2 mm, ream the greater trochanter to
17 mm and never to hammer the nail into place. In addition, sev-
eral modifications to the design of the Gamma nail and its instru-
mentation have occurred since its introduction. The most recent
version of the nail is the Trochanteric Gamma nail (Gamma III).
However, it remains uncertain whether such attention to operative
technique or changes to the design of the implant will reduce the
risk of later fracture of the femur. The most recent study (Ovesen
2006) still reported an increased incidence of fracture healing com-
plications and re-operations with the nail. These technical issues
and the use of a modified nail require further investigation.
The problem of a learning curve for a new implant may jeopar-
dise effective assessment within randomised trials. Thus it may be
that some of the complications experienced with the Gamma nail
would not have occurred had the surgeons been as familiar with
the operative technique as theywere with the SHS, themore estab-
lished implant. Four trials (Benum 1994; Goldhagen 1994; Guyer
1991; Hoffman 1996) specifically referred to a learning curve for
Gamma nail insertion, and a further trial (O’Brien 1995) men-
tioned a performance bias with regards to surgery. Many trials,
however, tried to overcome this by restricting the number of sur-
geons, or using only those experienced in intramedullary fixation.
Analysis of those trials which stated that operations were only per-
formed by surgeons experienced with the two devices, in compari-
son with the other trials, failed to show any statistically significant
difference in outcome measures (specifically cut-out and operative
fracture) between these two groups.
Later fracture below the nail is probably the most significant dif-
ference between these two implants. This complication, although
rare is devastating for the patient requiring either major revision
surgery or a prolonged period of traction and bed rest. Whilst op-
erative fracture of the femur is more common with the Gamma
nail, this complication may not require any specific treatment and
was generally treated by ensuring the Gamma nail was locked dis-
tally at surgery or using a longer Gamma nail. The other technical
complication of cut-out of the lag screw from the femoral head
showed no significant difference between the two implants. Nei-
ther was there any difference in wound infection or haematoma
with the Gamma nail.
There is no substantial difference in mortality between the two
implants. Although incomplete outcome data for functional out-
comes remains a problem for the evaluation of the Gamma nail,
the limited data available formorbidity, as assessed by residual pain
and change in function, suggest there is no important difference.
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No definite conclusions of effect can be drawn from the limited
and heterogeneous data available for the operative details of length
of surgery, operative blood loss and length of radiographic screen-
ing time. The inconsistency between studies for the last two out-
comes may in part reflect the known disparity in the experience
of the surgeons performing the two operations in Leung 1992. Ir-
respective of this, the main differences between the implants con-
tinue to be related to operative and later femur fractures.
We were unable to obtain adequate information from the included
studies to make any distinction in outcome for unstable versus
stable trochanteric fractures. The Gamma nail may have advan-
tages for selected fracture types such as subtrochanteric fractures
and trochanteric fractures with a reversed obliquity fracture line.
These fractures have a high incidence of fixation failure when
treated with an extramedullary fixation implant such as the SHS
(Haidukewych 2001), and intramedullary fixation for such frac-
tures is often recommended. Further studies are required to clar-
ify if the Gamma nail or another intramedullary nail is superior
for these fractures. We have been unable to obtain additional data
from those studies which included subtrochanteric fractures about
the outcomes for these patients. The more recent introduction of
the long Gamma nail for subtrochanteric fractures again requires
further evaluation.
Intramedullary hip screw (IMHS) versus the sliding hip screw
Only limited conclusions can be drawn given the smaller number
of patients studied in the five included studies. Nonetheless the
eight cases of operative fracture of the femur and the four cases of
later fractures below the implant all occurred in the IMHS group.
This suggests that this implant has similar characteristics to those
of the Gamma nail. These complications, particularly that of later
fracture below the implant, may be technically demanding to treat
and will outweigh the potential benefits claimed for the IMHS
of a reduced operative time and operative blood loss. Neither of
these claims have been demonstrated within the included studies.
Post-operative complications, mortality and functional outcomes
were similar in both groups. There was some indication of en-
hanced early regain of mobility in the IMHS group inHardy 1998
and earlier weight-bearing for this group in Hoffmann 1999, but
there was little indication of a sustained functional effect and the
slight tendency to more long term pain in the IMHS group in
Baumgaertner 1998 and Hardy 1998 is of concern.
Proximal femoral nail (PFN) versus the sliding hip screw
Pooled results of the three trials for this comparison showed no
statistically significant differences between the two implants in
fracture fixation complications, reoperation, wound infection and
length of stay. The statistically significant findings of individual
trials, namely the increased radiographic screening time and uri-
nary tract infection for the PFN (Saudan 2002), and the better
mobility of survivors of the PFN group (Pajarinen 2005) need to
be seen as being results from one trial only and in context of the
other outcomes (for instance, there was no significant difference
in overall medical complications in Saudan 2002). Overall, there
is insufficient evidence for this comparison. Four of the five re-
operations in the PFN group of Papasimos 2005 resulted from
the ’Z effect’, which describes the cutting out of one of the PFN
proximal pins with backing out of the other pin. Other instances
of this have been reported in case series and it was these difficul-
ties for the PFN that led to the suspension of Moran 2000 (see
’Characteristics of excluded studies’ table).
Targon PF nail versus the sliding hip screw
The single and small trial making this comparison (Giraud 2005)
provided insufficient evidence to conclude on the relative effec-
tiveness of the two implants.
Mini-invasive intramedullary nail versus the sliding hip screw
As acknowledged by Dujardin 2001, no definite conclusions
should be made regarding the use of this presently experimental
implant from this small trial. Whilst the use of one surgeon to
undertake each type of operation may reduce problems with op-
erator inexperience, it is possible that differences, especially in op-
erative times and blood loss, may be related to differences in the
techniques of the individual surgeons involved as well as due to
other confounding factors. Dujardin 2001 state that a multicentre
study, justified by the preliminary results of their study, is now
underway.
Kuntscher-Y nail versus the sliding hip screw (SHS)
Results from the only trial identified (Davis 1988) indicate compa-
rable results between the Kuntscher nail and the SHS. The overall
incidence of fixation failure was high in both groups, with a cut-
out rate of 14.9% for the SHS group. In contrast, this review has
identified a cut-out rate of 2.9% for the SHSwhen compared with
the Gamma nail. The only outcome measures that were signifi-
cantly different between implants were those of limb shortening
and recovery of mobility for those with good pre-fracture mobility.
Both were superior for the SHS. Future use and further trials using
the Kuntscher-Y nail seem inappropriate given that the outdated
implant is now superseded by newer intramedullary nails that have
improved instrumentation and the capacity for distal locking to
reduce the risk of limb shortening.
Femoral nails versus the Medoff sliding plate
Two trials (Ekstrom 2007; Miedel 2005) addressing this com-
parison showed no notable differences between the two implants
in final outcomes. Pooling of the results for the outcomes of re-
operation and wound infection was not done due to significant
heterogeneity in the findings of the two trials. Results for both
these outcomes favoured the Gamma nail in Miedel 2005, and
the Medoff plate in Ekstrom 2007. It is not possible, given the
limited evidence available for this comparison, to make any clear
recommendation on the relative effectiveness of the nails versus
the Medoff plate.
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Femoral nails versus condylar screw or blade plates
Both studies for this comparison (Sadowski 2002; Pelet 2001) in-
cluded fractures occurring at the level of the lesser trochanter; this
includes transverse and reverse obliquity fracture types. Such frac-
tures are known to have a markedly increased risk of fixation fail-
ure in comparison to trochanteric fractures (Haidukewych 2001).
Only 65 cases were included overall, reflecting the relatively rare
occurrence of these types of fracture. The comparison implants
(Gamma nail and PFN; dynamic condylar screw (DSC) plate and
the 90 degree blade plate) for these studies are sufficiently similar
to warrant the studies being considered in one category. For these
fractures, both the DSC and blade plates act as a rigid and static
fixation plate.
The intramedullary nails were associated with better results for
length of surgery, transfusion requirements, fixation failure rate,
reoperation rate and hospital stay in comparison with the plates.
Final outcome measures appeared to be similar between the two
groups. Thus for these fractures, an intramedullary nail appears to
give superior results to those of static plate fixation.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Accumulated data from randomised controlled trials show no ev-
idence of clinical advantage for the Gamma nail when compared
with the sliding hip screw (SHS). The Gamma nail incurs compli-
cations of intra-operative and later fracture around the implant.
Therefore, for trochanteric fractures, the SHS appears to be the
better device.
Results from randomised trials comparing the Intramedullary Hip
Screw (IMHS) with the SHS suggest that this implant suffers
from similar complications to that of the Gamma nail. Additional
studies are required to confirm this and to provide data to support
any claims of longer term functional advantage.
Pooled results of two trials evaluating the proximal femoral nail
(PFN) against the SHS showed no advantages for the PFN for
trochanteric fractures. Further evidence would be required to jus-
tify the use of the PFN for these fractures.
The two small studies comparing an intramedullary nail with static
plate fixation for treating more distal and uncommon trochanteric
fractures suggested that intramedullary nailing gave better intra-
operative and fracture fixation results. However this needs to be
viewed with caution given the limited number of participants.
Implications for research
Future research on contemporary implants should be plannedwith
close attention to improving the quality of trial design and report-
ing (seeCONSORT statement: Moher 2001). Particular deficien-
cies in the published literature are poor concealment of allocation,
failure to report outcomes related to fracture type and limited in-
formation on participants who withdrew or for whom follow up
was incomplete, limited reporting of functional outcomes and pa-
tient-derived quality of life measures, and insufficiently long fol-
low up.
Appropriate directions for future research include the place of
intramedullary nails in subtrochanteric and reversed-obliquity
trochanteric fractures. Design changes to different types of in-
tramedullary nails, claimed to reduce the risk of post-operative
fracture, should be tested versus the SHS in adequately powered
randomised trials.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Adams 2001
Methods Randomised by sequentially numbered closed opaque sealed envelopes
Surgical experience (see Footnotes): Yes (Claimed experience in both implants)
Participants Orthopaedic hospital, UK.
400 participants
Trochanteric proximal femoral fractures.
Age: mean 81 years
% male: 22%
Number lost to follow up: 0.3%
Interventions Gamma intramedullary nail versus Richards Compression hip screw
Outcomes Length of follow up: 12 months
Length of surgery
Operative blood loss
Fall in haemoglobin
Number of patients transfused
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Detachment of the plate from the femur
Reoperation
Deep wound infection
Superficial wound infection
Deep vein thrombosis
Mortality
Use of walking aids
Place of residence at follow up
Harris hip score
Notes Information of study supplied by trialists prior to publication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Ahrengart 1994
Methods Randomised by consecutively opened sealed envelopes
Surgical experience: Yes (Gamma nail: learning period before trial; SHS: routine)
Participants Five orthopaedic hospitals, Sweden and Finland
548 participants
Trochanteric and subtrochanteric fractures. But the 2002 report only included 492 trochanteric proximal
femoral fractures. The baseline data and early results for 66 patients lost to follow-up were not reported.
Age: median 80 years (range 32-99 years)
% male: 29%
Number lost to follow up: 13%
Interventions Gamma intramedullary nail versus Compression hip screw
Outcomes Length of follow up: 6 months
Length of surgery
Blood loss
Transfusion
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Non-union (pseudarthrosis)
Delayed healing
Reoperation
Wound infection
Deep wound infection
Superficial wound infection
Thromboembolic complication (deep vein thrombosis, pulmonary embolism)
Clinical complications (pneumonia)
Length of hospital stay
Shortening of leg
Varus displacement
Mortality at 6 months
Pain at follow up
Return to pre-fracture residential status
Failure to regain mobility
Use of walking aids
Length of skin incision
Notes A report (2002) of the results for patients with trochanteric fractures from all five centres of this study is
now available. It is however less comprehensive than the report, used in previous versions of this review,
by Fornander et al 1994 which gave the results for two centres and 209 patients, including 19 with
subtrochanteric fractures. Fornander also provided a pre-publication report and additional information
for these two centres.
Clarification on results and methods from Leif Ahrengart is pending (September 2003).
Given the absence of information on 66 patients lost to follow up in the five centre report and some lack of
clarity or potential inconsistencies with the two centre study regarding surgical experience, trial inclusion
criteria, outcome definitions and some results (i.e. there was one deep wound infection in the SHS group
in the Fornander report but none in the five-centre report), we have kept the data from the two centre
report.
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Ahrengart 1994 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Baumgaertner 1998
Methods Randomised by sealed opaque envelopes opened sequentially
Surgical experience: No (Gamma nail: familiar with IM nailing but not the Gamma nail; SHS routine;
surgery by residents under supervision, 30 participating surgeons)
Participants Two orthopaedic hospitals, USA
131 participants
135 trochanteric femoral fractures (4 of these were fractures which occurred several months later in the
same patients)
Excluded: pathological fractures.
Age: mean 79 years (range 40-99 years)
% male: 34%
Number lost to follow up: none
Interventions Intramedullary hip screw versus Sliding hip screw
Outcomes Length of follow up: mean 28 months (range 4-54 months)
Length of surgery
Operative blood loss
Transfusion
Radiographic screening time
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Non-union
Wound haematoma
Major medical complication
Length of hospital stay
Mortality
Hip pain at follow up
Return to pre-fracture residence
Patient mobility
Notes Slight confusion with use of patient or fracture numbers in the trial report. Trialist explained that 4
patients had 2 fractures which were operated on several months apart (they were not bilateral fractures).
These were considered separate operations and different cases for pre-op and operative data. Two of the
4 patients received both IMHS and SHS, and were excluded from longer term follow-up data but not
mortality.
Curtin’s abstract reporting early results for 70 patients shows the dangers of interim trial reports.
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Baumgaertner 1998 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Benum 1994
Methods Randomised by envelopes
Surgical experience: No (Unknown for all centres but for sub-group from one centre, Aune et al 1993:
Gamma nail: residents with varying experience of IM nailing (refers to learning curve); SHS: routine)
Participants Orthopaedic hospitals, Norway
912 participants (interim results for 460)
Trochanteric and subtrochanteric proximal femoral fractures.
Age: not stated
% male: not stated
Number lost to follow up: 21%
Interventions Gamma intramedullary nail versus Compression hip screw
Outcomes Length of follow up: 6 months
Length of surgery
Blood loss
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant (fracture dislocation)
Non-union (fracture healing)
Reoperation
Wound infection
Deep vein thrombosis
Pulmonary embolism
Length of hospital stay
Mortality
Institutional stay
Walking function
Notes Data used in analyses tables are based on interim data for 460 patients published in 1992 in an abstract.
Details for the completed trial of 912 patients were given in an another abstract published in 1994. The
references Aune et al 1993 and Ekeland et al 1993 (x2) report the results of 378 patients recruited by one
of the centres of the multicentre trial reported by Benum. Madsen et al 1996 refers to a subgroup from
this centre. The follow up for these patients was 10 to 27 months. A later trial report by Madsen et al
1998 also includes a subgroup from this trial.
A slightly modified Gamma nail was used (6 degree valgus angle).
Not included in the analyses for reoperation are the final data for Benum 1994 (29/429 versus 7/467),
which are consistent with the general result.
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Benum 1994 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Bridle 1991
Methods “Randomised”: method not specified
Surgical experience: Yes (All 4 surgeons familiar with closed nailing techniques)
Participants Orthopaedic hospital, UK
100 participants
Trochanteric proximal femoral fractures.
Age: mean 82 years (all over 60 years)
% male: 16%
Number lost to follow up: 6%
Interventions Gamma intramedullary nail versus Dynamic hip screw
Outcomes Length of follow up: 6 months
Length of surgery
Blood loss
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Non-union
Reoperation (incomplete data)
Wound infection
Wound haematoma
Pneumonia
Pressure sore
Pulmonary embolism
Any medical complication
Length of hospital stay
Shortening of femur (leg) (no information)
Mortality
Pain (no information)
Eventual discharge residence
Patient mobility
Notes Some discrepancies between tables and text in report.
Risk of bias
Item Authors’ judgement Description
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Bridle 1991 (Continued)
Allocation concealment? Unclear B - Unclear
Butt 1995
Methods Quasi-randomised by even or odd numbered weeks
Surgical experience: No (Unknown; same surgeons did both operations)
Participants Orthopaedic hospital, UK
95 participants
Trochanteric and subtrochanteric proximal femoral fractures.
Age: mean 78.5 years (range 47-101 years)
% male: 31%
Number lost to follow up: none
Interventions Gamma intramedullary nail versus Dynamic hip screw
Outcomes Length of follow up: ’to fracture union’ (generally < 6 months)
Length of surgery
Blood loss
Later fracture of the femur
Cut-out of implant (incomplete data?)
Non-union (time to union)
Reoperation (total inferred)
Wound infection
Pneumonia
Pressure sore
Deep vein thrombosis
Any medical complication
Length of hospital stay
Mortality
Notes Gamma nail technique modified without apparent advantage after 37 gamma nail patients.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Davis 1988
Methods Randomised using numbered sealed opaque envelopes opened after patient assigned a trial numbers (via
random numbers table)
Surgical experience: No (Unknown; operations performed by consultants or trainees)
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Davis 1988 (Continued)
Participants Two orthopaedic hospitals, UK
230 participants
Intertrochanteric proximal femoral fractures.
Excluded: patients aged <50, pathological and Pagets fractures.
Age: mean 81 years
% male: 17%
Number lost to follow up: none
Interventions Kuntscher-Y nail versus Sliding hip screw
Outcomes Length of follow up: 12 months
Length of surgery
Blood loss
Mean units blood transfused
Radiographic screening time
Length of hospital stay
Length of hospital stay and convalescence
Mortality (1 month and 6 months)
Radiographic healing time
Time to weight bearing
Salvati and Wilson score
Functional deficit
Power and motion at hip
Knee mobility
Time till painless mobilisation
Notes Hip nail used was described as an experimental device which is not available commercially
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Dujardin 2001
Methods Randomised: method not stated
Surgical experience: Yes (All operations were undertaken by two surgeons with experience of the surgical
technique; one surgeon did all the SHS operations and the other did all the nail operations)
Participants Orthopaedic hospital, Rouen, France
60 participants
Intertrochanteric proximal femoral fracture (stable and unstable fractures).
Excluded: patients aged <60, pathological, lower limb arteriopathy, fractures extending to the diaphysis,
previous lesions of the hip, surgery after 2 days from fracture, cutaneous lesions, abnormal calcium or
phosphorus metabolism and no consent.
Age: mean 83.5 years
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Dujardin 2001 (Continued)
% male: 20%
Number lost to follow up: not stated
Interventions A mini-invasive static intramedullary nail versus Sliding hip screw
Outcomes Length of follow up: 6 months
Length of surgery
Blood loss
Mean units blood transfused
Radiographic screening time
Non-union; time to union
Early post-op complications (infection, thromboembolism, further operation)
Pneumonia
Pressure sores
All medical complications
Length of hospital stay
Varus deformity (reported for the nail group)
Angular restoration
Mortality
Pain
Failure to regain mobility
Hip function
Knee mobility
Notes This experimental nail is not available commercially.
The paper reported on radiographic measurements of anatomical restoration (cervicotrochanteric short-
ening and cervico-diaphyseal angle). However clinical outcomes such as leg shortening were not reported.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Ekstrom 2007
Methods Randomised using numbered sealed opaque envelopes
Surgical experience: No (Operations performed by 43 different surgeons, consultants or trainees)
Participants Two orthopaedic hospitals, Sweden
210 participants (see Notes)
Unstable intertrochanteric proximal femoral fractures (172) and subtrochanteric fractures (31).
Excluded: people with stable trochanteric fractures, high energy trauma, pathological fractures, previous
surgery to the proximal femur, daily steroids of more than 10 mg of prednisolone, ongoing chemotherapy,
irradiation treatment, presence of degenerative osteoarthrosis of the injured hip.
Age: mean 82 years (range 48 -97 years)
% male: 24%
Number lost to follow up: 25% (50 surviving patients were unable to attend the follow-up clinic at one
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Ekstrom 2007 (Continued)
year from injury)
Interventions Proximal femoral nail versus theMedoff sliding plate (4 or 6 hole plate used in biaxial mode for trochanteric
fractures and uni-axial mode for the subtrochanteric fractures)
Outcomes Length of follow up: 12 months
Length of surgery
Blood loss
Radiographic screening time
Cut-out of implant
Non-union
Operative fracture of the femur
Later fracture of the femur
Other fracture healing complications
Reoperation
Wound infection
Wound haematoma
Length of hospital stay
Mortality
Failure to return to pre-fracture residential status
Pain
Inability to walk 15 metres
Inability to rise from the chair
Inability to climb a curb
Need to use walking aids
Abductor strength
Notes Of 210 randomised patients, 7 were excluded: 5 wrong fracture and 2 wrong treatment
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Giraud 2005
Methods Randomised using random numbers table
Surgical experience: No (Unknown)
Participants Orthopaedic hospital, Reims, France
60 participants
Intertrochanteric proximal femoral fracture (stable and unstable fractures: AO 31-A1,A2 and A3).
Age: mean 81/82 years
% male: 23%
Number lost to follow up: none
Interventions Targon PF (proximal femoral) nail versus Dynamic hip screw
36Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Giraud 2005 (Continued)
Outcomes Length of follow up: 3 months
Length of surgery
Blood loss
Cut-out of implant
Later fracture of the femur
Reoperation
Wound infection (none)
Pneumonia (pulmonary congestion: “Pulmonaire”)
Deep vein thrombosis
Length of hospital stay
Mortality
Time to walking
Harris hip score
Notes Extra information supplied by trialists.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Goldhagen 1994
Methods Quasi-randomised according to patient’s medical record number
Surgical experience: No (Gamma nail: refers to significant learning curve. A “multiplicity of operating
surgeons”)
Participants Orthopaedic hospital, USA
75 participants
Trochanteric and subtrochanteric proximal femoral fractures.
Age: median 76 years (range 28-91 years)
% male: 30%
Number lost to follow up: none
Interventions Gamma intramedullary nail versus Compression hip screw
Outcomes Length of follow up: 6-9 months
Length of surgery
Blood loss
Radiographic screening time
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Non-union
Reoperation
Length of hospital stay
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Goldhagen 1994 (Continued)
Mortality
Pain at follow up
Non return to previous residence
Impaired walking
Notes Slight discrepancies in numbers Tables 1 and 2.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Guyer 1991
Methods Quasi-randomised by alternating patients
Surgical experience: No (Gamma nail: refers to inexperience of surgeons with implant)
Participants Orthopaedic hospital, Switzerland
100 participants
Trochanteric and subtrochanteric proximal femoral fractures.
Age: mean 80 years
% male: 15%
Number lost to follow up: 24%
Interventions Gamma intramedullary nail versus Dynamic hip screw
Outcomes Length of follow up: 12 weeks
Length of surgery
Blood loss
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Non-union
Reoperation
Deep wound infection
Wound haematoma
Length of hospital stay
Shortening of leg (>1 cm)
Mortality
Pain at follow up
Non-return to previous residence
Impaired walking
Notes
Risk of bias
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Guyer 1991 (Continued)
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Hardy 1998
Methods Quasi-randomised by even or odd medical record numbers
Surgical experience: No (IMHS: refers to prolonged learning curve required for insertion; SHS routine;
2 senior operating surgeons, 3 junior attending surgeons)
Participants University hospital, Belgium
100 participants (see Notes)
Trochanteric proximal femoral fractures.
Excluded: Patients aged <60, pathological fractures, incorrect anatomy, history of fracture or operation
involving same limb.
Age: mean 81 years
% male: 23%
Number lost to follow up: none
Interventions Intramedullary hip screw versus Sliding hip screw
Outcomes Length of follow up: 1 year (see Notes)
Length of surgery
Operative blood loss
Transfusion
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Non-union
Reoperation
Wound infection
Wound haematoma
Pneumonia
Thromboembolic complications (deep vein thrombosis, pulmonary embolism)
Urinary tract infection
Leg shortening
Mortality
Mid-thigh pain
Hip pain at follow up
Eventual discharge residence
Patient mobility
Social function
Notes Since a full report of the trial was published in 1998, a conference abstract presenting the results of 160
patients at 18 months follow up has become available (Hardy 1999). The limited results presented within
Hardy 1999 require clarification and thus have not yet been included in this review.
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Hardy 1998 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Harrington 2002
Methods Randomised by opening sealed envelope on the admission ward
Surgical experience: No (Reference made to some surgeons who had only used the IMHS on bone model
sessions)
Participants Orthopaedic hospital, UK
102 participants
Unstable trochanteric proximal femoral fractures.
Excluded: Patients aged <65 years, pathological fractures, previous fracture, other fracture.
Age: mean 83 years
% male: 21%
Number lost to follow up: not stated
Interventions Intramedullary hip screw versus Sliding hip screw
Outcomes Length of follow up: 12 months
Length of surgery
Radiographic screening time
Transfusion requirements
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Non-union of fracture
Other fracture healing complications
Length of hospital stay
Mortality
Patient mobility
Regain of pre-fracture living status
Notes Additional information provided by authors
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Haynes 1996
Methods Randomisation by cards, but trial entry optional
Surgical experience: No (Not clear. Gamma nail: prior experience with five insertions but speaks of
unfamiliarity of the surgeons (various) with the treatment as a reason for exclusion (see Notes); SHS:
routine)
Participants Orthopaedic hospital, UK
50 participants
Trochanteric or ’high’ subtrochanteric proximal femoral fractures.
Excluded: Previous non-consolidated femur fracture.
Age: mean 80 years.
% male: 28%
Number lost to follow up: none
Interventions Gamma intramedullary nail versus Dynamic hip screw
Outcomes Length of follow up: 6 months
Length of surgery
Blood loss
Operative fracture of femur*
Cut-out
Non-union*
Reoperation
Wound infection*
Pneumonia*
Pressure sore*
Wound haematoma*
Deep vein thrombosis*
Pulmonary embolism*
Length of hospital stay
Shortening of leg*
Mortality
Pain at follow up*
Non return to previous residence
Impaired walking
* outcomes listed on data extraction form but not reported
Notes Trial report was part of PhD research.
Trial sponsored and part administered by Howmedica.
Imbalance in numbers explained by unfamiliarity of surgeons with Gamma nail treatment. “This resulted
in a temptation to omit the patient from the trial if a Gamma nail was drawn as treatment, from the
randomisation cards”. This was despite the efforts made to familiarise the surgeons to the Gamma nail:
“a minimum of 5 Gamma Nails were then inserted by each surgeon before any cases were included in the
trial”
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
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Hoffman 1996
Methods Randomised by sealed opaque envelopes (a stiff card was used to prevent disclosure of allocation)
Surgical experience: No (Gamma nail: refers to a longer learning curve than with SHS; 4 orthopaedic
trainees, normal supervision)
Participants Orthopaedic hospital, New Zealand
69 participants
Trochanteric proximal femoral fractures.
Patients aged over 50 years.
Pathological fractures were excluded.
Age: mean 81 years
% male: 23%
Number lost to follow up: none
Interventions Gamma intramedullary nail versus Ambi hip screw
Outcomes Length of follow up: 6 months
Length of surgery
Blood loss
Radiographic screening time
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Non-union (time to union)
Reoperation
Wound infection
Pneumonia
Pressure sores
Deep vein thrombosis
Any medical complication
Length of hospital stay
Shortening of leg
Mortality
Pain at follow up
Non return to previous residence
Patient mobility
Notes Additional data received. There were 69 patients randomised but 2 died before surgery and were therefore
not included.
Updated recommendations on locking for Gamma nail insertion from manufacturers were implemented
after patient 50.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Hoffmann 1999
Methods Randomised by sealed envelopes; blinding indicated
Surgical experience: No (Operations by junior and senior staff )
Participants Orthopaedic hospital, Germany
110 participants
Trochanteric proximal femoral fractures.
Excluded: pathological fractures.
Age: mean 82 years
% male: 20%
Number lost to follow up: 3.6%
Interventions Intramedullary hip screw versus Sliding hip screw
Outcomes Length of follow up: mean 3.7 months
Length of anaesthesia
Length of surgery
Operative blood loss
Difference in haemoglobin
Radiographic screening time
Operative fracture of the femur
Later fracture of the femur
Loss of fracture reduction requiring reoperation
Reoperation
Wound infection
Deep wound infection
Wound haematoma
Superficial wound infection
Thromboembolic complication
Clinical complications
Length of acute hospital stay
Shortening of leg (> 1 cm)
Rotational deformity (’relevant’)
Mortality
Pain at follow up
Return to pre-fracture residential status
Impaired walking
Merle d’Aubigne hip score
Notes Article in German - limited translation only obtained.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Kukla 1997
Methods Randomised using sealed envelopes
Surgical experience: Yes (Senior surgeons experienced in both operations)
Participants Orthopaedic hospital, Austria
120 participants
Trochanteric proximal femoral fractures.
Excluded: Patients aged <60 years, pathological fractures, multiple injury patients.
Age: mean 83 years (range 60-99 years)
% male: 15%
Number lost to follow up: 3 (3%)
Interventions Gamma intramedullary nail versus Sliding hip screw
Outcomes Length of follow up: 6 months
Length of surgery
Blood loss
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Non-union
Reoperation
Wound infection
Deep wound infection
Wound haematoma
Pneumonia
Deep vein thrombosis
Pulmonary embolism
Any medical complication
Length of hospital stay
Shortening of leg (>2 cm)
Mortality
Non-return to previous residence
Impaired walking
Notes Additional information received from authors included draft report prior to publication.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Kuwabara 1998
Methods Randomised trial: method not stated
Surgical experience: No (Unknown)
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Kuwabara 1998 (Continued)
Participants Orthopaedic hospital, Japan
43 participants
Trochanteric proximal femoral fractures.
Excluded: patients <65 years.
Age: mean 81 years
% male: 28%
Number lost to follow up: not known
Interventions Gamma intramedullary nail versus Compression hip screw
Outcomes Length of follow up: mean 6 months (5.7 and 6.5 months respectively for the two groups)
Length of surgery
Operative blood loss
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Wound infection
Inversion deformity
Eversion deformity
Loss in mobility and use of walking aids
Notes Trial published in Japanese. Only a limited translation obtained.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Leung 1992
Methods Quasi-randomised by alternating patients
Surgical experience: No (Imbalance in experience (see Notes): Gamma nail: mostly by one experienced
surgeon; SHS: by less experienced surgeons)
Participants Orthopaedic hospitals, Hong Kong
225 participants
226 trochanteric proximal femoral fractures.
Excluded: Patients aged <65 years.
Age: mean 80 years
% male: 30% (excluding deaths)
Number lost to follow up: none
Interventions Gamma intramedullary nail versus Dynamic hip screw
Outcomes Length of follow up: mean 7 months
Length of surgery
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Leung 1992 (Continued)
Blood loss
Radiographic screening time
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Non-union (fracture healing)
Reoperation
Deep wound infection
Pneumonia
Any medical complication (incomplete)
Length of hospital stay (mixed location)
External rotational deformity
Shortening of leg (>2 cm)
Varus displacement (>10 degrees)
Mortality
Pain at follow up
Impaired walking
Notes The 40 patients who died within 6 months of surgery were not included in the full assessment of results.
Further information obtained from author. Most of the Gamma nail operations were performed by one
senior surgeon with a special interest in intramedullary nailing, whilst the sliding hip screw operations
were performed by a number of less experienced surgeons.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Marques Lopez 2002
Methods Quasi-randomised according to medical record number
Surgical experience: No (Variable)
Participants Orthopaedic hospital, Barcelona, Spain
103 participants
Trochanteric proximal femoral fractures.
Age: mean 84 years
% male: 35%
Number lost to follow up: not stated
Interventions Gamma intramedullary nail versus Dynamic hip screw
Outcomes Length of follow up: 12 months
Length of surgery
Post-operative transfusion
Change in haematocrit
Radiographic screening time
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Marques Lopez 2002 (Continued)
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Reoperation
Wound infection
Wound haematoma
Deep vein thrombosis
Pneumonia
Pressure sores
Mortality
Mobility
Mean time to fracture consolidation
Notes The outcome of post-operative transfusion was inadequately defined. Mortality at one year was only given
as percentages; there was inadequate information to determine if all randomised patients were included
in the calculation of these percentages.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Mehdi 2000
Methods Randomised by sealed envelopes.
Surgical experience: No (Reference made to relative inexperience with IMHS at start of trial)
Participants Orthopaedic hospital, UK
180 participants
Extracapsular proximal femoral fractures.
Age: mean 76 years
% male: unknown
Number lost to follow up: 19%
Interventions Intramedullary hip screw versus Sliding hip screw
Outcomes Length of follow up: minimum 6 months (mean 13 months, range 6 to 36 months)
Length of surgery
Operative blood loss
Operative fracture of the femur
Later fracture of femur (none)
Cut-out of implant
Peri-operative complication
Fracture reduction
Wound infection (superficial and deep)
Mortality
Mobility
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Mehdi 2000 (Continued)
Harris hip scores
Notes Abstract only published.
Unpublished report made available by trialist.
Because of the large range of final follow-up times and high and unequal losses to follow up, we decided
against presenting final follow-up results (mortality, later fracture and mobility) in the review.
Two cases of IMHS required conversion to SHS fixation due to “excessive bowing”.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Michos 2001
Methods Randomised: method not stated
Surgical experience: No (Unknown)
Participants Orthopaedic hospital, Greece
52 participants
Trochanteric proximal femoral fractures. Some may have had subtrochanteric extension.
Age: mean 78.5 years
% male: unknown
Number lost to follow up: not known
Interventions Gamma intramedullary nail (“Trochanteric Gamma Nail” used if no subtrochanteric extension)versus
Sliding hip screw
Outcomes Length of follow up: 3-6 months
Operative blood loss
Later fracture of the femur
Cut-out of implant
Non-union
Plate detachment
Mortality (peri-operative)
Notes Abstract only.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Miedel 2005
Methods Randomised by sealed envelopes
Surgical experience: No (Half of the operations in each group were by consultant orthopaedic surgeons)
Participants Orthopaedic hospital, Stockholm, Sweden
217 participants
Unstable trochanteric and subtrochanteric proximal femoral fractures.
Age: mean 84 years (range 65-99 years)
% male: 19%
Number lost to follow up: 6 (3%) (at 12 months)
Interventions Gamma intramedullary nail versus Medoff sliding plate (eight hole Medoff plate used in biaxial dynami-
sation mode)
Outcomes Length of follow up: 12 months
Length of surgery
Operative blood loss
Post-operative transfusion
Operative fracture of the femur
Technical failure
Later fracture of the femur
Cut-out of implant
Displacement (medialisation of the femur requiring surgery)
Reoperation
Wound infection (superficial and deep)
Severe medical complications
Length of hospital stay
Discharge location
Mortality
Mobility
Pain
Hip function
Activities of daily living
Health related quality of life
Notes Details of the reoperations removed from the text in the update (issue 1, 2008):
All three reoperations, involving total hip replacement, in the Gamma group were for cut-out. Nine
reoperations were required in the Medoff group, two (one Girdlestone arthroplasty and one multiple
debridements)for sepsis, three (one Girdlestone arthroplasty and two total hip replacement)for cut-out,
three (two to intramedullary nails and one to a fixed nail plate with subsequent total hip replacement)for
femur displacement (medialisation), and one removal of the Medoff plate due to pain with later revision
to a total hip replacement.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Mott 1993
Methods Randomised using computer-generated random numbers table
Surgical experience: No
Participants Three orthopaedic hospitals, Detroit, USA.
69 participants
Trochanteric proximal femoral fractures.
Age: mean 76 years (range 19-99 years)
% male: 42%
Number lost to follow up: not stated
Interventions Gamma intramedullary nail versus Sliding hip screw
Outcomes Length of follow up: not stated
Length of surgery
Operative blood loss
Blood transfusion
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Reoperation
Deep wound infection
Superficial wound infection
Wound haematoma
Deep vein thrombosis
Myocardial infarction
Pneumonia
Urinary tract infection
Mortality (1 week)
Notes Trial information supplied by trialists
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
O’Brien 1995
Methods Blinded randomisation of patients using opaque envelopes
Surgical experience: No (Refers to “performance bias” during operation)
Participants Orthopaedic hospital, Canada.
101 participants
102 trochanteric proximal femoral fractures.
Age: mean 80 years (range 39-95 years)
% male: 26%
Number lost to follow up: 18%
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O’Brien 1995 (Continued)
Interventions Gamma intramedullary nail versus Dynamic hip screw
Outcomes Length of follow up: average 52 weeks (range 11 to 82 weeks)
Length of surgery
Blood loss
Radiographic screening time
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Non-union (time to union)
Reoperation
Wound infection
Deep wound infection
Wound haematoma
Pneumonia
Pressure sores
Pulmonary embolism
Any medical complication
Length of hospital stay
Mortality
Pain at follow up
Loss of independence
Loss in mobility
Notes Additional information received from authors. Themortality ratemay be higher than that reported because
of the number of patients lost to follow up. The number of patients that may have died in the follow-up
period is unclear.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Ovesen 2006
Methods Randomised by consecutively opened sealed opaque envelopes (computer generated sequence)
Surgical experience: No (Operations by surgical team on call: 49 surgeons participated in trial)
Participants Orthopaedic hospital, Odense, Denmark
150 participants with 151 fractures (see Notes)
Trochanteric fractures.
Age: mean 79 years (range not stated)
% male: 28%
Number lost to follow up: 17%
Interventions Trochanteric Gamma intramedullary nail versus Dynamic hip screw
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Ovesen 2006 (Continued)
Outcomes Length of follow up: 12 months
Length of surgery
Blood loss
Transfusion
Operative fracture of the femur (none)
Later fracture of the femur
Cut-out of implant
Non-union (none)
Reoperation
Wound infection
Medical complications (none)
Length of hospital stay
Mortality at 12 months
Use of walking aids at discharge and 4 months
Notes Five cases were excluded post-randomisation: 2 wrong diagnosis and 3 transferred out of the hospital
catchment area.
Extra information supplied by trialists. There were three cases of redislocation of the fracture in which
there was major loss of reduction and/or implant position. These cases were included as cases of cut-out.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Pahlpatz 1993
Methods Randomised: method not stated
Surgical experience: No (Unknown: operations by surgical residents with assistance of staff member as
required)
Participants Orthopaedic hospital, Netherlands
113 participants
Trochanteric proximal femoral fractures.
Age: mean and range - not stated
% male: not stated
Number lost to follow up: not stated
Interventions Gamma intramedullary nail versus Sliding hip screw
Outcomes Length of follow up: 6 months minimum
Mortality
Failure to regain residential status
Notes The paper states these are preliminary results of the study and only reports on two outcome measures. No
additional results have since been made available.
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Pahlpatz 1993 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Pajarinen 2005
Methods Randomised by numbered sealed opaque envelopes;
Surgical experience: Yes (Trialist confirmed all surgeons were experienced in both procedures)
Participants Orthopaedic hospital, Helsinki, Finland
108 participants
Trochanteric proximal femoral fracture.
Age: mean 81 years
% male: 25%
Number lost to follow up: 15 (14%)
Interventions Proximal femoral nail versus Dynamic hip screw
Outcomes Length of follow up: 4 months
Length of surgery
Blood loss
Units of blood transfused
Later fracture of femur
Cut-out
Failure of fixation (redisplacement)
Reoperation
Superficial wound infection
Deep wound infection
Deep vein thrombosis
Femoral neck and shaft shortening on X-ray
Length of hospital stay
Mortality
Failure to regain pre-fracture residential status
Non recovery of previous mobility
Notes Additional information supplied by trialists, who also confirmed that the participants of a separately
reported radiological study were also (“for most parts of the series”) in the trial.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Papasimos 2005
Methods Randomised trial: method not stated
Surgical experience: No (Unknown)
Participants Orthopaedic hospital, Patras Hellas, Greece
141 participants
Unstable trochanteric proximal femoral fracture (see Notes)
Age: mean 81 years
% male: 39%
Number lost to follow up (of 141): 11 (8%)
Interventions Proximal femoral nail (PFN) versus Trochanteric Gamma nail versus Sliding hip screw.
11 or 12 mm diameter PFN with distal locking in 37 out of 40 participants. 135 degree Trochanteric
Gamma nail with 17 mm proximal diameter and 11 mm distal diameter and distal locking in all partici-
pants.
Outcomes Length of follow up: mean 12 months
Length of surgery
Operative blood loss
Radiographic screening time
Operative fracture (some of greater trochanter)
Cut-out of implant
Later fracture of the femur
Non-union
Reoperation
Superficial wound infection
Haematoma
Medical complications
Chest infection
Pneumonia
Mental disturbances
Deep vein thrombosis
Pulmonary embolism
Urinary infection
Length of hospital stay
Time to fracture consolidation
Function: Salvati and Wilson score
Notes There were 141 people randomised into this trial but the intervention groups for the 10 participants who
died before one year and the 11 who were lost to follow up were not identified.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Park 1998
Methods Quasi-randomised according to medical record number
Surgical experience: No (Unknown)
Participants University hospital, Korea
60 participants
Intertrochanteric femoral fracture.
Age: mean 73 years (all over 60 years)
% male: 40%
Number lost to follow up: none
Interventions Gamma AP (Asia-Pacific)intramedullary nail versus Compression hip screw
Outcomes Length of follow up: mean 18.5 months (range 12 - 31 months)
Length of surgery
Blood loss
Operative fracture of femur (none)
Later fracture of femur (greater trochanter)
Cut-out of implant
Non-union (time to union)
Wound infection
Varus deformity
Patient mobility
Notes The Gamma AP nail is a modification of the standard Gamma intramedullary nail for use in oriental
patients.
A request to the trialists for further information including mortality data has been sent.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Pelet 2001
Methods Randomised by the drawing of lots. Those with an even number drawn received one implant and those
with an odd number the other implant.
Surgical experience: No (More experience with Gamma nail)
Participants Orthopaedic hospital, Lausanne, Switzerland
26 participants
Trochanteric proximal femoral fractures, classified by the system of Kyle as type IV. These are equivalent
to type A3 (AO classification): reversed and transverse fracture lines at the level of the lesser trochanter.
Age: mean 71 years (range 21-96 years)
% male: 35%
Number lost to follow up: none
Interventions Gamma nail versus the 90 degree blade plate
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Pelet 2001 (Continued)
Outcomes Length of follow up: 12 months
Length of surgery
Operative blood loss
Operative fracture of the femur
Cut-out
Non-union (and time to consolidation)
Avascular necrosis
Implant failure
Reoperation
Wound infection
Pulmonary embolism
Cardiac failure
All medical complications
Length of hospital stay
External rotation deformity
Hip flexion
Mortality
Pain at follow up
Use of walking aids
Time to start of weight bearing
Time to full weight bearing
Notes Article in French
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Radford 1993
Methods “Randomised”: method not stated
Surgical experience: Yes (Gamma nail: personal training and 2 operations before trial; SHS routine;
registrar grade and above)
Participants Orthopaedic hospital, UK
200 participants
Trochanteric proximal femoral fractures.
Age: mean 80 years (range 60-97 years)
% male: 22%
Number lost to follow up: not stated
Interventions Gamma intramedullary nail versus Dynamic hip screw
Outcomes Length of follow up: 12 months
Length of surgery
Blood loss
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Radford 1993 (Continued)
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Non-union
Reoperation
Wound infection
Deep wound infection
Deep vein thrombosis
Length of hospital stay
Mortality
Transfer to long term care
Mobility level
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Sadowski 2002
Methods Randomised using computer generated randomised numbers
Surgical experience: Yes (All surgeons had performed at least eight of each operation before the study)
Participants Orthopaedic hospital, Geneva, Switzerland
39 participants
Trochanteric proximal femoral fractures, type A3 (AO classification): reversed and transverse fracture lines
at the level of the lesser trochanter.
Age: mean 79 years
% male: 31%
Number lost to follow up: none (one patient was unable to attend clinic so had follow up by phone)
Interventions Proximal femoral nail versus the Dynamic condylar screw
Outcomes Length of follow up: 12 months
Length of surgery
Operative blood loss
Mean units transfused
Number of patients transfused
Radiographic screening time
Cut-out
Non-union (and time to consolidation)
Implant failure
Reoperation
Wound infection
Pneumonia
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Sadowski 2002 (Continued)
Pressure sores
Deep vein thrombosis
Pulmonary embolism
Urinary infection
Cardiac failure/infarction
All medical complications
Mortality
Pain at follow up
Social function
Transfer to long term care
Mobility level
Notes Additional information supplied by authors
This trial was concurrent with the Saudan 2002
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Saudan 2002
Methods Randomised using computer generated randomised numbers
Surgical experience: Yes (All surgeons had performed at least eight of each operation before the study)
Participants Orthopaedic hospital, Geneva, Switzerland
206 participants
Trochanteric proximal femoral fractures, types A1 and A2 (AO classification).
Age: mean 83 years
% male: 22%
Number lost to follow up: 4%
Interventions Proximal femoral nail versus Dynamic hip screw
Outcomes Length of follow up: 12 months
Length of surgery
Operative blood loss
Mean units transfused
Number of patients transfused
Radiographic screening time
Cut-out
Non-union (and time to consolidation)
Implant failure
Reoperation
Wound infection
Pneumonia
Pressure sores
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Saudan 2002 (Continued)
Deep vein thrombosis
Pulmonary embolism
Urinary infection
Cardiac failure/infarction
All medical complications
Mortality
Pain at follow up
Social function
Transfer to long term care
Mobility level
Notes Additional information supplied by authors
This trial was concurrent with Sadowski 2002.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Utrilla 2005
Methods Randomised by sealed envelopes, order based on sequence of admission
Surgical experience: No (3 prior operations for the nail)
Participants Orthopaedic hospital, Alicante, Spain
210 participants
Trochanteric proximal femoral fractures. No subtrochanteric fractures
Age: mean 80 years (range 65-104 years)
% male: 31%
Number lost to follow up: 7 (3.3%)
Interventions Gamma intramedullary nail (Trochanteric Gamma Nail version) versus Sliding hip screw
Outcomes Length of follow up: 12 months
Length of surgery
Blood transfusion
Radiographic screening time
Operative fracture of the femur
Later fracture of the femur
Cut-out of implant
Reoperation
Deep wound sepsis
Local wound healing complications
Deep vein thrombosis
Shortening
Hip flexion
Mobility
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Utrilla 2005 (Continued)
Pain
Mortality at one year
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
“Surgical experience” in the Methods column gives details of prior experience of the operations the surgeons performed in the trial.
“Yes” = 1 in the quality assessment tool (item 5); “No” = 0, which could also reflect a lack of information.
IM: intramedullary
IMHS: intramedullary hip screw
PFN: proximal femoral nail
SHS: sliding hip screw
Characteristics of excluded studies [ordered by study ID]
Azzoni 2004 This was a retrospective comparison of 208 people with a trochanteric fracture treated with either an in-
tramedullary nail or a sliding hip screw. The study was excluded because there was no randomisation of patients.
Bhatti 2003 This was a prospective comparison of 70 people treated with either the proximal femoral nail or dynamic hip
screw, with the choice of treatment being the preference of the surgeon. It was excluded because it was not a
randomised study.
Bienkowski 2006 This was a prospective comparison of 60 people with a trochanteric fracture treated with either a trochanteric
femoral nail or a sliding hip screw. The study was excluded because the choice of treatment was according to the
preference and experience of the attending surgeon, with no randomisation of patients.
Davison 1996 An interim report of this randomised trial comparing the intramedullary hip screw with the sliding hip screw
was reported in a conference abstract published 1996. In 1995, 134 people had been entered in the study. Of the
63 available for clinic review at 6 months, there had been 6 cut-outs in each group. There were no other implant
failures or femoral fractures reported. Pain and mobility were similar in both groups. The trial was stated to be
continuing but no further results have been presented or made available and correspondence with the author
indicated that further information was not available. The study was excluded because it reported only very limited
and interim outcomes.
DiCicco 2000 In this study, people with femoral shaft fractures were allocated antegrade or retrograde nailing of femur fracture
according to their medical record numbers. All subtrochanteric fractures, which were not included in the quasi-
randomised trial, were treatedwith retrograde nailing. The studywas excludedbecause therewas no randomisation
of proximal femoral fractures.
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(Continued)
Fritz 1999 Randomised comparison with 80 people allocated to either the Gamma nail or a gliding nail, which is the same
as a gamma nail except the lag screw is changed to a nail. It was excluded because there was no extramedullary
comparison group, but has been included in the Cochrane review comparing different types of intramedullary
nails for extracapsular hip fractures.
Hardy 2003 This randomised trial of 80 people with a trochanteric fracture compared the use of a standard intramedullary
hip screw against an intramedullary hip screw with a slotted distal locking hole. It was excluded because there
was no extramedullary comparison group, but has been included in the Cochrane review comparing different
types of intramedullary nails for extracapsular hip fractures.
Herrera 2002 This was a randomised comparison of 125 people treated with the Gamma nail versus 125 people treated with
the proximal femoral nail. It was excluded becuase there was no extramedullary comparison group, but has been
included in the Cochrane review comparing different types of intramedullary nails for extracapsular hip fractures.
Hogh 1992 This randomised trial from Denmark of 299 cases compared the Gamma nail with the sliding hip screw. The
study was reported in conference abstracts only. The results as detailed showed “no difference” in mean operative
times, operative blood loss, wound drainage or post-operative haemoglobin levels. Mortality was similar in both
groups. Cut-out occurred in six cases in the sliding hip screw group and 10 in the Gamma nail group. There were
eight cases in the Gamma nail group of operative or later fracture around the nail. Reoperations were required
in six cases in the sliding hip screw group and 12 in the Gamma group.
The studywas excluded because the exact numbers of cases allocated to each group was not given. Correspondence
with medical staff at the trial hospital indicated that no further information was now available.
Kafer 2005 Study, reported in German, comparing the results of 53 people treated with a proximal femoral nail versus 59
people treated with a dynamic hip screw. This study was excluded because there was no randomisation of patients.
Khan 2002 The contact trialist listed in the National Research Register (UK) entry for this study, reported to compare the
trochanteric intramedullary nail versus the dynamic compression screw, confirmed that the trial did not “get off
the ground”.
Klinger 2005 This was a comparative study of 122 people with unstable trochanteric fractures treated with the proximal femoral
nail and 51 treated with the dynamic hip screw with a trochanteric buttress-press plate. It was excluded because
it was not a randomised study.
Merenyi 1995 This conference abstract suggested a randomised trial comparing 40 Ender nails with 40 angle plates, and 40
Gamma nails (3 types). Correspondence with the authors indicated that there was no randomisation of patients
only a random selection of people who had been previously treated with one of the different implants.
Moran 2000 This was a randomised trial of unstable intertrochanteric fractures comparing the proximal femoral nail and the
dynamic hip screw. The trial co-ordinator was Mr CG Morgan, Department of Trauma & Orthopaedics, C
Floor, West Block, University Hospital, Nottingham, NG7 2UH, UK. Recruitment to the study was suspended
in 1999 due to problems with the proximal femoral nail and no outcome data for the limited number of trial
participants has been made available.
Nuber 2003 Study, reported in German, comparing the results of 65 people treated with a proximal femur nail versus 64
people treated with a dynamic hip screw with trochanteric stabilisation plate. This study was excluded when it
was confirmed to be a retrospective comparison of two cohorts by Annette Blumle of the German Cochrane
Centre.
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Prinz 1996 Only preliminary results were provided in the conference abstract report of this randomised trial. There were 38
people treated with a sliding hip screw, 43 with a Gamma nail and 41 with an intramedullary hip screw recruited
between 01/03/1995 and 01/03/1996.
The study was excluded because of the inadequate reporting of the trial outcomes; preliminary results only being
available. Should a full report of this ever become available, it is likely that we will reconsider this decision.
Roder 1995 This was a randomised trial of 75 people with stable trochanteric fracture: 25 were treated with a sliding hip
screw 25 with a Gamma nail and 25 with a Gamma nail with a modification of the surgical technique using a
4.5 mm drill hole in the lateral femur approximately 5 cm distal to the tip of the nail. The aim was to determine
if the drill hole would reduce the risk of bone marrow vascular embolism. The only outcome measure was the
degree of marrow embolisation as determined by transoesophageal ultrasound. The results indicated minimal
bone marrow embolisation with the SHS and mild embolisation with the Gamma nail inserted with a distal
femoral drill hole. For the 25 people treated with the Gamma nail inserted without a drill hole there was heavy
bone marrow embolisation as judged by ultrasound.
The trial was excluded as:
1. There were no clinical outcomes relevant to this review of SHS versus Gamma nail
2. There was no follow up of trial participants
The study is included in the Cochrane review ’ Osteotomy, compression and reaming techniques for internal
fixation of extracapsular hip fractures’
Schipper 2004 This was a randomised trial comparing the Gamma nail with the proximal femoral nail in 424 people. It was
excluded because there was no extramedullary comparison group, but has been included in the Cochrane review
comparing different types of intramedullary nails for extracapsular hip fractures.
Tarantino 2005 This was a two-centre comparison between theGamma nail versus a variable angle sliding hip screw in 142 people
with extracapsular hip fractures. Patients who had undergone fixation with the Gamma nail at one hospital were
matched by age, sex and type of fracture to patients treated with a sliding screw device at the other hospital. The
study was excluded because there was no randomisation of patients.
Characteristics of ongoing studies [ordered by study ID]
Parker
Trial name or title Randomised trial of Targon intramedullary nail versus sliding hip screw for trochanteric fractures
Methods
Participants 400 patients with a trochanteric hip fracture which is to be treated surgically
Interventions Targon intramedullary nail versus Sliding hip screw
Outcomes Full record of operative and follow-up outcomes until one year from injury with a blinded assessment of
outcome
Starting date 2001
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D A T A A N D A N A L Y S E S
Comparison 1. Femoral nail (4 types) versus sliding hip screw (SHS)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Length of surgery (minutes) -
random-effects model
10 1588 Mean Difference (IV, Random, 95% CI) 3.83 [-1.51, 9.17]
1.1 Gamma nail 6 1045 Mean Difference (IV, Random, 95% CI) 2.48 [-3.60, 8.56]
1.2 Intramedullary hip screw
(IMHS)
3 337 Mean Difference (IV, Random, 95% CI) 8.81 [-7.43, 25.05]
1.3 Proximal femoral nail
(PFN)
1 206 Mean Difference (IV, Random, 95% CI) -1.0 [-9.14, 7.14]
1.4 Targon PF nail 0 0 Mean Difference (IV, Random, 95% CI) Not estimable
2 Operative fracture of the femur 24 3603 Risk Ratio (M-H, Fixed, 95% CI) 3.25 [1.74, 6.08]
2.1 Gamma nail (minus
Papasimos 2005, see sub-
category 05)
17 2650 Risk Ratio (M-H, Fixed, 95% CI) 3.02 [1.48, 6.14]
2.2 Intramedullary hip screw
(IMHS)
5 627 Risk Ratio (M-H, Fixed, 95% CI) 5.01 [1.11, 22.65]
2.3 Proximal femoral nail
(PFN) (minus Papasimos 2005,
see sub-category 05)
1 206 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.4 Targon PF nail 0 0 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.5 Three-group trial results:
Gamma nail or PFN
1 120 Risk Ratio (M-H, Fixed, 95% CI) 1.52 [0.06, 36.46]
3 Later fracture of the femur 26 3328 Risk Ratio (M-H, Fixed, 95% CI) 5.22 [2.56, 10.64]
3.1 Gamma nail (minus
Papasimos 2005, see sub-
category 05)
19 2593 Risk Ratio (M-H, Fixed, 95% CI) 5.23 [2.46, 11.14]
3.2 Intramedullary hip screw
(IMHS)
4 447 Risk Ratio (M-H, Fixed, 95% CI) 5.12 [0.61, 43.33]
3.3 Proximal femoral nail
(PFN) (minus Papasimos 2005,
see sub-category 05)
1 108 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3.4 Targon PF nail 1 60 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3.5 Three-group trial results:
Gamma nail or PFN
1 120 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
4 Cut-out (overall denominators
used)
27 3803 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.80, 1.66]
4.1 Gamma nail (minus
Papasimos 2005, see sub-
category 05)
19 2792 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.77, 1.79]
4.2 Intramedullary hip screw
(IMHS)
4 517 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.24, 2.84]
4.3 Proximal femoral nail
(PFN) (minus Papasimos 2005,
see sub-category 05)
2 314 Risk Ratio (M-H, Fixed, 95% CI) 2.07 [0.39, 11.10]
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4.4 Targon PF nail 1 60 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.21, 6.37]
4.5 Three-group trial results:
Gamma nail or PFN
1 120 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.13, 4.31]
5 Non-union (overall
denominators used)
14 1781 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.35, 2.42]
5.1 Gamma nail (minus
Papasimos 2005, see sub-
category 05)
8 1088 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.25, 3.93]
5.2 Intramedullary hip screw
(IMHS)
3 307 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.21, 4.95]
5.3 Proximal femoral nail
(PFN) (minus Papasimos 2005,
see sub-category 05)
1 206 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.4 Targon PF nail 1 60 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.5 Three-group trial results:
Gamma nail or PFN
1 120 Risk Ratio (M-H, Fixed, 95% CI) 0.5 [0.03, 7.79]
6 All technical complications of
fixation
28 3732 Risk Ratio (M-H, Fixed, 95% CI) 1.97 [1.51, 2.58]
6.1 Gamma nail (minus
Papasimos 2005, see sub-
category 05)
20 2791 Risk Ratio (M-H, Fixed, 95% CI) 2.03 [1.49, 2.76]
6.2 Intramedullary hip screw
(IMHS)
4 447 Risk Ratio (M-H, Fixed, 95% CI) 2.02 [0.93, 4.39]
6.3 Proximal femoral nail
(PFN) (minus Papasimos 2005,
see sub-category 05)
2 314 Risk Ratio (M-H, Fixed, 95% CI) 1.71 [0.42, 6.99]
6.4 Targon PF nail 1 60 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.21, 6.37]
6.5 Three-group trial results:
Gamma nail or PFN
1 120 Risk Ratio (M-H, Fixed, 95% CI) 1.67 [0.49, 5.72]
7 Reoperation (overall
denominators used)
23 3388 Risk Ratio (M-H, Fixed, 95% CI) 1.58 [1.17, 2.12]
7.1 Gamma nail (minus
Papasimos 2005, see sub-
category 05)
17 2684 Risk Ratio (M-H, Fixed, 95% CI) 1.71 [1.22, 2.40]
7.2 Intramedullary hip screw
(IMHS)
2 210 Risk Ratio (M-H, Fixed, 95% CI) 0.53 [0.15, 1.88]
7.3 Proximal femoral nail
(PFN) (minus Papasimos 2005,
see sub-category 05)
2 314 Risk Ratio (M-H, Fixed, 95% CI) 2.07 [0.64, 6.73]
7.4 Targon PF nail 1 60 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.21, 6.37]
7.5 Three-group trial results:
Gamma nail or PFN
1 120 Risk Ratio (M-H, Fixed, 95% CI) 1.33 [0.37, 4.75]
8 Deep wound infection 18 2595 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.54, 2.17]
8.1 Gamma nail 12 1869 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.46, 2.17]
8.2 Intramedullary hip screw
(IMHS)
3 390 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.08]
8.3 Proximal femoral nail
(PFN)
2 276 Risk Ratio (M-H, Fixed, 95% CI) 3.38 [0.36, 31.84]
8.4 Targon PF nail 1 60 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
9 Mortality 23 3123 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.84, 1.12]
9.1 Gamma nail 16 2306 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.81, 1.12]
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9.2 Intramedullary hip screw
(IMHS)
4 443 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.67, 1.24]
9.3 Proximal femoral nail
(PFN)
2 314 Risk Ratio (M-H, Fixed, 95% CI) 1.40 [0.75, 2.62]
9.4 Targon PF nail 1 60 Risk Ratio (M-H, Fixed, 95% CI) 1.53 [0.15, 15.97]
10 Pain at follow up 8 897 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.93, 1.30]
10.1 Gamma nail 5 634 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.90, 1.30]
10.2 Intramedullary hip screw
(IMHS)
3 263 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [0.79, 1.75]
10.3 Proximal femoral nail
(PFN)
0 0 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
10.4 Targon PF nail 0 0 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
11 Non return to previous
residence or dead
9 1070 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.88, 1.16]
11.1 Gamma nail 4 439 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.70, 1.15]
11.2 Intramedullary hip screw
(IMHS)
3 330 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.82, 1.33]
11.3 Proximal femoral nail
(PFN)
2 301 Risk Ratio (M-H, Fixed, 95% CI) 1.11 [0.89, 1.39]
11.4 Targon PF nail 0 0 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 2. Gamma nail versus sliding hip screw (SHS)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Length of surgery (minutes) -
random-effects model
6 1045 Mean Difference (IV, Random, 95% CI) 2.48 [-3.60, 8.56]
2 Blood loss (ml) - random-effects
model
5 953 Mean Difference (IV, Random, 95% CI) -29.04 [-73.17,
15.10]
3 Number of people given
transfusion - random-effects
model
3 756 Risk Ratio (M-H, Random, 95% CI) 1.06 [0.67, 1.68]
4 Radiographic screening time
(seconds) - random-effects
model
4 Mean Difference (IV, Random, 95% CI) Totals not selected
5 Operative fracture of femur 18 2730 Risk Ratio (M-H, Fixed, 95% CI) 3.02 [1.51, 6.03]
6 Operative fracture of femur
(reported experience with
devices)
18 2730 Risk Ratio (M-H, Fixed, 95% CI) 3.02 [1.51, 6.03]
6.1 Experienced surgeon
(score = 1)
5 1029 Risk Ratio (M-H, Fixed, 95% CI) 2.71 [0.80, 9.15]
6.2 Not experienced surgeon
(score = 0)
11 1412 Risk Ratio (M-H, Fixed, 95% CI) 3.84 [1.45, 10.22]
6.3 Mixed experience (score =
0)
2 289 Risk Ratio (M-H, Fixed, 95% CI) 1.5 [0.26, 8.77]
7 Later fracture of femur 20 2673 Risk Ratio (M-H, Fixed, 95% CI) 5.23 [2.46, 11.14]
8 Cut-out 20 2695 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.76, 1.72]
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9 Cut-out (reported experience
with devices)
20 2695 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.76, 1.72]
9.1 Experienced surgeon
(score = 1)
5 964 Risk Ratio (M-H, Fixed, 95% CI) 1.12 [0.54, 2.33]
9.2 Not experienced surgeon
(score = 0)
13 1442 Risk Ratio (M-H, Fixed, 95% CI) 1.30 [0.77, 2.19]
9.3 Mixed experience (score =
0)
2 289 Risk Ratio (M-H, Fixed, 95% CI) 0.51 [0.11, 2.28]
10 Cut-out: overall denominators
used
20 2872 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [0.78, 1.76]
11 Non-union 9 1050 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.29, 3.31]
12 Non-union: overall
denominators used
9 1168 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.29, 3.40]
13 All technical complications of
fixation
21 2871 Risk Ratio (M-H, Fixed, 95% CI) 2.00 [1.48, 2.69]
14 Reoperation 18 2665 Risk Ratio (M-H, Fixed, 95% CI) 1.66 [1.19, 2.31]
15 Reoperation: overall
denominators used
18 2764 Risk Ratio (M-H, Fixed, 95% CI) 1.67 [1.20, 2.32]
16Wound infection or haematoma 17 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
16.1 Wound infection - any
type
14 1794 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.62, 1.50]
16.2 Deep wound infection 12 1869 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.46, 2.17]
16.3 Wound haematoma 8 819 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.34, 1.79]
17 Pneumonia 9 921 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.47, 1.83]
18 Pressure sore 5 466 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.32, 1.42]
19 Thromboembolic
complications
12 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
19.1 Thromboembolic
complication
11 1627 Risk Ratio (M-H, Fixed, 95% CI) 1.46 [0.90, 2.36]
19.2 Deep vein thrombosis 10 1506 Risk Ratio (M-H, Fixed, 95% CI) 1.26 [0.77, 2.06]
19.3 Pulmonary embolism 4 401 Risk Ratio (M-H, Fixed, 95% CI) 1.97 [0.50, 7.82]
20 Any medical complication 6 629 Risk Ratio (M-H, Random, 95% CI) 1.13 [0.69, 1.84]
21 Length of hospital stay (days) 5 620 Mean Difference (IV, Fixed, 95% CI) -0.13 [-1.50, 1.24]
22 Anatomical deformity 8 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
22.1 Shortening of leg 3 335 Risk Ratio (M-H, Fixed, 95% CI) 0.46 [0.21, 1.03]
22.2 Varus deformity 5 679 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.34, 1.37]
22.3 External rotational
deformity
2 229 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.28, 4.19]
23 Mortality 16 2306 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.81, 1.12]
24 Mortality (allocation
concealment: Cochrane rating
A,B,C)
16 2306 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.81, 1.12]
24.1 Allocation concealment:
A (fully concealed)
3 314 Risk Ratio (M-H, Fixed, 95% CI) 2.01 [0.94, 4.33]
24.2 Allocation concealment:
B (unknown)
7 1343 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.74, 1.10]
24.3 Allocation concealment:
C (not concealed)
6 649 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.66, 1.31]
25 Pain at follow up 5 634 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.90, 1.30]
26 Non-return to previous
residence
4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
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26.1 Non-return to previous
residence (survivors)
3 189 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.39, 1.31]
26.2 Non-return to previous
residence or dead
4 439 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.70, 1.15]
27 Impaired walking 8 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
27.1 Impaired walking 8 984 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.89, 1.10]
27.2 Impaired walking
(overall denominators used)
8 1311 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.89, 1.13]
28 Reoperation - subgrouped by
type of Gamma nail
18 2665 Risk Ratio (M-H, Fixed, 95% CI) 1.66 [1.19, 2.31]
28.1 Gamma 1 nail 15 2276 Risk Ratio (M-H, Fixed, 95% CI) 1.80 [1.24, 2.62]
28.2 Trochanteric Gamma
nail
3 389 Risk Ratio (M-H, Fixed, 95% CI) 1.23 [0.61, 2.47]
Comparison 3. Intramedullary hip screw (IMHS) versus sliding hip screw (SHS)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Length of surgery (minutes) -
random-effects model
3 337 Mean Difference (IV, Random, 95% CI) 8.81 [-7.43, 25.05]
2 Blood loss (ml) 2 235 Mean Difference (IV, Fixed, 95% CI) -62.42 [-98.56, -
26.28]
3 Transfusion (units of red cells) -
random-effects model
2 235 Mean Difference (IV, Random, 95% CI) -0.00 [-0.68, 0.67]
4 Number of patients transfused 1 102 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.52, 1.39]
5 Radiographic screening time
(minutes)
2 237 Mean Difference (IV, Fixed, 95% CI) 1.15 [0.83, 1.47]
6 Fracture fixation complications 5 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 Operative fracture of
femur
5 627 Risk Ratio (M-H, Fixed, 95% CI) 5.01 [1.11, 22.65]
6.2 Later fracture of femur 4 447 Risk Ratio (M-H, Fixed, 95% CI) 5.12 [0.61, 43.33]
6.3 Cut-out 4 517 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.24, 2.84]
6.4 Non-union 3 307 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.21, 4.95]
6.5 Detachment of the plate
from the femur
1 102 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.01, 8.31]
6.6 All technical complications
of fixation
4 447 Risk Ratio (M-H, Fixed, 95% CI) 2.02 [0.93, 4.39]
6.7 Reoperation 2 210 Risk Ratio (M-H, Fixed, 95% CI) 0.53 [0.15, 1.88]
7 Wound infection or haematoma 4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7.1 Wound infection - any
type
3 390 Risk Ratio (M-H, Fixed, 95% CI) 0.4 [0.08, 2.01]
7.2 Deep wound infection 3 390 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.08]
7.3 Wound haematoma 3 345 Risk Ratio (M-H, Fixed, 95% CI) 1.47 [0.54, 4.02]
8 Post-operative complications 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
8.1 Mortality 2 210 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.35, 2.83]
8.2 Thromboembolic
complication
1 100 Risk Ratio (M-H, Fixed, 95% CI) 0.5 [0.05, 5.34]
8.3 Deep vein thrombosis 2 210 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.17, 5.62]
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8.4 Pulmonary embolism 1 100 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 7.99]
8.5 Major medical
complication
2 245 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.64, 2.10]
9 Length of hospital stay (days) 2 237 Mean Difference (IV, Fixed, 95% CI) 1.00 [-1.37, 3.37]
10 Mean limb shortening (cm) 1 64 Mean Difference (IV, Fixed, 95% CI) -0.70 [-1.13, -0.27]
11 Final outcome measures 4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
11.1 Mortality 4 443 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.67, 1.24]
11.2 Pain 3 263 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [0.79, 1.75]
11.3 Failure to return home
(survivors)
3 256 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.78, 1.73]
11.4 Failure to return home
or dead
3 330 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.82, 1.33]
11.5 Failure to return home
or dead (overall denominators
used)
3 341 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.79, 1.28]
11.6 Failure to regain mobility 1 105 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.53, 1.73]
11.7 Poor mobility 1 88 Risk Ratio (M-H, Fixed, 95% CI) 0.80 [0.48, 1.35]
Comparison 4. Proximal femoral nail (PFN) versus sliding hip screw (SHS)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Length of surgery (minutes) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2 Blood loss and transfusion 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Blood loss (ml) 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2.2 Transfusion (units of red
blood cells)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
3 Number of patients transfused 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4 Radiographic screening time
(minutes)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5 Fracture fixation complications 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Operative fracture femur 1 80 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.2 Later fracture of femur 2 188 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.3 Cut-out 3 356 Risk Ratio (M-H, Fixed, 95% CI) 1.31 [0.36, 4.75]
5.4 Cut-out: overall
denominators used
3 394 Risk Ratio (M-H, Fixed, 95% CI) 1.28 [0.35, 4.67]
5.5 Non-union 2 248 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 7.95]
5.6 All technical complications
of fixation
3 394 Risk Ratio (M-H, Fixed, 95% CI) 1.86 [0.71, 4.85]
5.7 Reoperation 3 356 Risk Ratio (M-H, Fixed, 95% CI) 1.94 [0.80, 4.71]
5.8 Reoperation: overall
denominators used
3 394 Risk Ratio (M-H, Fixed, 95% CI) 1.90 [0.78, 4.62]
6 Wound infection or haematoma 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 Superficial wound
infection
2 188 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.06, 15.44]
6.2 Deep wound infection 2 276 Risk Ratio (M-H, Fixed, 95% CI) 3.38 [0.36, 31.84]
6.3 Haematoma 1 80 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.21, 4.66]
7 Post-operative complications 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
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7.1 Pneumonia 2 286 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.39, 2.91]
7.2 Pressure sores 1 206 Risk Ratio (M-H, Fixed, 95% CI) 0.80 [0.18, 3.46]
7.3 Deep vein thrombosis 3 394 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.12, 3.98]
7.4 Pulmonary embolism 2 286 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.12, 3.98]
7.5 Urinary tract infection 2 286 Risk Ratio (M-H, Fixed, 95% CI) 1.48 [0.95, 2.30]
7.6 Any medical complication 1 206 Risk Ratio (M-H, Fixed, 95% CI) 1.12 [0.85, 1.49]
8 Length of hospital stay (days) 2 314 Mean Difference (IV, Fixed, 95% CI) 0.27 [-0.76, 1.30]
9 Final outcome measures 2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
9.1 Mortality at 4 months 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
9.2 Mortality at 1 year 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
9.3 In nursing home at 1 year 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
9.4 In nursing home or dead
at 1 year
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
9.5 In nursing home or dead
at 1 year (overall denominators
used)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
9.6 Failure to regain pre-
fracture residential status at 4
months
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
9.7 Failure to regain pre-
fracture residential status,
seriously ill or dead at 4 months
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
9.8 Failure to recover previous
mobility at 4 months
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
9.9 Failure to recover previous
mobility or dead at 4 months
(overall denominators used)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 5. Targon PF (proximal femoral) nail versus sliding hip screw (SHS)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Fracture fixation complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Later fracture of the femur 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Cut-out 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Non-union 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.4 All technical complications
of fixation
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.5 Reoperation 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2 Wound infection 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 All wound infections 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.2 Deep wound infection 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3 Post-operative compiications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Pneumonia 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3.2 Deep vein thrombosis 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
4 Mortality 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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Comparison 6. Mini-invasive static (experimental) nail versus sliding hip screw (SHS)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Operative details 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Length of surgery
(minutes)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.2 Operative blood loss (ml) 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.3 Total blood loss (ml) 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.4 Radiographic screening
time (seconds)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2 Time to radiographic healing
(weeks)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3 Mortality 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4 Time to effective weight bearing
(weeks)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
Comparison 7. Kuntscher-Y nail versus sliding hip screw (SHS)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Fracture fixation complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Cut-out 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 All fixation complications 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Reoperation 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2 Wound infection 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Superficial wound
infection
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.2 Deep wound infection 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3 Post-operative complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Thromboembolic
complications
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3.2 Pneumonia 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3.3 Pressure sores 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3.4 All medical complications 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
4 Anatomical deformity 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 Leg shortening 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
4.2 Varus deformity 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
4.3 External rotation
deformity
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5 Final outcome measures 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 Mortality 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.2 Failure to regain pre-
fracture mobility
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.3 Death or failure to regain
pre-fracture mobility
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
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Comparison 8. Femoral nail (2 types) versus Medoff sliding plate
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Length of surgery (minutes) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Proximal femoral nail
(PFN)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2 Operative blood loss (mls) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Proximal femoral nail
(PFN)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
3 Radiographic screening time
(minutes)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 Proximal femoral nail
(PFN)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4 Operative fracture of the femur 2 420 Risk Ratio (M-H, Fixed, 95% CI) 4.84 [0.57, 40.81]
4.1 Gamma nail 1 217 Risk Ratio (M-H, Fixed, 95% CI) 6.94 [0.36, 132.70]
4.2 Proximal femoral nail
(PFN)
1 203 Risk Ratio (M-H, Fixed, 95% CI) 2.80 [0.12, 67.98]
5 Later fracture of femur 2 420 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.1 Gamma nail 1 217 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.2 Proximal femoral nail
(PFN)
1 203 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
6 Cut-out 2 420 Risk Ratio (M-H, Fixed, 95% CI) 1.44 [0.52, 4.01]
6.1 Gamma nail 1 217 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.17, 3.24]
6.2 Proximal femoral nail
(PFN)
1 203 Risk Ratio (M-H, Fixed, 95% CI) 2.8 [0.58, 13.55]
7 Non-union 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
7.1 Proximal femoral nail
(PFN)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
8 All technical complications of
fixation
2 420 Risk Ratio (M-H, Fixed, 95% CI) 1.23 [0.57, 2.65]
8.1 Gamma nail 1 217 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.29, 2.45]
8.2 Proximal femoral nail
(PFN)
1 203 Risk Ratio (M-H, Fixed, 95% CI) 1.87 [0.58, 6.00]
9 Reoperation 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
9.1 Gamma nail 1 217 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.09, 1.19]
9.2 Proximal femoral nail
(PFN)
1 203 Risk Ratio (M-H, Fixed, 95% CI) 8.4 [1.08, 65.09]
10 Wound infection - any type 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
10.1 Gamma nail 1 217 Risk Ratio (M-H, Fixed, 95% CI) 0.25 [0.05, 1.14]
10.2 Proximal femoral nail
(PFN)
1 203 Risk Ratio (M-H, Fixed, 95% CI) 3.73 [0.81, 17.15]
11 Deep wound infection 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
11.1 Gamma nail 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
12 Wound haematoma 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
12.1 Proximal femoral nail
(PFN)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
13 Severe medical complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
13.1 Gamma nail 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
14 Mortality at 1 year 2 420 Risk Ratio (M-H, Fixed, 95% CI) 0.77 [0.53, 1.12]
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14.1 Gamma nail 1 217 Risk Ratio (M-H, Fixed, 95% CI) 0.77 [0.48, 1.22]
14.2 Proximal femoral nail
(PFN)
1 203 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.42, 1.46]
15 Inability to walk 15 metres at
one year
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
15.1 Proximal femoral nail
(PFN)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
16 Inability to rise from a chair at
one year
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
16.1 Proximal femoral nail
(PFN)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
17 Inability to climb a curb at one
year
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
17.1 Proximal femoral nail
(PFN)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
18 Need to use walking aids at one
year
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
18.1 Proximal femoral nail
(PFN)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 9. Femoral nail (2 types) versus condylar or blade plate
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Length of surgery (minutes) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Proximal femoral nail
(PFN) versus Dynamic
Condylar Plate (DCP)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2 Number of patients transfused 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Proximal femoral nail
(PFN) versus Dynamic
Condylar Plate (DCP)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3 Radiographic screening time
(minutes)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 Proximal femoral nail
(PFN) versus Dynamic
Condylar Plate (DCP)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4 Operative fracture of femur 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.2 Gamma nail versus 90
degree blade plate
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5 Cut-out 2 65 Risk Ratio (M-H, Fixed, 95% CI) 0.32 [0.07, 1.53]
5.1 Proximal femoral nail
(PFN) versus Dynamic
Condylar Plate (DCP)
1 39 Risk Ratio (M-H, Fixed, 95% CI) 0.09 [0.01, 1.47]
5.2 Gamma nail versus 90
degree blade plate
1 26 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.13, 67.51]
6 Non-union 2 61 Risk Ratio (M-H, Fixed, 95% CI) 0.42 [0.06, 2.69]
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6.1 Proximal femoral nail
(PFN) versus Dynamic
Condylar Plate (DCP)
1 35 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.06, 13.93]
6.2 Gamma nail versus 90
degree blade plate
1 26 Risk Ratio (M-H, Fixed, 95% CI) 0.2 [0.01, 3.80]
7 All technical complications of
fixation
2 61 Risk Ratio (M-H, Fixed, 95% CI) 0.23 [0.07, 0.71]
7.1 Proximal femoral nail
(PFN) versus Dynamic
Condylar Plate (DCP)
1 35 Risk Ratio (M-H, Fixed, 95% CI) 0.13 [0.02, 0.98]
7.2 Gamma nail versus 90
degree blade plate
1 26 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.08, 1.36]
8 Reoperation 2 65 Risk Ratio (M-H, Fixed, 95% CI) 0.07 [0.00, 1.22]
8.1 Proximal femoral nail
(PFN) versus Dynamic
Condylar Plate (DCP)
1 39 Risk Ratio (M-H, Fixed, 95% CI) 0.07 [0.00, 1.22]
8.2 Gamma nail versus 90
degree blade plate
1 26 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
9 Deep wound infection 2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
9.1 Proximal femoral nail
(PFN) versus Dynamic
Condylar Plate (DCP)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
9.2 Gamma nail versus 90
degree blade plate
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
10 Pneumonia 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
10.1 Proximal femoral
nail (PFN) versus Dynamic
Condylar Plate (DCP)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
11 Pressure sores 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
11.1 Proximal femoral
nail (PFN) versus Dynamic
Condylar Plate (DCP)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
12 Deep vein thrombosis 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
12.1 Proximal femoral
nail (PFN) versus Dynamic
Condylar Plate (DCP)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
13 Pulmonary embolism 2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
13.1 Proximal femoral
nail (PFN) versus Dynamic
Condylar Plate (DCP)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
13.2 Gamma nail versus 90
degree blade plate
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
14 All medical complications 2 65 Risk Ratio (M-H, Fixed, 95% CI) 1.20 [0.69, 2.06]
14.1 Proximal femoral
nail (PFN) versus Dynamic
Condylar Plate (DCP)
1 39 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [0.57, 2.62]
14.2 Gamma nail versus 90
degree blade plate
1 26 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [0.54, 2.53]
15 Length of hospital stay (days) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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15.1 Proximal femoral
nail (PFN) versus Dynamic
Condylar Plate (DCP)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
16 Mortality (1 year) 2 65 Risk Ratio (M-H, Fixed, 95% CI) 1.9 [0.19, 19.27]
16.1 Proximal femoral
nail (PFN) versus Dynamic
Condylar Plate (DCP)
1 39 Risk Ratio (M-H, Fixed, 95% CI) 1.9 [0.19, 19.27]
16.2 Gamma nail versus 90
degree blade plate
1 26 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
17 Pain at follow up 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
17.2 Gamma nail versus 90
degree blade plate
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
18 In nursing home at one year
from injury
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
18.1 Proximal femoral
nail (PFN) versus Dynamic
Condylar Plate (DCP)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
19 In nursing home or dead at one
year from injury
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
19.1 Proximal femoral
nail (PFN) versus Dynamic
Condylar Plate (DCP)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
20 Use of walking aids 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
20.2 Gamma nail versus 90
degree blade plate
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
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Analysis 1.1. Comparison 1 Femoral nail (4 types) versus sliding hip screw (SHS), Outcome 1 Length of
surgery (minutes) - random-effects model.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 1 Femoral nail (4 types) versus sliding hip screw (SHS)
Outcome: 1 Length of surgery (minutes) - random-effects model
Study or subgroup Short femoral nail Sliding hip screw Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Gamma nail
Adams 2001 203 55.4 (20) 197 61.3 (22.2) 11.9 % -5.90 [ -10.04, -1.76 ]
Hoffman 1996 31 56.7 (17) 36 54.3 (16.4) 9.9 % 2.40 [ -5.63, 10.43 ]
Kukla 1997 60 47.1 (20.8) 60 53.4 (8.3) 11.2 % -6.30 [ -11.97, -0.63 ]
O’Brien 1995 53 59 (23.9) 49 47 (13.3) 10.2 % 12.00 [ 4.57, 19.43 ]
Ovesen 2006 73 65 (29) 73 51 (22) 9.7 % 14.00 [ 5.65, 22.35 ]
Utrilla 2005 104 46 (11) 106 44 (15) 12.1 % 2.00 [ -1.55, 5.55 ]
Subtotal (95% CI) 524 521 65.0 % 2.48 [ -3.60, 8.56 ]
Heterogeneity: Tau2 = 47.36; Chi2 = 34.80, df = 5 (P<0.00001); I2 =86%
Test for overall effect: Z = 0.80 (P = 0.42)
2 Intramedullary hip screw (IMHS)
Baumgaertner 1998 67 72 (33) 68 80 (35) 8.0 % -8.00 [ -19.47, 3.47 ]
Hardy 1998 50 71 (28.9) 50 57 (24.8) 8.5 % 14.00 [ 3.44, 24.56 ]
Harrington 2002 50 108 (26.8) 52 88 (27.5) 8.5 % 20.00 [ 9.46, 30.54 ]
Subtotal (95% CI) 167 170 25.1 % 8.81 [ -7.43, 25.05 ]
Heterogeneity: Tau2 = 175.30; Chi2 = 13.45, df = 2 (P = 0.001); I2 =85%
Test for overall effect: Z = 1.06 (P = 0.29)
3 Proximal femoral nail (PFN)
Saudan 2002 100 64 (33) 106 65 (26) 9.9 % -1.00 [ -9.14, 7.14 ]
Subtotal (95% CI) 100 106 9.9 % -1.00 [ -9.14, 7.14 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.24 (P = 0.81)
4 Targon PF nail
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 791 797 100.0 % 3.83 [ -1.51, 9.17 ]
Heterogeneity: Tau2 = 58.02; Chi2 = 56.04, df = 9 (P<0.00001); I2 =84%
Test for overall effect: Z = 1.41 (P = 0.16)
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Analysis 1.2. Comparison 1 Femoral nail (4 types) versus sliding hip screw (SHS), Outcome 2 Operative
fracture of the femur.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 1 Femoral nail (4 types) versus sliding hip screw (SHS)
Outcome: 2 Operative fracture of the femur
Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail (minus Papasimos 2005, see sub-category 05)
Adams 2001 1/203 0/197 2.91 [ 0.12, 71.05 ]
Ahrengart 1994 0/105 1/104 0.33 [ 0.01, 8.01 ]
Benum 1994 4/226 0/234 9.32 [ 0.50, 172.07 ]
Bridle 1991 1/49 0/51 3.12 [ 0.13, 74.80 ]
Goldhagen 1994 0/36 0/39 0.0 [ 0.0, 0.0 ]
Guyer 1991 1/50 0/50 3.00 [ 0.13, 71.92 ]
Hoffman 1996 1/31 0/36 3.47 [ 0.15, 82.21 ]
Kukla 1997 0/60 0/60 0.0 [ 0.0, 0.0 ]
Kuwabara 1998 0/20 0/23 0.0 [ 0.0, 0.0 ]
Leung 1992 3/93 2/93 1.50 [ 0.26, 8.77 ]
Marques Lopez 2002 0/43 0/60 0.0 [ 0.0, 0.0 ]
Mott 1993 3/35 0/34 6.81 [ 0.36, 127.00 ]
O’Brien 1995 2/53 0/49 4.63 [ 0.23, 94.10 ]
Ovesen 2006 0/73 0/73 0.0 [ 0.0, 0.0 ]
Park 1998 0/30 0/30 0.0 [ 0.0, 0.0 ]
Radford 1993 6/100 1/100 6.00 [ 0.74, 48.94 ]
Utrilla 2005 4/104 2/106 2.04 [ 0.38, 10.89 ]
Subtotal (95% CI) 1311 1339 3.02 [ 1.48, 6.14 ]
Total events: 26 (Short femoral nail), 6 (Sliding hip screw)
Heterogeneity: Chi2 = 4.03, df = 10 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 3.05 (P = 0.0023)
2 Intramedullary hip screw (IMHS)
Baumgaertner 1998 2/67 0/68 5.07 [ 0.25, 103.74 ]
Hardy 1998 3/50 0/50 7.00 [ 0.37, 132.10 ]
Harrington 2002 1/50 0/52 3.12 [ 0.13, 74.78 ]
Hoffmann 1999 2/56 0/54 4.82 [ 0.24, 98.24 ]
0.001 0.01 0.1 1 10 100 1000
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(. . . Continued)
Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Mehdi 2000 0/90 0/90 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 313 314 5.01 [ 1.11, 22.65 ]
Total events: 8 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: Chi2 = 0.14, df = 3 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 2.09 (P = 0.036)
3 Proximal femoral nail (PFN) (minus Papasimos 2005, see sub-category 05)
Saudan 2002 0/100 0/106 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 100 106 0.0 [ 0.0, 0.0 ]
Total events: 0 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
4 Targon PF nail
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 0 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 Three-group trial results: Gamma nail or PFN
Papasimos 2005 1/80 0/40 1.52 [ 0.06, 36.46 ]
Subtotal (95% CI) 80 40 1.52 [ 0.06, 36.46 ]
Total events: 1 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.26 (P = 0.80)
Total (95% CI) 1804 1799 3.25 [ 1.74, 6.08 ]
Total events: 35 (Short femoral nail), 6 (Sliding hip screw)
Heterogeneity: Chi2 = 4.78, df = 15 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 3.70 (P = 0.00022)
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Analysis 1.3. Comparison 1 Femoral nail (4 types) versus sliding hip screw (SHS), Outcome 3 Later fracture
of the femur.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 1 Femoral nail (4 types) versus sliding hip screw (SHS)
Outcome: 3 Later fracture of the femur
Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail (minus Papasimos 2005, see sub-category 05)
Adams 2001 2/203 1/197 1.94 [ 0.18, 21.23 ]
Ahrengart 1994 2/87 0/81 4.66 [ 0.23, 95.61 ]
Benum 1994 5/226 0/234 11.39 [ 0.63, 204.76 ]
Bridle 1991 3/34 0/32 6.60 [ 0.35, 122.96 ]
Butt 1995 8/47 0/48 17.35 [ 1.03, 292.39 ]
Goldhagen 1994 1/36 0/39 3.24 [ 0.14, 77.15 ]
Guyer 1991 0/50 0/50 0.0 [ 0.0, 0.0 ]
Hoffman 1996 1/23 1/31 1.35 [ 0.09, 20.44 ]
Kukla 1997 0/45 0/44 0.0 [ 0.0, 0.0 ]
Kuwabara 1998 1/20 0/23 3.43 [ 0.15, 79.74 ]
Leung 1992 2/93 0/93 5.00 [ 0.24, 102.75 ]
Marques Lopez 2002 0/30 0/38 0.0 [ 0.0, 0.0 ]
Michos 2001 1/25 0/24 2.88 [ 0.12, 67.53 ]
Mott 1993 1/35 0/34 2.92 [ 0.12, 69.20 ]
O’Brien 1995 1/53 0/49 2.78 [ 0.12, 66.62 ]
Ovesen 2006 2/73 0/73 5.00 [ 0.24, 102.38 ]
Park 1998 0/30 0/30 0.0 [ 0.0, 0.0 ]
Radford 1993 5/100 0/100 11.00 [ 0.62, 196.33 ]
Utrilla 2005 0/82 0/81 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 1292 1301 5.23 [ 2.46, 11.14 ]
Total events: 35 (Short femoral nail), 2 (Sliding hip screw)
Heterogeneity: Chi2 = 3.45, df = 13 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 4.29 (P = 0.000018)
2 Intramedullary hip screw (IMHS)
Baumgaertner 1998 3/67 0/68 7.10 [ 0.37, 134.92 ]
Hardy 1998 0/50 0/50 0.0 [ 0.0, 0.0 ]
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Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Harrington 2002 1/50 0/52 3.12 [ 0.13, 74.78 ]
Hoffmann 1999 0/56 0/54 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 223 224 5.12 [ 0.61, 43.33 ]
Total events: 4 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: Chi2 = 0.14, df = 1 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 1.50 (P = 0.13)
3 Proximal femoral nail (PFN) (minus Papasimos 2005, see sub-category 05)
Pajarinen 2005 0/54 0/54 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 54 54 0.0 [ 0.0, 0.0 ]
Total events: 0 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
4 Targon PF nail
Giraud 2005 0/34 0/26 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 34 26 0.0 [ 0.0, 0.0 ]
Total events: 0 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
5 Three-group trial results: Gamma nail or PFN
Papasimos 2005 0/80 0/40 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 80 40 0.0 [ 0.0, 0.0 ]
Total events: 0 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Total (95% CI) 1683 1645 5.22 [ 2.56, 10.64 ]
Total events: 39 (Short femoral nail), 2 (Sliding hip screw)
Heterogeneity: Chi2 = 3.59, df = 15 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 4.55 (P < 0.00001)
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Analysis 1.4. Comparison 1 Femoral nail (4 types) versus sliding hip screw (SHS), Outcome 4 Cut-out
(overall denominators used).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 1 Femoral nail (4 types) versus sliding hip screw (SHS)
Outcome: 4 Cut-out (overall denominators used)
Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail (minus Papasimos 2005, see sub-category 05)
Adams 2001 8/203 4/197 1.94 [ 0.59, 6.34 ]
Ahrengart 1994 3/105 3/104 0.99 [ 0.20, 4.80 ]
Benum 1994 5/226 2/234 2.59 [ 0.51, 13.21 ]
Bridle 1991 2/49 3/51 0.69 [ 0.12, 3.98 ]
Goldhagen 1994 2/36 0/39 5.41 [ 0.27, 108.93 ]
Guyer 1991 1/50 3/50 0.33 [ 0.04, 3.10 ]
Haynes 1996 2/19 3/31 1.09 [ 0.20, 5.93 ]
Hoffman 1996 1/31 1/36 1.16 [ 0.08, 17.80 ]
Kukla 1997 0/60 0/60 0.0 [ 0.0, 0.0 ]
Kuwabara 1998 1/20 1/23 1.15 [ 0.08, 17.22 ]
Leung 1992 2/113 3/113 0.67 [ 0.11, 3.91 ]
Marques Lopez 2002 0/43 2/60 0.28 [ 0.01, 5.63 ]
Michos 2001 0/26 1/26 0.33 [ 0.01, 7.82 ]
Mott 1993 3/35 1/34 2.91 [ 0.32, 26.66 ]
O’Brien 1995 3/53 1/49 2.77 [ 0.30, 25.78 ]
Ovesen 2006 7/73 5/73 1.40 [ 0.47, 4.21 ]
Park 1998 1/30 1/30 1.00 [ 0.07, 15.26 ]
Radford 1993 2/100 3/100 0.67 [ 0.11, 3.90 ]
Utrilla 2005 1/104 2/106 0.51 [ 0.05, 5.53 ]
Subtotal (95% CI) 1376 1416 1.18 [ 0.77, 1.79 ]
Total events: 44 (Short femoral nail), 39 (Sliding hip screw)
Heterogeneity: Chi2 = 8.30, df = 17 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.76 (P = 0.45)
2 Intramedullary hip screw (IMHS)
Baumgaertner 1998 2/67 2/68 1.01 [ 0.15, 7.00 ]
Hardy 1998 0/50 1/50 0.33 [ 0.01, 7.99 ]
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Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Harrington 2002 1/50 1/52 1.04 [ 0.07, 16.18 ]
Mehdi 2000 1/90 1/90 1.00 [ 0.06, 15.74 ]
Subtotal (95% CI) 257 260 0.83 [ 0.24, 2.84 ]
Total events: 4 (Short femoral nail), 5 (Sliding hip screw)
Heterogeneity: Chi2 = 0.40, df = 3 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.30 (P = 0.77)
3 Proximal femoral nail (PFN) (minus Papasimos 2005, see sub-category 05)
Pajarinen 2005 1/54 1/54 1.00 [ 0.06, 15.58 ]
Saudan 2002 3/100 1/106 3.18 [ 0.34, 30.07 ]
Subtotal (95% CI) 154 160 2.07 [ 0.39, 11.10 ]
Total events: 4 (Short femoral nail), 2 (Sliding hip screw)
Heterogeneity: Chi2 = 0.41, df = 1 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 0.85 (P = 0.39)
4 Targon PF nail
Giraud 2005 3/34 2/26 1.15 [ 0.21, 6.37 ]
Subtotal (95% CI) 34 26 1.15 [ 0.21, 6.37 ]
Total events: 3 (Short femoral nail), 2 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.16 (P = 0.88)
5 Three-group trial results: Gamma nail or PFN
Papasimos 2005 3/80 2/40 0.75 [ 0.13, 4.31 ]
Subtotal (95% CI) 80 40 0.75 [ 0.13, 4.31 ]
Total events: 3 (Short femoral nail), 2 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.32 (P = 0.75)
Total (95% CI) 1901 1902 1.15 [ 0.80, 1.66 ]
Total events: 58 (Short femoral nail), 50 (Sliding hip screw)
Heterogeneity: Chi2 = 9.95, df = 25 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.75 (P = 0.45)
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Analysis 1.5. Comparison 1 Femoral nail (4 types) versus sliding hip screw (SHS), Outcome 5 Non-union
(overall denominators used).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 1 Femoral nail (4 types) versus sliding hip screw (SHS)
Outcome: 5 Non-union (overall denominators used)
Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail (minus Papasimos 2005, see sub-category 05)
Ahrengart 1994 2/105 2/104 0.99 [ 0.14, 6.90 ]
Goldhagen 1994 0/36 0/39 0.0 [ 0.0, 0.0 ]
Kukla 1997 0/60 0/60 0.0 [ 0.0, 0.0 ]
Leung 1992 1/113 0/113 3.00 [ 0.12, 72.87 ]
Michos 2001 0/26 0/26 0.0 [ 0.0, 0.0 ]
Ovesen 2006 0/73 0/73 0.0 [ 0.0, 0.0 ]
Park 1998 0/30 1/30 0.33 [ 0.01, 7.87 ]
Radford 1993 0/100 0/100 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 543 545 1.00 [ 0.25, 3.93 ]
Total events: 3 (Short femoral nail), 3 (Sliding hip screw)
Heterogeneity: Chi2 = 0.92, df = 2 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
2 Intramedullary hip screw (IMHS)
Baumgaertner 1998 1/67 1/68 1.01 [ 0.06, 15.90 ]
Hardy 1998 0/35 1/35 0.33 [ 0.01, 7.91 ]
Harrington 2002 1/50 0/52 3.12 [ 0.13, 74.78 ]
Subtotal (95% CI) 152 155 1.02 [ 0.21, 4.95 ]
Total events: 2 (Short femoral nail), 2 (Sliding hip screw)
Heterogeneity: Chi2 = 0.95, df = 2 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.02 (P = 0.98)
3 Proximal femoral nail (PFN) (minus Papasimos 2005, see sub-category 05)
Saudan 2002 0/100 0/106 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 100 106 0.0 [ 0.0, 0.0 ]
Total events: 0 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
4 Targon PF nail
Giraud 2005 0/34 0/26 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 34 26 0.0 [ 0.0, 0.0 ]
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Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 0 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
5 Three-group trial results: Gamma nail or PFN
Papasimos 2005 1/80 1/40 0.50 [ 0.03, 7.79 ]
Subtotal (95% CI) 80 40 0.50 [ 0.03, 7.79 ]
Total events: 1 (Short femoral nail), 1 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.49 (P = 0.62)
Total (95% CI) 909 872 0.92 [ 0.35, 2.42 ]
Total events: 6 (Short femoral nail), 6 (Sliding hip screw)
Heterogeneity: Chi2 = 2.09, df = 6 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 0.16 (P = 0.87)
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Analysis 1.6. Comparison 1 Femoral nail (4 types) versus sliding hip screw (SHS), Outcome 6 All technical
complications of fixation.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 1 Femoral nail (4 types) versus sliding hip screw (SHS)
Outcome: 6 All technical complications of fixation
Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail (minus Papasimos 2005, see sub-category 05)
Adams 2001 11/203 7/197 1.52 [ 0.60, 3.85 ]
Ahrengart 1994 7/105 6/104 1.16 [ 0.40, 3.32 ]
Benum 1994 14/226 2/234 7.25 [ 1.67, 31.53 ]
Bridle 1991 7/49 3/51 2.43 [ 0.67, 8.86 ]
Butt 1995 11/47 3/48 3.74 [ 1.11, 12.58 ]
Goldhagen 1994 3/36 0/39 7.57 [ 0.40, 141.62 ]
Guyer 1991 3/50 3/50 1.00 [ 0.21, 4.72 ]
Haynes 1996 3/18 3/23 1.28 [ 0.29, 5.59 ]
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Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Hoffman 1996 3/31 2/36 1.74 [ 0.31, 9.76 ]
Kukla 1997 0/60 0/60 0.0 [ 0.0, 0.0 ]
Kuwabara 1998 2/20 1/23 2.30 [ 0.23, 23.51 ]
Leung 1992 8/93 5/93 1.60 [ 0.54, 4.71 ]
Marques Lopez 2002 0/43 2/60 0.28 [ 0.01, 5.63 ]
Michos 2001 1/26 2/26 0.50 [ 0.05, 5.18 ]
Mott 1993 7/35 1/34 6.80 [ 0.88, 52.37 ]
O’Brien 1995 6/53 1/49 5.55 [ 0.69, 44.45 ]
Ovesen 2006 9/73 5/73 1.80 [ 0.63, 5.11 ]
Park 1998 1/30 2/30 0.50 [ 0.05, 5.22 ]
Radford 1993 13/100 4/100 3.25 [ 1.10, 9.63 ]
Utrilla 2005 5/82 5/81 0.99 [ 0.30, 3.28 ]
Subtotal (95% CI) 1380 1411 2.03 [ 1.49, 2.76 ]
Total events: 114 (Short femoral nail), 57 (Sliding hip screw)
Heterogeneity: Chi2 = 16.40, df = 18 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 4.52 (P < 0.00001)
2 Intramedullary hip screw (IMHS)
Baumgaertner 1998 9/67 3/68 3.04 [ 0.86, 10.76 ]
Hardy 1998 3/50 2/50 1.50 [ 0.26, 8.60 ]
Harrington 2002 4/50 2/52 2.08 [ 0.40, 10.86 ]
Hoffmann 1999 2/56 2/54 0.96 [ 0.14, 6.60 ]
Subtotal (95% CI) 223 224 2.02 [ 0.93, 4.39 ]
Total events: 18 (Short femoral nail), 9 (Sliding hip screw)
Heterogeneity: Chi2 = 1.09, df = 3 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.77 (P = 0.076)
3 Proximal femoral nail (PFN) (minus Papasimos 2005, see sub-category 05)
Pajarinen 2005 2/54 2/54 1.00 [ 0.15, 6.84 ]
Saudan 2002 3/100 1/106 3.18 [ 0.34, 30.07 ]
Subtotal (95% CI) 154 160 1.71 [ 0.42, 6.99 ]
Total events: 5 (Short femoral nail), 3 (Sliding hip screw)
Heterogeneity: Chi2 = 0.59, df = 1 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 0.75 (P = 0.45)
4 Targon PF nail
Giraud 2005 3/34 2/26 1.15 [ 0.21, 6.37 ]
Subtotal (95% CI) 34 26 1.15 [ 0.21, 6.37 ]
Total events: 3 (Short femoral nail), 2 (Sliding hip screw)
Heterogeneity: not applicable
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Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 0.16 (P = 0.88)
5 Three-group trial results: Gamma nail or PFN
Papasimos 2005 10/80 3/40 1.67 [ 0.49, 5.72 ]
Subtotal (95% CI) 80 40 1.67 [ 0.49, 5.72 ]
Total events: 10 (Short femoral nail), 3 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.81 (P = 0.42)
Total (95% CI) 1871 1861 1.97 [ 1.51, 2.58 ]
Total events: 150 (Short femoral nail), 74 (Sliding hip screw)
Heterogeneity: Chi2 = 18.45, df = 26 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 4.94 (P < 0.00001)
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Analysis 1.7. Comparison 1 Femoral nail (4 types) versus sliding hip screw (SHS), Outcome 7 Reoperation
(overall denominators used).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 1 Femoral nail (4 types) versus sliding hip screw (SHS)
Outcome: 7 Reoperation (overall denominators used)
Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail (minus Papasimos 2005, see sub-category 05)
Adams 2001 12/203 8/197 12.1 % 1.46 [ 0.61, 3.48 ]
Ahrengart 1994 6/105 8/104 12.0 % 0.74 [ 0.27, 2.07 ]
Benum 1994 16/226 3/234 4.4 % 5.52 [ 1.63, 18.69 ]
Butt 1995 3/47 0/48 0.7 % 7.15 [ 0.38, 134.67 ]
Goldhagen 1994 3/36 0/39 0.7 % 7.57 [ 0.40, 141.62 ]
Guyer 1991 5/50 6/50 9.0 % 0.83 [ 0.27, 2.55 ]
Haynes 1996 2/19 0/31 0.6 % 8.00 [ 0.40, 158.22 ]
Hoffman 1996 1/31 1/36 1.4 % 1.16 [ 0.08, 17.80 ]
Kukla 1997 1/60 1/60 1.5 % 1.00 [ 0.06, 15.62 ]
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Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Leung 1992 4/113 2/113 3.0 % 2.00 [ 0.37, 10.70 ]
Marques Lopez 2002 2/43 4/60 5.0 % 0.70 [ 0.13, 3.64 ]
Michos 2001 1/26 1/26 1.5 % 1.00 [ 0.07, 15.15 ]
Mott 1993 3/35 0/34 0.8 % 6.81 [ 0.36, 127.00 ]
O’Brien 1995 5/53 2/49 3.1 % 2.31 [ 0.47, 11.37 ]
Ovesen 2006 12/73 6/73 9.0 % 2.00 [ 0.79, 5.04 ]
Radford 1993 6/100 3/100 4.5 % 2.00 [ 0.51, 7.78 ]
Utrilla 2005 1/104 4/106 5.9 % 0.25 [ 0.03, 2.24 ]
Subtotal (95% CI) 1324 1360 75.0 % 1.71 [ 1.22, 2.40 ]
Total events: 83 (Short femoral nail), 49 (Sliding hip screw)
Heterogeneity: Chi2 = 16.38, df = 16 (P = 0.43); I2 =2%
Test for overall effect: Z = 3.11 (P = 0.0018)
2 Intramedullary hip screw (IMHS)
Hoffmann 1999 0/56 2/54 3.8 % 0.19 [ 0.01, 3.93 ]
Hardy 1998 3/50 4/50 6.0 % 0.75 [ 0.18, 3.18 ]
Subtotal (95% CI) 106 104 9.8 % 0.53 [ 0.15, 1.88 ]
Total events: 3 (Short femoral nail), 6 (Sliding hip screw)
Heterogeneity: Chi2 = 0.65, df = 1 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 0.98 (P = 0.33)
3 Proximal femoral nail (PFN) (minus Papasimos 2005, see sub-category 05)
Pajarinen 2005 2/54 2/54 3.0 % 1.00 [ 0.15, 6.84 ]
Saudan 2002 6/100 2/106 2.9 % 3.18 [ 0.66, 15.39 ]
Subtotal (95% CI) 154 160 5.9 % 2.07 [ 0.64, 6.73 ]
Total events: 8 (Short femoral nail), 4 (Sliding hip screw)
Heterogeneity: Chi2 = 0.83, df = 1 (P = 0.36); I2 =0.0%
Test for overall effect: Z = 1.22 (P = 0.22)
4 Targon PF nail
Giraud 2005 3/34 2/26 3.4 % 1.15 [ 0.21, 6.37 ]
Subtotal (95% CI) 34 26 3.4 % 1.15 [ 0.21, 6.37 ]
Total events: 3 (Short femoral nail), 2 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.16 (P = 0.88)
5 Three-group trial results: Gamma nail or PFN
Papasimos 2005 8/80 3/40 6.0 % 1.33 [ 0.37, 4.75 ]
Subtotal (95% CI) 80 40 6.0 % 1.33 [ 0.37, 4.75 ]
Total events: 8 (Short femoral nail), 3 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.44 (P = 0.66)
Total (95% CI) 1698 1690 100.0 % 1.58 [ 1.17, 2.12 ]
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Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 105 (Short femoral nail), 64 (Sliding hip screw)
Heterogeneity: Chi2 = 20.25, df = 22 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 2.99 (P = 0.0027)
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Analysis 1.8. Comparison 1 Femoral nail (4 types) versus sliding hip screw (SHS), Outcome 8 Deep wound
infection.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 1 Femoral nail (4 types) versus sliding hip screw (SHS)
Outcome: 8 Deep wound infection
Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Adams 2001 3/203 2/197 1.46 [ 0.25, 8.62 ]
Ahrengart 1994 0/105 1/104 0.33 [ 0.01, 8.01 ]
Guyer 1991 0/50 1/50 0.33 [ 0.01, 7.99 ]
Hoffman 1996 0/31 0/36 0.0 [ 0.0, 0.0 ]
Kukla 1997 2/60 0/60 5.00 [ 0.25, 102.00 ]
Leung 1992 1/93 3/93 0.33 [ 0.04, 3.15 ]
Mott 1993 0/35 0/34 0.0 [ 0.0, 0.0 ]
O’Brien 1995 0/53 0/49 0.0 [ 0.0, 0.0 ]
Ovesen 2006 2/73 1/73 2.00 [ 0.19, 21.58 ]
Park 1998 1/30 1/30 1.00 [ 0.07, 15.26 ]
Radford 1993 1/100 0/100 3.00 [ 0.12, 72.77 ]
Utrilla 2005 0/104 1/106 0.34 [ 0.01, 8.24 ]
Subtotal (95% CI) 937 932 0.99 [ 0.46, 2.17 ]
Total events: 10 (Short femoral nail), 10 (Sliding hip screw)
Heterogeneity: Chi2 = 4.33, df = 8 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
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Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
2 Intramedullary hip screw (IMHS)
Hardy 1998 0/50 0/50 0.0 [ 0.0, 0.0 ]
Hoffmann 1999 0/56 0/54 0.0 [ 0.0, 0.0 ]
Mehdi 2000 0/90 1/90 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 196 194 0.33 [ 0.01, 8.08 ]
Total events: 0 (Short femoral nail), 1 (Sliding hip screw)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.68 (P = 0.50)
3 Proximal femoral nail (PFN)
Pajarinen 2005 0/54 0/54 0.0 [ 0.0, 0.0 ]
Saudan 2002 3/79 1/89 3.38 [ 0.36, 31.84 ]
Subtotal (95% CI) 133 143 3.38 [ 0.36, 31.84 ]
Total events: 3 (Short femoral nail), 1 (Sliding hip screw)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 1.06 (P = 0.29)
4 Targon PF nail
Giraud 2005 0/34 0/26 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 34 26 0.0 [ 0.0, 0.0 ]
Total events: 0 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Total (95% CI) 1300 1295 1.08 [ 0.54, 2.17 ]
Total events: 13 (Short femoral nail), 12 (Sliding hip screw)
Heterogeneity: Chi2 = 5.89, df = 10 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 0.21 (P = 0.83)
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Analysis 1.9. Comparison 1 Femoral nail (4 types) versus sliding hip screw (SHS), Outcome 9 Mortality.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 1 Femoral nail (4 types) versus sliding hip screw (SHS)
Outcome: 9 Mortality
Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Adams 2001 59/203 61/197 20.8 % 0.94 [ 0.70, 1.27 ]
Ahrengart 1994 18/105 23/104 7.8 % 0.78 [ 0.45, 1.35 ]
Bridle 1991 15/49 19/51 6.3 % 0.82 [ 0.47, 1.43 ]
Butt 1995 5/47 2/48 0.7 % 2.55 [ 0.52, 12.52 ]
Goldhagen 1994 2/36 1/39 0.3 % 2.17 [ 0.21, 22.89 ]
Guyer 1991 8/50 8/50 2.7 % 1.00 [ 0.41, 2.46 ]
Haynes 1996 1/19 8/31 2.0 % 0.20 [ 0.03, 1.51 ]
Hoffman 1996 8/31 5/36 1.6 % 1.86 [ 0.68, 5.10 ]
Kukla 1997 14/60 14/60 4.7 % 1.00 [ 0.52, 1.91 ]
Leung 1992 20/113 20/113 6.7 % 1.00 [ 0.57, 1.75 ]
Marques Lopez 2002 13/43 22/60 6.2 % 0.82 [ 0.47, 1.45 ]
O’Brien 1995 6/52 1/49 0.3 % 5.65 [ 0.71, 45.29 ]
Ovesen 2006 3/73 3/73 1.0 % 1.00 [ 0.21, 4.79 ]
Pahlpatz 1993 6/51 10/53 3.3 % 0.62 [ 0.24, 1.59 ]
Radford 1993 12/100 10/100 3.4 % 1.20 [ 0.54, 2.65 ]
Utrilla 2005 19/104 21/106 7.0 % 0.92 [ 0.53, 1.61 ]
Subtotal (95% CI) 1136 1170 74.7 % 0.95 [ 0.81, 1.12 ]
Total events: 209 (Short femoral nail), 228 (Sliding hip screw)
Heterogeneity: Chi2 = 10.99, df = 15 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 0.59 (P = 0.56)
2 Intramedullary hip screw (IMHS)
Baumgaertner 1998 10/65 17/66 5.7 % 0.60 [ 0.30, 1.21 ]
Hardy 1998 15/50 15/50 5.0 % 1.00 [ 0.55, 1.82 ]
Harrington 2002 20/50 19/52 6.3 % 1.09 [ 0.67, 1.79 ]
Hoffmann 1999 9/56 9/54 3.1 % 0.96 [ 0.41, 2.24 ]
Subtotal (95% CI) 221 222 20.0 % 0.91 [ 0.67, 1.24 ]
Total events: 54 (Short femoral nail), 60 (Sliding hip screw)
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Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 2.03, df = 3 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 0.59 (P = 0.55)
3 Proximal femoral nail (PFN)
Pajarinen 2005 4/54 2/54 0.7 % 2.00 [ 0.38, 10.47 ]
Saudan 2002 16/100 13/106 4.2 % 1.30 [ 0.66, 2.57 ]
Subtotal (95% CI) 154 160 4.9 % 1.40 [ 0.75, 2.62 ]
Total events: 20 (Short femoral nail), 15 (Sliding hip screw)
Heterogeneity: Chi2 = 0.22, df = 1 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 1.05 (P = 0.29)
4 Targon PF nail
Giraud 2005 2/34 1/26 0.4 % 1.53 [ 0.15, 15.97 ]
Subtotal (95% CI) 34 26 0.4 % 1.53 [ 0.15, 15.97 ]
Total events: 2 (Short femoral nail), 1 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: Z = 0.36 (P = 0.72)
Total (95% CI) 1545 1578 100.0 % 0.97 [ 0.84, 1.12 ]
Total events: 285 (Short femoral nail), 304 (Sliding hip screw)
Heterogeneity: Chi2 = 14.77, df = 22 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.45 (P = 0.65)
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Analysis 1.10. Comparison 1 Femoral nail (4 types) versus sliding hip screw (SHS), Outcome 10 Pain at
follow up.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 1 Femoral nail (4 types) versus sliding hip screw (SHS)
Outcome: 10 Pain at follow up
Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Ahrengart 1994 25/88 15/83 10.3 % 1.57 [ 0.89, 2.77 ]
Guyer 1991 19/28 18/32 11.2 % 1.21 [ 0.81, 1.80 ]
Hoffman 1996 9/23 9/31 5.1 % 1.35 [ 0.64, 2.85 ]
Leung 1992 22/93 32/93 21.4 % 0.69 [ 0.43, 1.09 ]
Utrilla 2005 50/82 45/81 30.3 % 1.10 [ 0.85, 1.42 ]
Subtotal (95% CI) 314 320 78.4 % 1.08 [ 0.90, 1.30 ]
Total events: 125 (Short femoral nail), 119 (Sliding hip screw)
Heterogeneity: Chi2 = 6.03, df = 4 (P = 0.20); I2 =34%
Test for overall effect: Z = 0.81 (P = 0.42)
2 Intramedullary hip screw (IMHS)
Baumgaertner 1998 15/52 12/53 8.0 % 1.27 [ 0.66, 2.45 ]
Hardy 1998 9/35 4/35 2.7 % 2.25 [ 0.76, 6.63 ]
Hoffmann 1999 14/45 16/43 11.0 % 0.84 [ 0.47, 1.50 ]
Subtotal (95% CI) 132 131 21.6 % 1.17 [ 0.79, 1.75 ]
Total events: 38 (Short femoral nail), 32 (Sliding hip screw)
Heterogeneity: Chi2 = 2.75, df = 2 (P = 0.25); I2 =27%
Test for overall effect: Z = 0.78 (P = 0.43)
3 Proximal femoral nail (PFN)
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Targon PF nail
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 446 451 100.0 % 1.10 [ 0.93, 1.30 ]
Total events: 163 (Short femoral nail), 151 (Sliding hip screw)
Heterogeneity: Chi2 = 8.75, df = 7 (P = 0.27); I2 =20%
Test for overall effect: Z = 1.10 (P = 0.27)
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Analysis 1.11. Comparison 1 Femoral nail (4 types) versus sliding hip screw (SHS), Outcome 11 Non return
to previous residence or dead.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 1 Femoral nail (4 types) versus sliding hip screw (SHS)
Outcome: 11 Non return to previous residence or dead
Study or subgroup Short femoral nail Sliding hip screw Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Ahrengart 1994 43/105 43/104 19.2 % 0.99 [ 0.72, 1.37 ]
Guyer 1991 11/36 11/40 4.6 % 1.11 [ 0.55, 2.25 ]
Haynes 1996 4/19 15/31 5.1 % 0.44 [ 0.17, 1.12 ]
Pahlpatz 1993 17/51 21/53 9.1 % 0.84 [ 0.50, 1.40 ]
Subtotal (95% CI) 211 228 38.0 % 0.90 [ 0.70, 1.15 ]
Total events: 75 (Short femoral nail), 90 (Sliding hip screw)
Heterogeneity: Chi2 = 3.04, df = 3 (P = 0.39); I2 =1%
Test for overall effect: Z = 0.88 (P = 0.38)
2 Intramedullary hip screw (IMHS)
Baumgaertner 1998 24/58 25/64 10.6 % 1.06 [ 0.69, 1.63 ]
Harrington 2002 31/50 30/52 13.1 % 1.07 [ 0.78, 1.48 ]
Hoffmann 1999 16/54 16/52 7.2 % 0.96 [ 0.54, 1.72 ]
Subtotal (95% CI) 162 168 30.8 % 1.04 [ 0.82, 1.33 ]
Total events: 71 (Short femoral nail), 71 (Sliding hip screw)
Heterogeneity: Chi2 = 0.11, df = 2 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 0.34 (P = 0.73)
3 Proximal femoral nail (PFN)
Pajarinen 2005 18/52 20/52 8.9 % 0.90 [ 0.54, 1.50 ]
Saudan 2002 58/95 52/102 22.3 % 1.20 [ 0.93, 1.54 ]
Subtotal (95% CI) 147 154 31.1 % 1.11 [ 0.89, 1.39 ]
Total events: 76 (Short femoral nail), 72 (Sliding hip screw)
Heterogeneity: Chi2 = 1.01, df = 1 (P = 0.32); I2 =1%
Test for overall effect: Z = 0.93 (P = 0.35)
4 Targon PF nail
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Short femoral nail), 0 (Sliding hip screw)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 520 550 100.0 % 1.01 [ 0.88, 1.16 ]
Total events: 222 (Short femoral nail), 233 (Sliding hip screw)
Heterogeneity: Chi2 = 5.87, df = 8 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.12 (P = 0.90)
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Analysis 2.1. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 1 Length of surgery
(minutes) - random-effects model.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 1 Length of surgery (minutes) - random-effects model
Study or subgroup Gamma nail SHS Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Adams 2001 203 55.4 (20) 197 61.3 (22.2) 18.5 % -5.90 [ -10.04, -1.76 ]
Hoffman 1996 31 56.7 (17) 36 54.3 (16.4) 15.0 % 2.40 [ -5.63, 10.43 ]
Kukla 1997 60 47.1 (20.8) 60 53.4 (8.3) 17.3 % -6.30 [ -11.97, -0.63 ]
O’Brien 1995 53 59 (23.9) 49 47 (13.3) 15.6 % 12.00 [ 4.57, 19.43 ]
Ovesen 2006 73 65 (29) 73 51 (22) 14.7 % 14.00 [ 5.65, 22.35 ]
Utrilla 2005 104 46 (11) 106 44 (15) 19.0 % 2.00 [ -1.55, 5.55 ]
Total (95% CI) 524 521 100.0 % 2.48 [ -3.60, 8.56 ]
Heterogeneity: Tau2 = 47.36; Chi2 = 34.80, df = 5 (P<0.00001); I2 =86%
Test for overall effect: Z = 0.80 (P = 0.42)
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Analysis 2.2. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 2 Blood loss (ml) -
random-effects model.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 2 Blood loss (ml) - random-effects model
Study or subgroup Gamma nail SHS Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Adams 2001 203 244.4 (384.9) 197 260.4 (325.5) 20.3 % -16.00 [ -85.78, 53.78 ]
Kukla 1997 60 152.3 (130.7) 60 160.3 (110.8) 29.5 % -8.00 [ -51.36, 35.36 ]
Leung 1992 93 814 (548) 93 1043 (508) 7.0 % -229.00 [ -380.87, -77.13 ]
O’Brien 1995 52 258.7 (145.4) 49 259.2 (137.5) 25.1 % -0.50 [ -55.67, 54.67 ]
Ovesen 2006 73 240 (190) 73 280 (280) 18.1 % -40.00 [ -117.62, 37.62 ]
Total (95% CI) 481 472 100.0 % -29.04 [ -73.17, 15.10 ]
Heterogeneity: Tau2 = 1230.33; Chi2 = 8.31, df = 4 (P = 0.08); I2 =52%
Test for overall effect: Z = 1.29 (P = 0.20)
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Analysis 2.3. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 3 Number of people
given transfusion - random-effects model.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 3 Number of people given transfusion - random-effects model
Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Random,95% CI M-H,Random,95% CI
Adams 2001 108/203 88/197 39.7 % 1.19 [ 0.97, 1.46 ]
Ovesen 2006 26/73 16/73 27.4 % 1.63 [ 0.95, 2.77 ]
Utrilla 2005 28/104 44/106 32.9 % 0.65 [ 0.44, 0.96 ]
Total (95% CI) 380 376 100.0 % 1.06 [ 0.67, 1.68 ]
Total events: 162 (Gamma nail), 148 (SHS)
Heterogeneity: Tau2 = 0.13; Chi2 = 9.77, df = 2 (P = 0.01); I2 =80%
Test for overall effect: Z = 0.25 (P = 0.80)
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Analysis 2.4. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 4 Radiographic screening
time (seconds) - random-effects model.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 4 Radiographic screening time (seconds) - random-effects model
Study or subgroup Gamma nail SHS Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Hoffman 1996 31 70.2 (33.6) 36 40.8 (21) 29.40 [ 15.73, 43.07 ]
Leung 1992 93 38.2 (8.7) 93 66.9 (13.7) -28.70 [ -32.00, -25.40 ]
O’Brien 1995 48 60 (46.2) 43 26 (18) 34.00 [ 19.87, 48.13 ]
Utrilla 2005 104 132 (72) 106 162 (72) -30.00 [ -49.48, -10.52 ]
-100 -50 0 50 100
Favours Gamma nail Favours SHS
Analysis 2.5. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 5 Operative fracture of
femur.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 5 Operative fracture of femur
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Adams 2001 1/203 0/197 2.91 [ 0.12, 71.05 ]
Ahrengart 1994 0/105 1/104 0.33 [ 0.01, 8.01 ]
Benum 1994 4/226 0/234 9.32 [ 0.50, 172.07 ]
Bridle 1991 1/49 0/51 3.12 [ 0.13, 74.80 ]
Goldhagen 1994 0/36 0/39 0.0 [ 0.0, 0.0 ]
Guyer 1991 1/50 0/50 3.00 [ 0.13, 71.92 ]
Hoffman 1996 1/31 0/36 3.47 [ 0.15, 82.21 ]
Kukla 1997 0/60 0/60 0.0 [ 0.0, 0.0 ]
Kuwabara 1998 0/20 0/23 0.0 [ 0.0, 0.0 ]
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Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Leung 1992 3/93 2/93 1.50 [ 0.26, 8.77 ]
Marques Lopez 2002 0/43 0/60 0.0 [ 0.0, 0.0 ]
Mott 1993 3/35 0/34 6.81 [ 0.36, 127.00 ]
O’Brien 1995 2/53 0/49 4.63 [ 0.23, 94.10 ]
Ovesen 2006 0/73 0/73 0.0 [ 0.0, 0.0 ]
Papasimos 2005 1/40 0/40 3.00 [ 0.13, 71.51 ]
Park 1998 0/30 0/30 0.0 [ 0.0, 0.0 ]
Radford 1993 6/100 1/100 6.00 [ 0.74, 48.94 ]
Utrilla 2005 4/104 2/106 2.04 [ 0.38, 10.89 ]
Total (95% CI) 1351 1379 3.02 [ 1.51, 6.03 ]
Total events: 27 (Gamma nail), 6 (SHS)
Heterogeneity: Chi2 = 4.03, df = 11 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 3.13 (P = 0.0018)
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Analysis 2.6. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 6 Operative fracture of
femur (reported experience with devices).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 6 Operative fracture of femur (reported experience with devices)
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Experienced surgeon (score = 1)
Adams 2001 1/203 0/197 2.91 [ 0.12, 71.05 ]
Ahrengart 1994 0/105 1/104 0.33 [ 0.01, 8.01 ]
Bridle 1991 1/49 0/51 3.12 [ 0.13, 74.80 ]
Kukla 1997 0/60 0/60 0.0 [ 0.0, 0.0 ]
Radford 1993 6/100 1/100 6.00 [ 0.74, 48.94 ]
Subtotal (95% CI) 517 512 2.71 [ 0.80, 9.15 ]
Total events: 8 (Gamma nail), 2 (SHS)
Heterogeneity: Chi2 = 2.23, df = 3 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.61 (P = 0.11)
2 Not experienced surgeon (score = 0)
Benum 1994 4/226 0/234 9.32 [ 0.50, 172.07 ]
Goldhagen 1994 0/36 0/39 0.0 [ 0.0, 0.0 ]
Guyer 1991 1/50 0/50 3.00 [ 0.13, 71.92 ]
Hoffman 1996 1/31 0/36 3.47 [ 0.15, 82.21 ]
Kuwabara 1998 0/20 0/23 0.0 [ 0.0, 0.0 ]
Mott 1993 3/35 0/34 6.81 [ 0.36, 127.00 ]
O’Brien 1995 2/53 0/49 4.63 [ 0.23, 94.10 ]
Ovesen 2006 0/73 0/73 0.0 [ 0.0, 0.0 ]
Papasimos 2005 1/40 0/40 3.00 [ 0.13, 71.51 ]
Park 1998 0/30 0/30 0.0 [ 0.0, 0.0 ]
Utrilla 2005 4/104 2/106 2.04 [ 0.38, 10.89 ]
Subtotal (95% CI) 698 714 3.84 [ 1.45, 10.22 ]
Total events: 16 (Gamma nail), 2 (SHS)
Heterogeneity: Chi2 = 1.12, df = 6 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 2.70 (P = 0.0069)
3 Mixed experience (score = 0)
Leung 1992 3/93 2/93 1.50 [ 0.26, 8.77 ]
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Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Marques Lopez 2002 0/43 0/60 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 136 153 1.50 [ 0.26, 8.77 ]
Total events: 3 (Gamma nail), 2 (SHS)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.45 (P = 0.65)
Total (95% CI) 1351 1379 3.02 [ 1.51, 6.03 ]
Total events: 27 (Gamma nail), 6 (SHS)
Heterogeneity: Chi2 = 4.03, df = 11 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 3.13 (P = 0.0018)
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Analysis 2.7. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 7 Later fracture of femur.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 7 Later fracture of femur
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Adams 2001 2/203 1/197 1.94 [ 0.18, 21.23 ]
Ahrengart 1994 2/87 0/81 4.66 [ 0.23, 95.61 ]
Benum 1994 5/226 0/234 11.39 [ 0.63, 204.76 ]
Bridle 1991 3/34 0/32 6.60 [ 0.35, 122.96 ]
Butt 1995 8/47 0/48 17.35 [ 1.03, 292.39 ]
Goldhagen 1994 1/36 0/39 3.24 [ 0.14, 77.15 ]
Guyer 1991 0/50 0/50 0.0 [ 0.0, 0.0 ]
Hoffman 1996 1/23 1/31 1.35 [ 0.09, 20.44 ]
Kukla 1997 0/45 0/44 0.0 [ 0.0, 0.0 ]
Kuwabara 1998 1/20 0/23 3.43 [ 0.15, 79.74 ]
Leung 1992 2/93 0/93 5.00 [ 0.24, 102.75 ]
Marques Lopez 2002 0/30 0/38 0.0 [ 0.0, 0.0 ]
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Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Michos 2001 1/25 0/24 2.88 [ 0.12, 67.53 ]
Mott 1993 1/35 0/34 2.92 [ 0.12, 69.20 ]
O’Brien 1995 1/53 0/49 2.78 [ 0.12, 66.62 ]
Ovesen 2006 2/73 0/73 5.00 [ 0.24, 102.38 ]
Papasimos 2005 0/40 0/40 0.0 [ 0.0, 0.0 ]
Park 1998 0/30 0/30 0.0 [ 0.0, 0.0 ]
Radford 1993 5/100 0/100 11.00 [ 0.62, 196.33 ]
Utrilla 2005 0/82 0/81 0.0 [ 0.0, 0.0 ]
Total (95% CI) 1332 1341 5.23 [ 2.46, 11.14 ]
Total events: 35 (Gamma nail), 2 (SHS)
Heterogeneity: Chi2 = 3.45, df = 13 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 4.29 (P = 0.000018)
0.001 0.01 0.1 1 10 100 1000
Favours Gamma nail Favours SHS
Analysis 2.8. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 8 Cut-out.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 8 Cut-out
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Adams 2001 8/203 4/197 1.94 [ 0.59, 6.34 ]
Ahrengart 1994 3/105 3/104 0.99 [ 0.20, 4.80 ]
Benum 1994 5/226 2/234 2.59 [ 0.51, 13.21 ]
Bridle 1991 2/34 3/32 0.63 [ 0.11, 3.51 ]
Goldhagen 1994 2/36 0/39 5.41 [ 0.27, 108.93 ]
Guyer 1991 1/50 3/50 0.33 [ 0.04, 3.10 ]
Haynes 1996 2/18 3/23 0.85 [ 0.16, 4.57 ]
Hoffman 1996 1/23 1/31 1.35 [ 0.09, 20.44 ]
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(. . . Continued)
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kukla 1997 0/45 0/44 0.0 [ 0.0, 0.0 ]
Kuwabara 1998 1/20 1/23 1.15 [ 0.08, 17.22 ]
Leung 1992 2/93 3/93 0.67 [ 0.11, 3.90 ]
Marques Lopez 2002 0/43 2/60 0.28 [ 0.01, 5.63 ]
Michos 2001 0/25 1/24 0.32 [ 0.01, 7.50 ]
Mott 1993 3/35 1/34 2.91 [ 0.32, 26.66 ]
O’Brien 1995 3/53 1/49 2.77 [ 0.30, 25.78 ]
Ovesen 2006 7/73 5/73 1.40 [ 0.47, 4.21 ]
Papasimos 2005 2/40 2/40 1.00 [ 0.15, 6.76 ]
Park 1998 1/30 1/30 1.00 [ 0.07, 15.26 ]
Radford 1993 2/100 3/100 0.67 [ 0.11, 3.90 ]
Utrilla 2005 1/82 2/81 0.49 [ 0.05, 5.34 ]
Total (95% CI) 1334 1361 1.15 [ 0.76, 1.72 ]
Total events: 46 (Gamma nail), 41 (SHS)
Heterogeneity: Chi2 = 8.69, df = 18 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 0.66 (P = 0.51)
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Analysis 2.9. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 9 Cut-out (reported
experience with devices).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 9 Cut-out (reported experience with devices)
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Experienced surgeon (score = 1)
Adams 2001 8/203 4/197 1.94 [ 0.59, 6.34 ]
Ahrengart 1994 3/105 3/104 0.99 [ 0.20, 4.80 ]
Bridle 1991 2/34 3/32 0.63 [ 0.11, 3.51 ]
Kukla 1997 0/45 0/44 0.0 [ 0.0, 0.0 ]
Radford 1993 2/100 3/100 0.67 [ 0.11, 3.90 ]
Subtotal (95% CI) 487 477 1.12 [ 0.54, 2.33 ]
Total events: 15 (Gamma nail), 13 (SHS)
Heterogeneity: Chi2 = 1.62, df = 3 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.32 (P = 0.75)
2 Not experienced surgeon (score = 0)
Benum 1994 5/226 2/234 2.59 [ 0.51, 13.21 ]
Goldhagen 1994 2/36 0/39 5.41 [ 0.27, 108.93 ]
Guyer 1991 1/50 3/50 0.33 [ 0.04, 3.10 ]
Haynes 1996 2/18 3/23 0.85 [ 0.16, 4.57 ]
Hoffman 1996 1/23 1/31 1.35 [ 0.09, 20.44 ]
Kuwabara 1998 1/20 1/23 1.15 [ 0.08, 17.22 ]
Michos 2001 0/25 1/24 0.32 [ 0.01, 7.50 ]
Mott 1993 3/35 1/34 2.91 [ 0.32, 26.66 ]
O’Brien 1995 3/53 1/49 2.77 [ 0.30, 25.78 ]
Ovesen 2006 7/73 5/73 1.40 [ 0.47, 4.21 ]
Papasimos 2005 2/40 2/40 1.00 [ 0.15, 6.76 ]
Park 1998 1/30 1/30 1.00 [ 0.07, 15.26 ]
Utrilla 2005 1/82 2/81 0.49 [ 0.05, 5.34 ]
Subtotal (95% CI) 711 731 1.30 [ 0.77, 2.19 ]
Total events: 29 (Gamma nail), 23 (SHS)
Heterogeneity: Chi2 = 5.71, df = 12 (P = 0.93); I2 =0.0%
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(. . . Continued)
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 0.98 (P = 0.33)
3 Mixed experience (score = 0)
Leung 1992 2/93 3/93 0.67 [ 0.11, 3.90 ]
Marques Lopez 2002 0/43 2/60 0.28 [ 0.01, 5.63 ]
Subtotal (95% CI) 136 153 0.51 [ 0.11, 2.28 ]
Total events: 2 (Gamma nail), 5 (SHS)
Heterogeneity: Chi2 = 0.25, df = 1 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.89 (P = 0.38)
Total (95% CI) 1334 1361 1.15 [ 0.76, 1.72 ]
Total events: 46 (Gamma nail), 41 (SHS)
Heterogeneity: Chi2 = 8.69, df = 18 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 0.66 (P = 0.51)
0.001 0.01 0.1 1 10 100 1000
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Analysis 2.10. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 10 Cut-out: overall
denominators used.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 10 Cut-out: overall denominators used
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Adams 2001 8/203 4/197 1.94 [ 0.59, 6.34 ]
Ahrengart 1994 3/105 3/104 0.99 [ 0.20, 4.80 ]
Benum 1994 5/226 2/234 2.59 [ 0.51, 13.21 ]
Bridle 1991 2/49 3/51 0.69 [ 0.12, 3.98 ]
Goldhagen 1994 2/36 0/39 5.41 [ 0.27, 108.93 ]
Guyer 1991 1/50 3/50 0.33 [ 0.04, 3.10 ]
Haynes 1996 2/19 3/31 1.09 [ 0.20, 5.93 ]
Hoffman 1996 1/31 1/36 1.16 [ 0.08, 17.80 ]
Kukla 1997 0/60 0/60 0.0 [ 0.0, 0.0 ]
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Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kuwabara 1998 1/20 1/23 1.15 [ 0.08, 17.22 ]
Leung 1992 2/113 3/113 0.67 [ 0.11, 3.91 ]
Marques Lopez 2002 0/43 2/60 0.28 [ 0.01, 5.63 ]
Michos 2001 0/26 1/26 0.33 [ 0.01, 7.82 ]
Mott 1993 3/35 1/34 2.91 [ 0.32, 26.66 ]
O’Brien 1995 3/53 1/49 2.77 [ 0.30, 25.78 ]
Ovesen 2006 7/73 5/73 1.40 [ 0.47, 4.21 ]
Papasimos 2005 2/40 2/40 1.00 [ 0.15, 6.76 ]
Park 1998 1/30 1/30 1.00 [ 0.07, 15.26 ]
Radford 1993 2/100 3/100 0.67 [ 0.11, 3.90 ]
Utrilla 2005 1/104 2/106 0.51 [ 0.05, 5.53 ]
Total (95% CI) 1416 1456 1.17 [ 0.78, 1.76 ]
Total events: 46 (Gamma nail), 41 (SHS)
Heterogeneity: Chi2 = 8.32, df = 18 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 0.74 (P = 0.46)
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Analysis 2.11. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 11 Non-union.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 11 Non-union
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ahrengart 1994 2/87 2/81 0.93 [ 0.13, 6.46 ]
Goldhagen 1994 0/34 0/38 0.0 [ 0.0, 0.0 ]
Kukla 1997 0/45 0/44 0.0 [ 0.0, 0.0 ]
Leung 1992 1/93 0/93 3.00 [ 0.12, 72.71 ]
Michos 2001 0/25 0/24 0.0 [ 0.0, 0.0 ]
Ovesen 2006 0/73 0/73 0.0 [ 0.0, 0.0 ]
Papasimos 2005 1/40 1/40 1.00 [ 0.06, 15.44 ]
Park 1998 0/30 1/30 0.33 [ 0.01, 7.87 ]
Radford 1993 0/100 0/100 0.0 [ 0.0, 0.0 ]
Total (95% CI) 527 523 0.97 [ 0.29, 3.31 ]
Total events: 4 (Gamma nail), 4 (SHS)
Heterogeneity: Chi2 = 0.92, df = 3 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 0.05 (P = 0.96)
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Analysis 2.12. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 12 Non-union: overall
denominators used.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 12 Non-union: overall denominators used
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ahrengart 1994 2/105 2/104 0.99 [ 0.14, 6.90 ]
Goldhagen 1994 0/36 0/39 0.0 [ 0.0, 0.0 ]
Kukla 1997 0/60 0/60 0.0 [ 0.0, 0.0 ]
Leung 1992 1/113 0/113 3.00 [ 0.12, 72.87 ]
Michos 2001 0/26 0/26 0.0 [ 0.0, 0.0 ]
Ovesen 2006 0/73 0/73 0.0 [ 0.0, 0.0 ]
Papasimos 2005 1/40 1/40 1.00 [ 0.06, 15.44 ]
Park 1998 0/30 1/30 0.33 [ 0.01, 7.87 ]
Radford 1993 0/100 0/100 0.0 [ 0.0, 0.0 ]
Total (95% CI) 583 585 1.00 [ 0.29, 3.40 ]
Total events: 4 (Gamma nail), 4 (SHS)
Heterogeneity: Chi2 = 0.92, df = 3 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 1.0)
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Analysis 2.13. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 13 All technical
complications of fixation.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 13 All technical complications of fixation
Study or subgroup Gamma nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Adams 2001 11/203 7/197 1.52 [ 0.60, 3.85 ]
Ahrengart 1994 7/105 6/104 1.16 [ 0.40, 3.32 ]
Benum 1994 14/226 2/234 7.25 [ 1.67, 31.53 ]
Bridle 1991 7/49 3/51 2.43 [ 0.67, 8.86 ]
Butt 1995 11/47 3/48 3.74 [ 1.11, 12.58 ]
Goldhagen 1994 3/36 0/39 7.57 [ 0.40, 141.62 ]
Guyer 1991 3/50 3/50 1.00 [ 0.21, 4.72 ]
Haynes 1996 3/18 3/23 1.28 [ 0.29, 5.59 ]
Hoffman 1996 3/31 2/36 1.74 [ 0.31, 9.76 ]
Kukla 1997 0/60 0/60 0.0 [ 0.0, 0.0 ]
Kuwabara 1998 2/20 1/23 2.30 [ 0.23, 23.51 ]
Leung 1992 8/93 5/93 1.60 [ 0.54, 4.71 ]
Marques Lopez 2002 0/43 2/60 0.28 [ 0.01, 5.63 ]
Michos 2001 1/26 2/26 0.50 [ 0.05, 5.18 ]
Mott 1993 7/35 1/34 6.80 [ 0.88, 52.37 ]
O’Brien 1995 6/53 1/49 5.55 [ 0.69, 44.45 ]
Ovesen 2006 9/73 5/73 1.80 [ 0.63, 5.11 ]
Papasimos 2005 4/40 3/40 1.33 [ 0.32, 5.58 ]
Park 1998 1/30 2/30 0.50 [ 0.05, 5.22 ]
Radford 1993 13/100 4/100 3.25 [ 1.10, 9.63 ]
Utrilla 2005 5/82 5/81 0.99 [ 0.30, 3.28 ]
Total (95% CI) 1420 1451 2.00 [ 1.48, 2.69 ]
Total events: 118 (Gamma nail), 60 (Sliding hip screw)
Heterogeneity: Chi2 = 16.62, df = 19 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 4.52 (P < 0.00001)
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Analysis 2.14. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 14 Reoperation.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 14 Reoperation
Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Adams 2001 12/203 8/197 15.2 % 1.46 [ 0.61, 3.48 ]
Ahrengart 1994 6/105 8/104 15.0 % 0.74 [ 0.27, 2.07 ]
Benum 1994 16/226 3/234 5.5 % 5.52 [ 1.63, 18.69 ]
Butt 1995 3/47 0/48 0.9 % 7.15 [ 0.38, 134.67 ]
Goldhagen 1994 3/36 0/39 0.9 % 7.57 [ 0.40, 141.62 ]
Guyer 1991 5/50 6/50 11.2 % 0.83 [ 0.27, 2.55 ]
Haynes 1996 2/18 0/23 0.8 % 6.32 [ 0.32, 123.86 ]
Hoffman 1996 1/31 1/36 1.7 % 1.16 [ 0.08, 17.80 ]
Kukla 1997 1/60 1/60 1.9 % 1.00 [ 0.06, 15.62 ]
Leung 1992 4/93 2/93 3.7 % 2.00 [ 0.38, 10.65 ]
Marques Lopez 2002 2/43 4/60 6.3 % 0.70 [ 0.13, 3.64 ]
Michos 2001 1/25 1/24 1.9 % 0.96 [ 0.06, 14.50 ]
Mott 1993 3/35 0/34 0.9 % 6.81 [ 0.36, 127.00 ]
O’Brien 1995 5/53 2/49 3.9 % 2.31 [ 0.47, 11.37 ]
Ovesen 2006 12/73 6/73 11.2 % 2.00 [ 0.79, 5.04 ]
Papasimos 2005 3/40 3/40 5.6 % 1.00 [ 0.21, 4.66 ]
Radford 1993 6/100 3/100 5.6 % 2.00 [ 0.51, 7.78 ]
Utrilla 2005 1/82 4/81 7.5 % 0.25 [ 0.03, 2.16 ]
Total (95% CI) 1320 1345 100.0 % 1.66 [ 1.19, 2.31 ]
Total events: 86 (Gamma nail), 52 (SHS)
Heterogeneity: Chi2 = 16.52, df = 17 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 3.01 (P = 0.0026)
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Analysis 2.15. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 15 Reoperation: overall
denominators used.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 15 Reoperation: overall denominators used
Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Adams 2001 12/203 8/197 15.2 % 1.46 [ 0.61, 3.48 ]
Ahrengart 1994 6/105 8/104 15.1 % 0.74 [ 0.27, 2.07 ]
Benum 1994 16/226 3/234 5.5 % 5.52 [ 1.63, 18.69 ]
Butt 1995 3/47 0/48 0.9 % 7.15 [ 0.38, 134.67 ]
Goldhagen 1994 3/36 0/39 0.9 % 7.57 [ 0.40, 141.62 ]
Guyer 1991 5/50 6/50 11.3 % 0.83 [ 0.27, 2.55 ]
Haynes 1996 2/19 0/31 0.7 % 8.00 [ 0.40, 158.22 ]
Hoffman 1996 1/31 1/36 1.7 % 1.16 [ 0.08, 17.80 ]
Kukla 1997 1/60 1/60 1.9 % 1.00 [ 0.06, 15.62 ]
Leung 1992 4/113 2/113 3.8 % 2.00 [ 0.37, 10.70 ]
Marques Lopez 2002 2/43 4/60 6.3 % 0.70 [ 0.13, 3.64 ]
Michos 2001 1/26 1/26 1.9 % 1.00 [ 0.07, 15.15 ]
Mott 1993 3/35 0/34 1.0 % 6.81 [ 0.36, 127.00 ]
O’Brien 1995 5/53 2/49 3.9 % 2.31 [ 0.47, 11.37 ]
Ovesen 2006 12/73 6/73 11.3 % 2.00 [ 0.79, 5.04 ]
Papasimos 2005 3/40 3/40 5.6 % 1.00 [ 0.21, 4.66 ]
Radford 1993 6/100 3/100 5.6 % 2.00 [ 0.51, 7.78 ]
Utrilla 2005 1/104 4/106 7.4 % 0.25 [ 0.03, 2.24 ]
Total (95% CI) 1364 1400 100.0 % 1.67 [ 1.20, 2.32 ]
Total events: 86 (Gamma nail), 52 (SHS)
Heterogeneity: Chi2 = 16.71, df = 17 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 3.05 (P = 0.0023)
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Analysis 2.16. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 16 Wound infection or
haematoma.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 16 Wound infection or haematoma
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Wound infection - any type
Adams 2001 9/203 6/197 1.46 [ 0.53, 4.01 ]
Ahrengart 1994 12/105 9/104 1.32 [ 0.58, 3.00 ]
Bridle 1991 1/49 2/51 0.52 [ 0.05, 5.56 ]
Butt 1995 2/47 2/48 1.02 [ 0.15, 6.95 ]
Hoffman 1996 0/31 0/36 0.0 [ 0.0, 0.0 ]
Kukla 1997 5/60 2/60 2.50 [ 0.50, 12.39 ]
Kuwabara 1998 0/20 1/23 0.38 [ 0.02, 8.86 ]
Marques Lopez 2002 2/43 4/60 0.70 [ 0.13, 3.64 ]
Mott 1993 0/35 3/34 0.14 [ 0.01, 2.59 ]
O’Brien 1995 0/53 1/49 0.31 [ 0.01, 7.40 ]
Ovesen 2006 2/73 1/73 2.00 [ 0.19, 21.58 ]
Papasimos 2005 0/40 1/40 0.33 [ 0.01, 7.95 ]
Park 1998 1/30 1/30 1.00 [ 0.07, 15.26 ]
Radford 1993 1/100 4/100 0.25 [ 0.03, 2.20 ]
Subtotal (95% CI) 889 905 0.97 [ 0.62, 1.50 ]
Total events: 35 (Gamma nail), 37 (SHS)
Heterogeneity: Chi2 = 7.75, df = 12 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.15 (P = 0.88)
2 Deep wound infection
Adams 2001 3/203 2/197 1.46 [ 0.25, 8.62 ]
Ahrengart 1994 0/105 1/104 0.33 [ 0.01, 8.01 ]
Guyer 1991 0/50 1/50 0.33 [ 0.01, 7.99 ]
Hoffman 1996 0/31 0/36 0.0 [ 0.0, 0.0 ]
Kukla 1997 2/60 0/60 5.00 [ 0.25, 102.00 ]
Leung 1992 1/93 3/93 0.33 [ 0.04, 3.15 ]
Mott 1993 0/35 0/34 0.0 [ 0.0, 0.0 ]
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Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
O’Brien 1995 0/53 0/49 0.0 [ 0.0, 0.0 ]
Ovesen 2006 2/73 1/73 2.00 [ 0.19, 21.58 ]
Park 1998 1/30 1/30 1.00 [ 0.07, 15.26 ]
Radford 1993 1/100 0/100 3.00 [ 0.12, 72.77 ]
Utrilla 2005 0/104 1/106 0.34 [ 0.01, 8.24 ]
Subtotal (95% CI) 937 932 0.99 [ 0.46, 2.17 ]
Total events: 10 (Gamma nail), 10 (SHS)
Heterogeneity: Chi2 = 4.33, df = 8 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
3 Wound haematoma
Bridle 1991 0/49 2/51 0.21 [ 0.01, 4.23 ]
Guyer 1991 2/50 2/50 1.00 [ 0.15, 6.82 ]
Kukla 1997 0/60 1/60 0.33 [ 0.01, 8.02 ]
Marques Lopez 2002 1/43 1/60 1.40 [ 0.09, 21.70 ]
Mott 1993 0/35 1/34 0.32 [ 0.01, 7.69 ]
O’Brien 1995 1/52 0/49 2.83 [ 0.12, 67.87 ]
Ovesen 2006 1/73 0/73 3.00 [ 0.12, 72.45 ]
Papasimos 2005 2/40 3/40 0.67 [ 0.12, 3.78 ]
Subtotal (95% CI) 402 417 0.78 [ 0.34, 1.79 ]
Total events: 7 (Gamma nail), 10 (SHS)
Heterogeneity: Chi2 = 2.90, df = 7 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.58 (P = 0.56)
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Analysis 2.17. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 17 Pneumonia.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 17 Pneumonia
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bridle 1991 1/49 3/51 0.35 [ 0.04, 3.22 ]
Butt 1995 3/47 4/48 0.77 [ 0.18, 3.24 ]
Hoffman 1996 1/31 1/36 1.16 [ 0.08, 17.80 ]
Kukla 1997 1/60 1/60 1.00 [ 0.06, 15.62 ]
Leung 1992 2/93 3/93 0.67 [ 0.11, 3.90 ]
Marques Lopez 2002 3/43 1/60 4.19 [ 0.45, 38.89 ]
Mott 1993 0/35 1/34 0.32 [ 0.01, 7.69 ]
O’Brien 1995 3/52 2/49 1.41 [ 0.25, 8.10 ]
Papasimos 2005 0/40 0/40 0.0 [ 0.0, 0.0 ]
Total (95% CI) 450 471 0.93 [ 0.47, 1.83 ]
Total events: 14 (Gamma nail), 16 (SHS)
Heterogeneity: Chi2 = 3.38, df = 7 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 0.22 (P = 0.82)
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Analysis 2.18. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 18 Pressure sore.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 18 Pressure sore
Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bridle 1991 4/49 1/51 6.0 % 4.16 [ 0.48, 35.95 ]
Butt 1995 1/47 5/48 30.1 % 0.20 [ 0.02, 1.68 ]
Hoffman 1996 0/31 1/36 8.5 % 0.39 [ 0.02, 9.13 ]
Marques Lopez 2002 3/43 6/60 30.5 % 0.70 [ 0.18, 2.64 ]
O’Brien 1995 2/52 4/49 25.0 % 0.47 [ 0.09, 2.46 ]
Total (95% CI) 222 244 100.0 % 0.67 [ 0.32, 1.42 ]
Total events: 10 (Gamma nail), 17 (SHS)
Heterogeneity: Chi2 = 4.27, df = 4 (P = 0.37); I2 =6%
Test for overall effect: Z = 1.04 (P = 0.30)
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Analysis 2.19. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 19 Thromboembolic
complications.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 19 Thromboembolic complications
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Thromboembolic complication
Adams 2001 9/203 10/197 0.87 [ 0.36, 2.10 ]
Ahrengart 1994 4/105 0/104 8.92 [ 0.49, 163.53 ]
Bridle 1991 1/49 0/51 3.12 [ 0.13, 74.80 ]
Butt 1995 2/47 3/48 0.68 [ 0.12, 3.89 ]
Hoffman 1996 1/31 0/36 3.47 [ 0.15, 82.21 ]
Kukla 1997 2/60 0/60 5.00 [ 0.25, 102.00 ]
Marques Lopez 2002 1/43 1/60 1.40 [ 0.09, 21.70 ]
Mott 1993 1/35 1/34 0.97 [ 0.06, 14.91 ]
O’Brien 1995 3/52 0/49 6.60 [ 0.35, 124.65 ]
Radford 1993 8/100 6/100 1.33 [ 0.48, 3.70 ]
Utrilla 2005 4/82 3/81 1.32 [ 0.30, 5.70 ]
Subtotal (95% CI) 807 820 1.46 [ 0.90, 2.36 ]
Total events: 36 (Gamma nail), 24 (SHS)
Heterogeneity: Chi2 = 5.82, df = 10 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 1.52 (P = 0.13)
2 Deep vein thrombosis
Adams 2001 9/203 10/197 0.87 [ 0.36, 2.10 ]
Ahrengart 1994 4/105 0/104 8.92 [ 0.49, 163.53 ]
Butt 1995 2/47 3/48 0.68 [ 0.12, 3.89 ]
Hoffman 1996 1/31 0/36 3.47 [ 0.15, 82.21 ]
Kukla 1997 2/60 0/60 5.00 [ 0.25, 102.00 ]
Marques Lopez 2002 1/43 1/60 1.40 [ 0.09, 21.70 ]
Mott 1993 1/35 1/34 0.97 [ 0.06, 14.91 ]
Papasimos 2005 1/40 2/40 0.50 [ 0.05, 5.30 ]
Radford 1993 8/100 6/100 1.33 [ 0.48, 3.70 ]
Utrilla 2005 4/82 3/81 1.32 [ 0.30, 5.70 ]
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Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Subtotal (95% CI) 746 760 1.26 [ 0.77, 2.06 ]
Total events: 33 (Gamma nail), 26 (SHS)
Heterogeneity: Chi2 = 4.73, df = 9 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 0.93 (P = 0.35)
3 Pulmonary embolism
Bridle 1991 1/49 0/51 3.12 [ 0.13, 74.80 ]
Kukla 1997 0/60 0/60 0.0 [ 0.0, 0.0 ]
O’Brien 1995 3/52 0/49 6.60 [ 0.35, 124.65 ]
Papasimos 2005 1/40 2/40 0.50 [ 0.05, 5.30 ]
Subtotal (95% CI) 201 200 1.97 [ 0.50, 7.82 ]
Total events: 5 (Gamma nail), 2 (SHS)
Heterogeneity: Chi2 = 2.03, df = 2 (P = 0.36); I2 =1%
Test for overall effect: Z = 0.97 (P = 0.33)
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Analysis 2.20. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 20 Any medical
complication.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 20 Any medical complication
Study or subgroup Gamma nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Random,95% CI M-H,Random,95% CI
Bridle 1991 10/49 4/51 2.60 [ 0.87, 7.75 ]
Butt 1995 10/47 22/48 0.46 [ 0.25, 0.87 ]
Hoffman 1996 16/31 15/36 1.24 [ 0.74, 2.07 ]
Kukla 1997 7/60 5/60 1.40 [ 0.47, 4.17 ]
O’Brien 1995 26/52 19/49 1.29 [ 0.83, 2.01 ]
Ovesen 2006 0/73 0/73 0.0 [ 0.0, 0.0 ]
Total (95% CI) 312 317 1.13 [ 0.69, 1.84 ]
Total events: 69 (Gamma nail), 65 (SHS)
Heterogeneity: Tau2 = 0.18; Chi2 = 10.48, df = 4 (P = 0.03); I2 =62%
Test for overall effect: Z = 0.47 (P = 0.64)
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Analysis 2.21. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 21 Length of hospital
stay (days).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 21 Length of hospital stay (days)
Study or subgroup Gamma nail SHS Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Hoffman 1996 31 29.8 (20.1) 36 28.5 (18.9) 2.1 % 1.30 [ -8.09, 10.69 ]
Kukla 1997 60 15.1 (8.5) 60 14.1 (8.3) 20.9 % 1.00 [ -2.01, 4.01 ]
Leung 1992 93 26.9 (8.2) 93 28.3 (4.5) 52.2 % -1.40 [ -3.30, 0.50 ]
O’Brien 1995 52 23.7 (19) 49 27.6 (26.8) 2.3 % -3.90 [ -13.01, 5.21 ]
Ovesen 2006 73 16.4 (8.4) 73 14.4 (9.4) 22.5 % 2.00 [ -0.89, 4.89 ]
Total (95% CI) 309 311 100.0 % -0.13 [ -1.50, 1.24 ]
Heterogeneity: Chi2 = 5.09, df = 4 (P = 0.28); I2 =21%
Test for overall effect: Z = 0.19 (P = 0.85)
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Analysis 2.22. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 22 Anatomical
deformity.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 22 Anatomical deformity
Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Shortening of leg
Guyer 1991 4/28 12/32 66.9 % 0.38 [ 0.14, 1.05 ]
Kukla 1997 0/45 3/44 21.1 % 0.14 [ 0.01, 2.63 ]
Leung 1992 3/93 2/93 11.9 % 1.50 [ 0.26, 8.77 ]
Subtotal (95% CI) 166 169 100.0 % 0.46 [ 0.21, 1.03 ]
Total events: 7 (Gamma nail), 17 (SHS)
Heterogeneity: Chi2 = 2.48, df = 2 (P = 0.29); I2 =19%
Test for overall effect: Z = 1.89 (P = 0.059)
2 Varus deformity
Ahrengart 1994 6/87 8/81 44.8 % 0.70 [ 0.25, 1.93 ]
Leung 1992 2/93 2/93 10.8 % 1.00 [ 0.14, 6.95 ]
O’Brien 1995 3/53 5/49 28.1 % 0.55 [ 0.14, 2.20 ]
Park 1998 1/30 2/30 10.8 % 0.50 [ 0.05, 5.22 ]
Utrilla 2005 1/82 1/81 5.4 % 0.99 [ 0.06, 15.53 ]
Subtotal (95% CI) 345 334 100.0 % 0.68 [ 0.34, 1.37 ]
Total events: 13 (Gamma nail), 18 (SHS)
Heterogeneity: Chi2 = 0.37, df = 4 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 1.08 (P = 0.28)
3 External rotational deformity
Kuwabara 1998 2/20 3/23 73.6 % 0.77 [ 0.14, 4.14 ]
Leung 1992 2/93 1/93 26.4 % 2.00 [ 0.18, 21.68 ]
Subtotal (95% CI) 113 116 100.0 % 1.09 [ 0.28, 4.19 ]
Total events: 4 (Gamma nail), 4 (SHS)
Heterogeneity: Chi2 = 0.42, df = 1 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 0.13 (P = 0.90)
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Analysis 2.23. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 23 Mortality.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 23 Mortality
Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Adams 2001 59/203 61/197 27.9 % 0.94 [ 0.70, 1.27 ]
Ahrengart 1994 18/105 23/104 10.4 % 0.78 [ 0.45, 1.35 ]
Bridle 1991 15/49 19/51 8.4 % 0.82 [ 0.47, 1.43 ]
Butt 1995 5/47 2/48 0.9 % 2.55 [ 0.52, 12.52 ]
Goldhagen 1994 2/36 1/39 0.4 % 2.17 [ 0.21, 22.89 ]
Guyer 1991 8/50 8/50 3.6 % 1.00 [ 0.41, 2.46 ]
Haynes 1996 1/19 8/31 2.7 % 0.20 [ 0.03, 1.51 ]
Hoffman 1996 8/31 5/36 2.1 % 1.86 [ 0.68, 5.10 ]
Kukla 1997 14/60 14/60 6.3 % 1.00 [ 0.52, 1.91 ]
Leung 1992 20/113 20/113 9.0 % 1.00 [ 0.57, 1.75 ]
Marques Lopez 2002 13/43 22/60 8.3 % 0.82 [ 0.47, 1.45 ]
O’Brien 1995 6/52 1/49 0.5 % 5.65 [ 0.71, 45.29 ]
Ovesen 2006 3/73 3/73 1.3 % 1.00 [ 0.21, 4.79 ]
Pahlpatz 1993 6/51 10/53 4.4 % 0.62 [ 0.24, 1.59 ]
Radford 1993 12/100 10/100 4.5 % 1.20 [ 0.54, 2.65 ]
Utrilla 2005 19/104 21/106 9.4 % 0.92 [ 0.53, 1.61 ]
Total (95% CI) 1136 1170 100.0 % 0.95 [ 0.81, 1.12 ]
Total events: 209 (Gamma nail), 228 (SHS)
Heterogeneity: Chi2 = 10.99, df = 15 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 0.59 (P = 0.56)
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Analysis 2.24. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 24 Mortality (allocation
concealment: Cochrane rating A,B,C).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 24 Mortality (allocation concealment: Cochrane rating A,B,C)
Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Allocation concealment: A (fully concealed)
Hoffman 1996 8/31 5/36 2.1 % 1.86 [ 0.68, 5.10 ]
O’Brien 1995 6/52 1/49 0.5 % 5.65 [ 0.71, 45.29 ]
Ovesen 2006 3/73 3/73 1.3 % 1.00 [ 0.21, 4.79 ]
Subtotal (95% CI) 156 158 3.9 % 2.01 [ 0.94, 4.33 ]
Total events: 17 (Gamma nail), 9 (SHS)
Heterogeneity: Chi2 = 1.74, df = 2 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 1.79 (P = 0.074)
2 Allocation concealment: B (unknown)
Adams 2001 59/203 61/197 27.9 % 0.94 [ 0.70, 1.27 ]
Ahrengart 1994 18/105 23/104 10.4 % 0.78 [ 0.45, 1.35 ]
Bridle 1991 15/49 19/51 8.4 % 0.82 [ 0.47, 1.43 ]
Kukla 1997 14/60 14/60 6.3 % 1.00 [ 0.52, 1.91 ]
Pahlpatz 1993 6/51 10/53 4.4 % 0.62 [ 0.24, 1.59 ]
Radford 1993 12/100 10/100 4.5 % 1.20 [ 0.54, 2.65 ]
Utrilla 2005 19/104 21/106 9.4 % 0.92 [ 0.53, 1.61 ]
Subtotal (95% CI) 672 671 71.2 % 0.90 [ 0.74, 1.10 ]
Total events: 143 (Gamma nail), 158 (SHS)
Heterogeneity: Chi2 = 1.66, df = 6 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 1.04 (P = 0.30)
3 Allocation concealment: C (not concealed)
Butt 1995 5/47 2/48 0.9 % 2.55 [ 0.52, 12.52 ]
Goldhagen 1994 2/36 1/39 0.4 % 2.17 [ 0.21, 22.89 ]
Guyer 1991 8/50 8/50 3.6 % 1.00 [ 0.41, 2.46 ]
Haynes 1996 1/19 8/31 2.7 % 0.20 [ 0.03, 1.51 ]
Leung 1992 20/113 20/113 9.0 % 1.00 [ 0.57, 1.75 ]
Marques Lopez 2002 13/43 22/60 8.3 % 0.82 [ 0.47, 1.45 ]
Subtotal (95% CI) 308 341 24.9 % 0.93 [ 0.66, 1.31 ]
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Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 49 (Gamma nail), 61 (SHS)
Heterogeneity: Chi2 = 4.52, df = 5 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.42 (P = 0.68)
Total (95% CI) 1136 1170 100.0 % 0.95 [ 0.81, 1.12 ]
Total events: 209 (Gamma nail), 228 (SHS)
Heterogeneity: Chi2 = 10.99, df = 15 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 0.59 (P = 0.56)
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Analysis 2.25. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 25 Pain at follow up.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 25 Pain at follow up
Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ahrengart 1994 25/88 15/83 13.2 % 1.57 [ 0.89, 2.77 ]
Guyer 1991 19/28 18/32 14.3 % 1.21 [ 0.81, 1.80 ]
Hoffman 1996 9/23 9/31 6.5 % 1.35 [ 0.64, 2.85 ]
Leung 1992 22/93 32/93 27.3 % 0.69 [ 0.43, 1.09 ]
Utrilla 2005 50/82 45/81 38.6 % 1.10 [ 0.85, 1.42 ]
Total (95% CI) 314 320 100.0 % 1.08 [ 0.90, 1.30 ]
Total events: 125 (Gamma nail), 119 (SHS)
Heterogeneity: Chi2 = 6.03, df = 4 (P = 0.20); I2 =34%
Test for overall effect: Z = 0.81 (P = 0.42)
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Analysis 2.26. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 26 Non-return to
previous residence.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 26 Non-return to previous residence
Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Non-return to previous residence (survivors)
Guyer 1991 3/28 3/32 13.9 % 1.14 [ 0.25, 5.21 ]
Haynes 1996 3/18 7/23 30.4 % 0.55 [ 0.16, 1.82 ]
Pahlpatz 1993 8/45 11/43 55.7 % 0.69 [ 0.31, 1.56 ]
Subtotal (95% CI) 91 98 100.0 % 0.71 [ 0.39, 1.31 ]
Total events: 14 (Gamma nail), 21 (SHS)
Heterogeneity: Chi2 = 0.56, df = 2 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 1.09 (P = 0.28)
2 Non-return to previous residence or dead
Ahrengart 1994 43/105 43/104 50.5 % 0.99 [ 0.72, 1.37 ]
Guyer 1991 11/36 11/40 12.2 % 1.11 [ 0.55, 2.25 ]
Haynes 1996 4/19 15/31 13.3 % 0.44 [ 0.17, 1.12 ]
Pahlpatz 1993 17/51 21/53 24.1 % 0.84 [ 0.50, 1.40 ]
Subtotal (95% CI) 211 228 100.0 % 0.90 [ 0.70, 1.15 ]
Total events: 75 (Gamma nail), 90 (SHS)
Heterogeneity: Chi2 = 3.04, df = 3 (P = 0.39); I2 =1%
Test for overall effect: Z = 0.88 (P = 0.38)
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Analysis 2.27. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 27 Impaired walking.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 27 Impaired walking
Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Impaired walking
Adams 2001 70/126 66/121 23.8 % 1.02 [ 0.81, 1.28 ]
Ahrengart 1994 53/87 61/81 22.3 % 0.81 [ 0.66, 1.00 ]
Guyer 1991 24/28 26/32 8.6 % 1.05 [ 0.84, 1.32 ]
Haynes 1996 13/18 11/23 3.4 % 1.51 [ 0.90, 2.53 ]
Kukla 1997 17/45 17/44 6.1 % 0.98 [ 0.58, 1.66 ]
Leung 1992 59/93 62/93 21.9 % 0.95 [ 0.77, 1.17 ]
Ovesen 2006 30/67 23/66 8.2 % 1.28 [ 0.84, 1.96 ]
Park 1998 14/30 16/30 5.7 % 0.88 [ 0.53, 1.45 ]
Subtotal (95% CI) 494 490 100.0 % 0.99 [ 0.89, 1.10 ]
Total events: 280 (Gamma nail), 282 (SHS)
Heterogeneity: Chi2 = 8.33, df = 7 (P = 0.30); I2 =16%
Test for overall effect: Z = 0.22 (P = 0.82)
2 Impaired walking (overall denominators used)
Adams 2001 70/203 66/197 23.9 % 1.03 [ 0.78, 1.35 ]
Ahrengart 1994 53/105 61/104 21.8 % 0.86 [ 0.67, 1.10 ]
Guyer 1991 24/50 26/50 9.3 % 0.92 [ 0.62, 1.37 ]
Haynes 1996 13/19 11/31 3.0 % 1.93 [ 1.10, 3.39 ]
Kukla 1997 17/60 17/60 6.1 % 1.00 [ 0.57, 1.77 ]
Leung 1992 59/113 62/113 22.1 % 0.95 [ 0.75, 1.21 ]
Ovesen 2006 30/73 23/73 8.2 % 1.30 [ 0.84, 2.02 ]
Park 1998 14/30 16/30 5.7 % 0.88 [ 0.53, 1.45 ]
Subtotal (95% CI) 653 658 100.0 % 1.00 [ 0.89, 1.13 ]
Total events: 280 (Gamma nail), 282 (SHS)
Heterogeneity: Chi2 = 8.67, df = 7 (P = 0.28); I2 =19%
Test for overall effect: Z = 0.07 (P = 0.95)
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Analysis 2.28. Comparison 2 Gamma nail versus sliding hip screw (SHS), Outcome 28 Reoperation -
subgrouped by type of Gamma nail.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 2 Gamma nail versus sliding hip screw (SHS)
Outcome: 28 Reoperation - subgrouped by type of Gamma nail
Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma 1 nail
Adams 2001 12/203 8/197 15.2 % 1.46 [ 0.61, 3.48 ]
Ahrengart 1994 6/105 8/104 15.0 % 0.74 [ 0.27, 2.07 ]
Benum 1994 16/226 3/234 5.5 % 5.52 [ 1.63, 18.69 ]
Butt 1995 3/47 0/48 0.9 % 7.15 [ 0.38, 134.67 ]
Goldhagen 1994 3/36 0/39 0.9 % 7.57 [ 0.40, 141.62 ]
Guyer 1991 5/50 6/50 11.2 % 0.83 [ 0.27, 2.55 ]
Haynes 1996 2/18 0/23 0.8 % 6.32 [ 0.32, 123.86 ]
Hoffman 1996 1/31 1/36 1.7 % 1.16 [ 0.08, 17.80 ]
Kukla 1997 1/60 1/60 1.9 % 1.00 [ 0.06, 15.62 ]
Leung 1992 4/93 2/93 3.7 % 2.00 [ 0.38, 10.65 ]
Marques Lopez 2002 2/43 4/60 6.3 % 0.70 [ 0.13, 3.64 ]
Michos 2001 1/25 1/24 1.9 % 0.96 [ 0.06, 14.50 ]
Mott 1993 3/35 0/34 0.9 % 6.81 [ 0.36, 127.00 ]
O’Brien 1995 5/53 2/49 3.9 % 2.31 [ 0.47, 11.37 ]
Radford 1993 6/100 3/100 5.6 % 2.00 [ 0.51, 7.78 ]
Subtotal (95% CI) 1125 1151 75.6 % 1.80 [ 1.24, 2.62 ]
Total events: 70 (Gamma nail), 39 (SHS)
Heterogeneity: Chi2 = 13.29, df = 14 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 3.07 (P = 0.0021)
2 Trochanteric Gamma nail
Ovesen 2006 12/73 6/73 11.2 % 2.00 [ 0.79, 5.04 ]
Papasimos 2005 3/40 3/40 5.6 % 1.00 [ 0.21, 4.66 ]
Utrilla 2005 1/82 4/81 7.5 % 0.25 [ 0.03, 2.16 ]
Subtotal (95% CI) 195 194 24.4 % 1.23 [ 0.61, 2.47 ]
Total events: 16 (Gamma nail), 13 (SHS)
Heterogeneity: Chi2 = 3.24, df = 2 (P = 0.20); I2 =38%
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(. . . Continued)
Study or subgroup Gamma nail SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 0.58 (P = 0.56)
Total (95% CI) 1320 1345 100.0 % 1.66 [ 1.19, 2.31 ]
Total events: 86 (Gamma nail), 52 (SHS)
Heterogeneity: Chi2 = 16.52, df = 17 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 3.01 (P = 0.0026)
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Analysis 3.1. Comparison 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS), Outcome 1
Length of surgery (minutes) - random-effects model.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS)
Outcome: 1 Length of surgery (minutes) - random-effects model
Study or subgroup IMHS SHS Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Baumgaertner 1998 67 72 (33) 68 80 (35) 32.8 % -8.00 [ -19.47, 3.47 ]
Hardy 1998 50 71 (28.9) 50 57 (24.8) 33.6 % 14.00 [ 3.44, 24.56 ]
Harrington 2002 50 108 (26.8) 52 88 (27.5) 33.6 % 20.00 [ 9.46, 30.54 ]
Total (95% CI) 167 170 100.0 % 8.81 [ -7.43, 25.05 ]
Heterogeneity: Tau2 = 175.30; Chi2 = 13.45, df = 2 (P = 0.001); I2 =85%
Test for overall effect: Z = 1.06 (P = 0.29)
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Analysis 3.2. Comparison 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS), Outcome 2
Blood loss (ml).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS)
Outcome: 2 Blood loss (ml)
Study or subgroup IMHS SHS Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Baumgaertner 1998 67 245 (145) 68 340 (302) 20.5 % -95.00 [ -174.74, -15.26 ]
Hardy 1998 50 144 (120.5) 50 198 (82.9) 79.5 % -54.00 [ -94.54, -13.46 ]
Total (95% CI) 117 118 100.0 % -62.42 [ -98.56, -26.28 ]
Heterogeneity: Chi2 = 0.81, df = 1 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 3.39 (P = 0.00071)
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Analysis 3.3. Comparison 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS), Outcome 3
Transfusion (units of red cells) - random-effects model.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS)
Outcome: 3 Transfusion (units of red cells) - random-effects model
Study or subgroup IMHS SHS Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Baumgaertner 1998 67 2.2 (2.4) 68 1.8 (1.7) 42.2 % 0.40 [ -0.30, 1.10 ]
Hardy 1998 50 0.9 (0.96) 50 1.2 (1.29) 57.8 % -0.30 [ -0.75, 0.15 ]
Total (95% CI) 117 118 100.0 % 0.00 [ -0.68, 0.67 ]
Heterogeneity: Tau2 = 0.15; Chi2 = 2.72, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 0.01 (P = 0.99)
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Analysis 3.4. Comparison 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS), Outcome 4
Number of patients transfused.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS)
Outcome: 4 Number of patients transfused
Study or subgroup IMHS SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Harrington 2002 18/50 22/52 100.0 % 0.85 [ 0.52, 1.39 ]
Total (95% CI) 50 52 100.0 % 0.85 [ 0.52, 1.39 ]
Total events: 18 (IMHS), 22 (SHS)
Heterogeneity: not applicable
Test for overall effect: Z = 0.65 (P = 0.52)
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Analysis 3.5. Comparison 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS), Outcome 5
Radiographic screening time (minutes).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS)
Outcome: 5 Radiographic screening time (minutes)
Study or subgroup IMHS SHS Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Baumgaertner 1998 67 4 (3.2) 68 2.8 (4.1) 6.6 % 1.20 [ -0.04, 2.44 ]
Harrington 2002 50 2.27 (0.89) 52 1.12 (0.81) 93.4 % 1.15 [ 0.82, 1.48 ]
Total (95% CI) 117 120 100.0 % 1.15 [ 0.83, 1.47 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 7.08 (P < 0.00001)
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Analysis 3.6. Comparison 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS), Outcome 6
Fracture fixation complications.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS)
Outcome: 6 Fracture fixation complications
Study or subgroup IMHS SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Operative fracture of femur
Baumgaertner 1998 2/67 0/68 5.07 [ 0.25, 103.74 ]
Hardy 1998 3/50 0/50 7.00 [ 0.37, 132.10 ]
Harrington 2002 1/50 0/52 3.12 [ 0.13, 74.78 ]
Hoffmann 1999 2/56 0/54 4.82 [ 0.24, 98.24 ]
Mehdi 2000 0/90 0/90 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 313 314 5.01 [ 1.11, 22.65 ]
Total events: 8 (IMHS), 0 (SHS)
Heterogeneity: Chi2 = 0.14, df = 3 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 2.09 (P = 0.036)
2 Later fracture of femur
Baumgaertner 1998 3/67 0/68 7.10 [ 0.37, 134.92 ]
Hardy 1998 0/50 0/50 0.0 [ 0.0, 0.0 ]
Harrington 2002 1/50 0/52 3.12 [ 0.13, 74.78 ]
Hoffmann 1999 0/56 0/54 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 223 224 5.12 [ 0.61, 43.33 ]
Total events: 4 (IMHS), 0 (SHS)
Heterogeneity: Chi2 = 0.14, df = 1 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 1.50 (P = 0.13)
3 Cut-out
Baumgaertner 1998 2/67 2/68 1.01 [ 0.15, 7.00 ]
Hardy 1998 0/50 1/50 0.33 [ 0.01, 7.99 ]
Harrington 2002 1/50 1/52 1.04 [ 0.07, 16.18 ]
Mehdi 2000 1/90 1/90 1.00 [ 0.06, 15.74 ]
Subtotal (95% CI) 257 260 0.83 [ 0.24, 2.84 ]
Total events: 4 (IMHS), 5 (SHS)
Heterogeneity: Chi2 = 0.40, df = 3 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.30 (P = 0.77)
4 Non-union
Baumgaertner 1998 1/67 1/68 1.01 [ 0.06, 15.90 ]
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(. . . Continued)
Study or subgroup IMHS SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Hardy 1998 0/35 1/35 0.33 [ 0.01, 7.91 ]
Harrington 2002 1/50 0/52 3.12 [ 0.13, 74.78 ]
Subtotal (95% CI) 152 155 1.02 [ 0.21, 4.95 ]
Total events: 2 (IMHS), 2 (SHS)
Heterogeneity: Chi2 = 0.95, df = 2 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.02 (P = 0.98)
5 Detachment of the plate from the femur
Harrington 2002 0/50 1/52 0.35 [ 0.01, 8.31 ]
Subtotal (95% CI) 50 52 0.35 [ 0.01, 8.31 ]
Total events: 0 (IMHS), 1 (SHS)
Heterogeneity: not applicable
Test for overall effect: Z = 0.65 (P = 0.51)
6 All technical complications of fixation
Baumgaertner 1998 9/67 3/68 3.04 [ 0.86, 10.76 ]
Hardy 1998 3/50 2/50 1.50 [ 0.26, 8.60 ]
Harrington 2002 4/50 2/52 2.08 [ 0.40, 10.86 ]
Hoffmann 1999 2/56 2/54 0.96 [ 0.14, 6.60 ]
Subtotal (95% CI) 223 224 2.02 [ 0.93, 4.39 ]
Total events: 18 (IMHS), 9 (SHS)
Heterogeneity: Chi2 = 1.09, df = 3 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.77 (P = 0.076)
7 Reoperation
Hardy 1998 3/50 4/50 0.75 [ 0.18, 3.18 ]
Hoffmann 1999 0/56 2/54 0.19 [ 0.01, 3.93 ]
Subtotal (95% CI) 106 104 0.53 [ 0.15, 1.88 ]
Total events: 3 (IMHS), 6 (SHS)
Heterogeneity: Chi2 = 0.65, df = 1 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 0.98 (P = 0.33)
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Analysis 3.7. Comparison 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS), Outcome 7
Wound infection or haematoma.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS)
Outcome: 7 Wound infection or haematoma
Study or subgroup IMHS SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Wound infection - any type
Hardy 1998 0/50 0/50 0.0 [ 0.0, 0.0 ]
Hoffmann 1999 0/56 0/54 0.0 [ 0.0, 0.0 ]
Mehdi 2000 2/90 5/90 0.40 [ 0.08, 2.01 ]
Subtotal (95% CI) 196 194 0.40 [ 0.08, 2.01 ]
Total events: 2 (IMHS), 5 (SHS)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 1.11 (P = 0.27)
2 Deep wound infection
Hardy 1998 0/50 0/50 0.0 [ 0.0, 0.0 ]
Hoffmann 1999 0/56 0/54 0.0 [ 0.0, 0.0 ]
Mehdi 2000 0/90 1/90 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 196 194 0.33 [ 0.01, 8.08 ]
Total events: 0 (IMHS), 1 (SHS)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.68 (P = 0.50)
3 Wound haematoma
Baumgaertner 1998 1/67 0/68 3.04 [ 0.13, 73.42 ]
Hardy 1998 4/50 0/50 9.00 [ 0.50, 162.89 ]
Hoffmann 1999 3/56 5/54 0.58 [ 0.15, 2.30 ]
Subtotal (95% CI) 173 172 1.47 [ 0.54, 4.02 ]
Total events: 8 (IMHS), 5 (SHS)
Heterogeneity: Chi2 = 3.46, df = 2 (P = 0.18); I2 =42%
Test for overall effect: Z = 0.75 (P = 0.45)
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Analysis 3.8. Comparison 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS), Outcome 8
Post-operative complications.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS)
Outcome: 8 Post-operative complications
Study or subgroup IMHS SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Mortality
Hardy 1998 4/50 6/50 92.2 % 0.67 [ 0.20, 2.22 ]
Hoffmann 1999 2/56 0/54 7.8 % 4.82 [ 0.24, 98.24 ]
Subtotal (95% CI) 106 104 100.0 % 0.99 [ 0.35, 2.83 ]
Total events: 6 (IMHS), 6 (SHS)
Heterogeneity: Chi2 = 1.48, df = 1 (P = 0.22); I2 =32%
Test for overall effect: Z = 0.02 (P = 0.99)
2 Thromboembolic complication
Hardy 1998 1/50 2/50 100.0 % 0.50 [ 0.05, 5.34 ]
Subtotal (95% CI) 50 50 100.0 % 0.50 [ 0.05, 5.34 ]
Total events: 1 (IMHS), 2 (SHS)
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
3 Deep vein thrombosis
Hardy 1998 1/50 2/50 79.7 % 0.50 [ 0.05, 5.34 ]
Hoffmann 1999 1/56 0/54 20.3 % 2.89 [ 0.12, 69.55 ]
Subtotal (95% CI) 106 104 100.0 % 0.99 [ 0.17, 5.62 ]
Total events: 2 (IMHS), 2 (SHS)
Heterogeneity: Chi2 = 0.76, df = 1 (P = 0.38); I2 =0.0%
Test for overall effect: Z = 0.02 (P = 0.99)
4 Pulmonary embolism
Hardy 1998 0/50 1/50 100.0 % 0.33 [ 0.01, 7.99 ]
Subtotal (95% CI) 50 50 100.0 % 0.33 [ 0.01, 7.99 ]
Total events: 0 (IMHS), 1 (SHS)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
5 Major medical complication
Baumgaertner 1998 10/67 6/68 34.7 % 1.69 [ 0.65, 4.39 ]
Hoffmann 1999 10/56 11/54 65.3 % 0.88 [ 0.41, 1.89 ]
Subtotal (95% CI) 123 122 100.0 % 1.16 [ 0.64, 2.10 ]
Total events: 20 (IMHS), 17 (SHS)
Heterogeneity: Chi2 = 1.11, df = 1 (P = 0.29); I2 =10%
Test for overall effect: Z = 0.49 (P = 0.62)
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Analysis 3.9. Comparison 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS), Outcome 9
Length of hospital stay (days).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS)
Outcome: 9 Length of hospital stay (days)
Study or subgroup IMHS SHS Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Baumgaertner 1998 67 13 (14) 68 11 (5) 44.4 % 2.00 [ -1.56, 5.56 ]
Harrington 2002 50 16.5 (8.8) 52 16.3 (7.5) 55.6 % 0.20 [ -2.98, 3.38 ]
Total (95% CI) 117 120 100.0 % 1.00 [ -1.37, 3.37 ]
Heterogeneity: Chi2 = 0.55, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.83 (P = 0.41)
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Analysis 3.10. Comparison 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS), Outcome 10
Mean limb shortening (cm).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS)
Outcome: 10 Mean limb shortening (cm)
Study or subgroup IMHS SHS Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Hardy 1998 27 0.6 (0.69) 37 1.3 (1.08) 100.0 % -0.70 [ -1.13, -0.27 ]
Total (95% CI) 27 37 100.0 % -0.70 [ -1.13, -0.27 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.16 (P = 0.0016)
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Analysis 3.11. Comparison 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS), Outcome 11
Final outcome measures.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 3 Intramedullary hip screw (IMHS) versus sliding hip screw (SHS)
Outcome: 11 Final outcome measures
Study or subgroup IMHS SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Mortality
Baumgaertner 1998 10/65 17/66 28.3 % 0.60 [ 0.30, 1.21 ]
Hardy 1998 15/50 15/50 25.1 % 1.00 [ 0.55, 1.82 ]
Harrington 2002 20/50 19/52 31.2 % 1.09 [ 0.67, 1.79 ]
Hoffmann 1999 9/56 9/54 15.4 % 0.96 [ 0.41, 2.24 ]
Subtotal (95% CI) 221 222 100.0 % 0.91 [ 0.67, 1.24 ]
Total events: 54 (IMHS), 60 (SHS)
Heterogeneity: Chi2 = 2.03, df = 3 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 0.59 (P = 0.55)
2 Pain
Baumgaertner 1998 15/52 12/53 36.9 % 1.27 [ 0.66, 2.45 ]
Hardy 1998 9/35 4/35 12.4 % 2.25 [ 0.76, 6.63 ]
Hoffmann 1999 14/45 16/43 50.7 % 0.84 [ 0.47, 1.50 ]
Subtotal (95% CI) 132 131 100.0 % 1.17 [ 0.79, 1.75 ]
Total events: 38 (IMHS), 32 (SHS)
Heterogeneity: Chi2 = 2.75, df = 2 (P = 0.25); I2 =27%
Test for overall effect: Z = 0.78 (P = 0.43)
3 Failure to return home (survivors)
Baumgaertner 1998 18/52 14/53 44.0 % 1.31 [ 0.73, 2.35 ]
Harrington 2002 11/30 11/33 33.3 % 1.10 [ 0.56, 2.16 ]
Hoffmann 1999 7/45 7/43 22.7 % 0.96 [ 0.37, 2.50 ]
Subtotal (95% CI) 127 129 100.0 % 1.16 [ 0.78, 1.73 ]
Total events: 36 (IMHS), 32 (SHS)
Heterogeneity: Chi2 = 0.35, df = 2 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 0.72 (P = 0.47)
4 Failure to return home or dead
Baumgaertner 1998 24/58 25/64 34.2 % 1.06 [ 0.69, 1.63 ]
Harrington 2002 31/50 30/52 42.3 % 1.07 [ 0.78, 1.48 ]
Hoffmann 1999 16/54 16/52 23.5 % 0.96 [ 0.54, 1.72 ]
Subtotal (95% CI) 162 168 100.0 % 1.04 [ 0.82, 1.33 ]
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(. . . Continued)
Study or subgroup IMHS SHS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 71 (IMHS), 71 (SHS)
Heterogeneity: Chi2 = 0.11, df = 2 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 0.34 (P = 0.73)
5 Failure to return home or dead (overall denominators used)
Baumgaertner 1998 24/65 25/64 35.5 % 0.95 [ 0.61, 1.47 ]
Harrington 2002 31/50 30/52 41.5 % 1.07 [ 0.78, 1.48 ]
Hoffmann 1999 16/56 16/54 23.0 % 0.96 [ 0.54, 1.73 ]
Subtotal (95% CI) 171 170 100.0 % 1.00 [ 0.79, 1.28 ]
Total events: 71 (IMHS), 71 (SHS)
Heterogeneity: Chi2 = 0.27, df = 2 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.03 (P = 0.98)
6 Failure to regain mobility
Baumgaertner 1998 15/52 16/53 100.0 % 0.96 [ 0.53, 1.73 ]
Subtotal (95% CI) 52 53 100.0 % 0.96 [ 0.53, 1.73 ]
Total events: 15 (IMHS), 16 (SHS)
Heterogeneity: not applicable
Test for overall effect: Z = 0.15 (P = 0.88)
7 Poor mobility
Hoffmann 1999 16/45 19/43 100.0 % 0.80 [ 0.48, 1.35 ]
Subtotal (95% CI) 45 43 100.0 % 0.80 [ 0.48, 1.35 ]
Total events: 16 (IMHS), 19 (SHS)
Heterogeneity: not applicable
Test for overall effect: Z = 0.82 (P = 0.41)
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Analysis 4.1. Comparison 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS), Outcome 1 Length
of surgery (minutes).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS)
Outcome: 1 Length of surgery (minutes)
Study or subgroup PFN SHS Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Saudan 2002 100 64 (33) 106 65 (26) -1.00 [ -9.14, 7.14 ]
-10 -5 0 5 10
Favours PFN Favours SHS
133Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.2. Comparison 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS), Outcome 2 Blood
loss and transfusion.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS)
Outcome: 2 Blood loss and transfusion
Study or subgroup PFN SHS Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Blood loss (ml)
Pajarinen 2005 54 320 (310) 54 357 (495) -37.00 [ -192.78, 118.78 ]
2 Transfusion (units of red blood cells)
Pajarinen 2005 54 2.6 (2.4) 54 2.6 (2) 0.0 [ -0.83, 0.83 ]
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Analysis 4.3. Comparison 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS), Outcome 3
Number of patients transfused.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS)
Outcome: 3 Number of patients transfused
Study or subgroup PFN SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Saudan 2002 55/100 72/106 0.81 [ 0.65, 1.01 ]
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Analysis 4.4. Comparison 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS), Outcome 4
Radiographic screening time (minutes).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS)
Outcome: 4 Radiographic screening time (minutes)
Study or subgroup PFN SHS Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Saudan 2002 100 4 (3) 106 3 (2) 1.00 [ 0.30, 1.70 ]
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Analysis 4.5. Comparison 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS), Outcome 5
Fracture fixation complications.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS)
Outcome: 5 Fracture fixation complications
Study or subgroup PFN SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Operative fracture femur
Papasimos 2005 0/40 0/40 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 40 40 0.0 [ 0.0, 0.0 ]
Total events: 0 (PFN), 0 (SHS)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
2 Later fracture of femur
Pajarinen 2005 0/54 0/54 0.0 [ 0.0, 0.0 ]
Papasimos 2005 0/40 0/40 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 94 94 0.0 [ 0.0, 0.0 ]
Total events: 0 (PFN), 0 (SHS)
Heterogeneity: Chi2 = 0.0, df = 0 (P<0.00001); I2 =0.0%
Test for overall effect: Z = 0.0 (P < 0.00001)
3 Cut-out
Pajarinen 2005 1/54 1/54 1.00 [ 0.06, 15.58 ]
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(. . . Continued)
Study or subgroup PFN SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Papasimos 2005 1/40 2/40 0.50 [ 0.05, 5.30 ]
Saudan 2002 3/79 1/89 3.38 [ 0.36, 31.84 ]
Subtotal (95% CI) 173 183 1.31 [ 0.36, 4.75 ]
Total events: 5 (PFN), 4 (SHS)
Heterogeneity: Chi2 = 1.36, df = 2 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 0.42 (P = 0.68)
4 Cut-out: overall denominators used
Pajarinen 2005 1/54 1/54 1.00 [ 0.06, 15.58 ]
Papasimos 2005 1/40 2/40 0.50 [ 0.05, 5.30 ]
Saudan 2002 3/100 1/106 3.18 [ 0.34, 30.07 ]
Subtotal (95% CI) 194 200 1.28 [ 0.35, 4.67 ]
Total events: 5 (PFN), 4 (SHS)
Heterogeneity: Chi2 = 1.27, df = 2 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 0.38 (P = 0.71)
5 Non-union
Papasimos 2005 0/40 1/40 0.33 [ 0.01, 7.95 ]
Saudan 2002 0/79 0/89 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 119 129 0.33 [ 0.01, 7.95 ]
Total events: 0 (PFN), 1 (SHS)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.68 (P = 0.50)
6 All technical complications of fixation
Pajarinen 2005 2/54 2/54 1.00 [ 0.15, 6.84 ]
Papasimos 2005 6/40 3/40 2.00 [ 0.54, 7.45 ]
Saudan 2002 3/100 1/106 3.18 [ 0.34, 30.07 ]
Subtotal (95% CI) 194 200 1.86 [ 0.71, 4.85 ]
Total events: 11 (PFN), 6 (SHS)
Heterogeneity: Chi2 = 0.63, df = 2 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 1.26 (P = 0.21)
7 Reoperation
Pajarinen 2005 2/54 2/54 1.00 [ 0.15, 6.84 ]
Papasimos 2005 5/40 3/40 1.67 [ 0.43, 6.51 ]
Saudan 2002 6/79 2/89 3.38 [ 0.70, 16.27 ]
Subtotal (95% CI) 173 183 1.94 [ 0.80, 4.71 ]
Total events: 13 (PFN), 7 (SHS)
Heterogeneity: Chi2 = 0.98, df = 2 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 1.47 (P = 0.14)
8 Reoperation: overall denominators used
Pajarinen 2005 2/54 2/54 1.00 [ 0.15, 6.84 ]
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(. . . Continued)
Study or subgroup PFN SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Papasimos 2005 5/40 3/40 1.67 [ 0.43, 6.51 ]
Saudan 2002 6/100 2/106 3.18 [ 0.66, 15.39 ]
Subtotal (95% CI) 194 200 1.90 [ 0.78, 4.62 ]
Total events: 13 (PFN), 7 (SHS)
Heterogeneity: Chi2 = 0.87, df = 2 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 1.41 (P = 0.16)
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Analysis 4.6. Comparison 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS), Outcome 6 Wound
infection or haematoma.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS)
Outcome: 6 Wound infection or haematoma
Study or subgroup PFN SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Superficial wound infection
Pajarinen 2005 0/54 0/54 0.0 [ 0.0, 0.0 ]
Papasimos 2005 1/40 1/40 1.00 [ 0.06, 15.44 ]
Subtotal (95% CI) 94 94 1.00 [ 0.06, 15.44 ]
Total events: 1 (PFN), 1 (SHS)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.0 (P = 1.0)
2 Deep wound infection
Pajarinen 2005 0/54 0/54 0.0 [ 0.0, 0.0 ]
Saudan 2002 3/79 1/89 3.38 [ 0.36, 31.84 ]
Subtotal (95% CI) 133 143 3.38 [ 0.36, 31.84 ]
Total events: 3 (PFN), 1 (SHS)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 1.06 (P = 0.29)
3 Haematoma
Papasimos 2005 3/40 3/40 1.00 [ 0.21, 4.66 ]
Subtotal (95% CI) 40 40 1.00 [ 0.21, 4.66 ]
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(. . . Continued)
Study or subgroup PFN SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 3 (PFN), 3 (SHS)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
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Analysis 4.7. Comparison 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS), Outcome 7 Post-
operative complications.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS)
Outcome: 7 Post-operative complications
Study or subgroup PFN SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Pneumonia
Papasimos 2005 0/40 0/40 0.0 [ 0.0, 0.0 ]
Saudan 2002 7/100 7/106 1.06 [ 0.39, 2.91 ]
Subtotal (95% CI) 140 146 1.06 [ 0.39, 2.91 ]
Total events: 7 (PFN), 7 (SHS)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.11 (P = 0.91)
2 Pressure sores
Saudan 2002 3/100 4/106 0.80 [ 0.18, 3.46 ]
Subtotal (95% CI) 100 106 0.80 [ 0.18, 3.46 ]
Total events: 3 (PFN), 4 (SHS)
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.76)
3 Deep vein thrombosis
Pajarinen 2005 0/54 0/54 0.0 [ 0.0, 0.0 ]
Papasimos 2005 1/40 2/40 0.50 [ 0.05, 5.30 ]
Saudan 2002 1/100 1/106 1.06 [ 0.07, 16.72 ]
Subtotal (95% CI) 194 200 0.68 [ 0.12, 3.98 ]
Total events: 2 (PFN), 3 (SHS)
Heterogeneity: Chi2 = 0.16, df = 1 (P = 0.68); I2 =0.0%
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(. . . Continued)
Study or subgroup PFN SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 0.42 (P = 0.67)
4 Pulmonary embolism
Papasimos 2005 1/40 2/40 0.50 [ 0.05, 5.30 ]
Saudan 2002 1/100 1/106 1.06 [ 0.07, 16.72 ]
Subtotal (95% CI) 140 146 0.68 [ 0.12, 3.98 ]
Total events: 2 (PFN), 3 (SHS)
Heterogeneity: Chi2 = 0.16, df = 1 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 0.42 (P = 0.67)
5 Urinary tract infection
Papasimos 2005 1/40 2/40 0.50 [ 0.05, 5.30 ]
Saudan 2002 34/100 23/106 1.57 [ 1.00, 2.47 ]
Subtotal (95% CI) 140 146 1.48 [ 0.95, 2.30 ]
Total events: 35 (PFN), 25 (SHS)
Heterogeneity: Chi2 = 0.87, df = 1 (P = 0.35); I2 =0.0%
Test for overall effect: Z = 1.73 (P = 0.083)
6 Any medical complication
Saudan 2002 52/100 49/106 1.12 [ 0.85, 1.49 ]
Subtotal (95% CI) 100 106 1.12 [ 0.85, 1.49 ]
Total events: 52 (PFN), 49 (SHS)
Heterogeneity: not applicable
Test for overall effect: Z = 0.83 (P = 0.41)
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Analysis 4.8. Comparison 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS), Outcome 8 Length
of hospital stay (days).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS)
Outcome: 8 Length of hospital stay (days)
Study or subgroup PFN SHS Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Pajarinen 2005 54 6.1 (3.3) 54 5.4 (3) 75.0 % 0.70 [ -0.49, 1.89 ]
Saudan 2002 100 13 (4) 106 14 (10) 25.0 % -1.00 [ -3.06, 1.06 ]
Total (95% CI) 154 160 100.0 % 0.27 [ -0.76, 1.30 ]
Heterogeneity: Chi2 = 1.96, df = 1 (P = 0.16); I2 =49%
Test for overall effect: Z = 0.52 (P = 0.60)
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Analysis 4.9. Comparison 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS), Outcome 9 Final
outcome measures.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 4 Proximal femoral nail (PFN) versus sliding hip screw (SHS)
Outcome: 9 Final outcome measures
Study or subgroup PFN SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Mortality at 4 months
Pajarinen 2005 4/54 2/54 2.00 [ 0.38, 10.47 ]
2 Mortality at 1 year
Saudan 2002 16/100 13/106 1.30 [ 0.66, 2.57 ]
3 In nursing home at 1 year
Saudan 2002 42/79 39/89 1.21 [ 0.89, 1.66 ]
4 In nursing home or dead at 1 year
Saudan 2002 58/95 52/102 1.20 [ 0.93, 1.54 ]
5 In nursing home or dead at 1 year (overall denominators used)
Saudan 2002 58/100 52/106 1.18 [ 0.92, 1.53 ]
6 Failure to regain pre-fracture residential status at 4 months
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Study or subgroup PFN SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Pajarinen 2005 8/42 9/41 0.87 [ 0.37, 2.03 ]
7 Failure to regain pre-fracture residential status, seriously ill or dead at 4 months
Pajarinen 2005 18/52 20/52 0.90 [ 0.54, 1.50 ]
8 Failure to recover previous mobility at 4 months
Pajarinen 2005 10/42 19/41 0.51 [ 0.27, 0.97 ]
9 Failure to recover previous mobility or dead at 4 months (overall denominators used)
Pajarinen 2005 14/54 21/54 0.67 [ 0.38, 1.17 ]
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Analysis 5.1. Comparison 5 Targon PF (proximal femoral) nail versus sliding hip screw (SHS), Outcome 1
Fracture fixation complications.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 5 Targon PF (proximal femoral) nail versus sliding hip screw (SHS)
Outcome: 1 Fracture fixation complications
Study or subgroup Targon PF nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Later fracture of the femur
Giraud 2005 0/34 0/26 0.0 [ 0.0, 0.0 ]
2 Cut-out
Giraud 2005 3/34 2/26 1.15 [ 0.21, 6.37 ]
3 Non-union
Giraud 2005 0/34 0/26 0.0 [ 0.0, 0.0 ]
4 All technical complications of fixation
Giraud 2005 3/34 2/26 1.15 [ 0.21, 6.37 ]
5 Reoperation
Giraud 2005 3/34 2/26 1.15 [ 0.21, 6.37 ]
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Analysis 5.2. Comparison 5 Targon PF (proximal femoral) nail versus sliding hip screw (SHS), Outcome 2
Wound infection.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 5 Targon PF (proximal femoral) nail versus sliding hip screw (SHS)
Outcome: 2 Wound infection
Study or subgroup Targon PF nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 All wound infections
Giraud 2005 0/34 0/26 0.0 [ 0.0, 0.0 ]
2 Deep wound infection
Giraud 2005 0/34 0/26 0.0 [ 0.0, 0.0 ]
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Analysis 5.3. Comparison 5 Targon PF (proximal femoral) nail versus sliding hip screw (SHS), Outcome 3
Post-operative compiications.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 5 Targon PF (proximal femoral) nail versus sliding hip screw (SHS)
Outcome: 3 Post-operative compiications
Study or subgroup Targon PF nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Pneumonia
Giraud 2005 1/34 0/26 2.31 [ 0.10, 54.60 ]
2 Deep vein thrombosis
Giraud 2005 1/34 0/26 2.31 [ 0.10, 54.60 ]
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Analysis 5.4. Comparison 5 Targon PF (proximal femoral) nail versus sliding hip screw (SHS), Outcome 4
Mortality.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 5 Targon PF (proximal femoral) nail versus sliding hip screw (SHS)
Outcome: 4 Mortality
Study or subgroup Targon PF nail SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Giraud 2005 2/34 1/26 1.53 [ 0.15, 15.97 ]
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Analysis 6.1. Comparison 6 Mini-invasive static (experimental) nail versus sliding hip screw (SHS),
Outcome 1 Operative details.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 6 Mini-invasive static (experimental) nail versus sliding hip screw (SHS)
Outcome: 1 Operative details
Study or subgroup Mini-invasive nail Sliding hip screw Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Length of surgery (minutes)
Dujardin 2001 30 24 (7) 30 46 (9) -22.00 [ -26.08, -17.92 ]
2 Operative blood loss (ml)
Dujardin 2001 30 37 (39) 30 172 (76) -135.00 [ -165.57, -104.43 ]
3 Total blood loss (ml)
Dujardin 2001 30 90 (75) 30 326 (161) -236.00 [ -299.56, -172.44 ]
4 Radiographic screening time (seconds)
Dujardin 2001 30 62 (35) 30 63 (40) -1.00 [ -20.02, 18.02 ]
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Analysis 6.2. Comparison 6 Mini-invasive static (experimental) nail versus sliding hip screw (SHS),
Outcome 2 Time to radiographic healing (weeks).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 6 Mini-invasive static (experimental) nail versus sliding hip screw (SHS)
Outcome: 2 Time to radiographic healing (weeks)
Study or subgroup Mini-invasive nail Sliding hip screw Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Dujardin 2001 30 10.4 (5.7) 30 10.2 (5.3) 0.20 [ -2.59, 2.99 ]
-10 -5 0 5 10
Favours nail Favours SHS
Analysis 6.3. Comparison 6 Mini-invasive static (experimental) nail versus sliding hip screw (SHS),
Outcome 3 Mortality.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 6 Mini-invasive static (experimental) nail versus sliding hip screw (SHS)
Outcome: 3 Mortality
Study or subgroup Mini-invasive nail Sliding hip screw Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Dujardin 2001 6/30 6/30 1.00 [ 0.36, 2.75 ]
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Analysis 6.4. Comparison 6 Mini-invasive static (experimental) nail versus sliding hip screw (SHS),
Outcome 4 Time to effective weight bearing (weeks).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 6 Mini-invasive static (experimental) nail versus sliding hip screw (SHS)
Outcome: 4 Time to effective weight bearing (weeks)
Study or subgroup Mini-invasive nail Sliding hip screw Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Dujardin 2001 21 5.8 (2.1) 22 8.3 (4) -2.50 [ -4.40, -0.60 ]
-10 -5 0 5 10
Favours nail Favours SHS
Analysis 7.1. Comparison 7 Kuntscher-Y nail versus sliding hip screw (SHS), Outcome 1 Fracture fixation
complications.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 7 Kuntscher-Y nail versus sliding hip screw (SHS)
Outcome: 1 Fracture fixation complications
Study or subgroup Kuntscher-Y SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Cut-out
Davis 1988 12/116 17/114 0.69 [ 0.35, 1.39 ]
2 All fixation complications
Davis 1988 16/116 22/114 0.71 [ 0.40, 1.29 ]
3 Reoperation
Davis 1988 4/116 4/114 0.98 [ 0.25, 3.84 ]
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Analysis 7.2. Comparison 7 Kuntscher-Y nail versus sliding hip screw (SHS), Outcome 2 Wound infection.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 7 Kuntscher-Y nail versus sliding hip screw (SHS)
Outcome: 2 Wound infection
Study or subgroup Kuntscher-Y SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Superficial wound infection
Davis 1988 7/116 13/114 0.53 [ 0.22, 1.28 ]
2 Deep wound infection
Davis 1988 2/116 1/114 1.97 [ 0.18, 21.38 ]
0.01 0.1 1 10 100
Favours Kuntscher-Y Favours SHS
Analysis 7.3. Comparison 7 Kuntscher-Y nail versus sliding hip screw (SHS), Outcome 3 Post-operative
complications.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 7 Kuntscher-Y nail versus sliding hip screw (SHS)
Outcome: 3 Post-operative complications
Study or subgroup Kuntscher-Y SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Thromboembolic complications
Davis 1988 7/116 6/114 1.15 [ 0.40, 3.31 ]
2 Pneumonia
Davis 1988 21/116 24/114 0.86 [ 0.51, 1.45 ]
3 Pressure sores
Davis 1988 42/116 50/114 0.83 [ 0.60, 1.14 ]
4 All medical complications
Davis 1988 98/116 104/114 0.93 [ 0.84, 1.02 ]
0.1 0.2 0.5 1 2 5 10
Favours Kuntscher-Y Favours SHS
146Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 7.4. Comparison 7 Kuntscher-Y nail versus sliding hip screw (SHS), Outcome 4 Anatomical
deformity.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 7 Kuntscher-Y nail versus sliding hip screw (SHS)
Outcome: 4 Anatomical deformity
Study or subgroup Kuntscher-Y SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Leg shortening
Davis 1988 17/48 9/54 2.13 [ 1.05, 4.31 ]
2 Varus deformity
Davis 1988 13/68 12/73 1.16 [ 0.57, 2.37 ]
3 External rotation deformity
Davis 1988 14/48 11/54 1.43 [ 0.72, 2.85 ]
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Analysis 7.5. Comparison 7 Kuntscher-Y nail versus sliding hip screw (SHS), Outcome 5 Final outcome
measures.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 7 Kuntscher-Y nail versus sliding hip screw (SHS)
Outcome: 5 Final outcome measures
Study or subgroup Kuntscher-Y SHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Mortality
Davis 1988 48/116 41/114 1.15 [ 0.83, 1.60 ]
2 Failure to regain pre-fracture mobility
Davis 1988 40/68 37/73 1.16 [ 0.86, 1.57 ]
3 Death or failure to regain pre-fracture mobility
Davis 1988 88/116 78/114 1.11 [ 0.94, 1.30 ]
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Analysis 8.1. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 1 Length of surgery
(minutes).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 1 Length of surgery (minutes)
Study or subgroup Intramedullary nail Medoff plate Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Proximal femoral nail (PFN)
Ekstrom 2007 105 56 (21) 98 62 (29) -6.00 [ -13.01, 1.01 ]
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Analysis 8.2. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 2 Operative blood
loss (mls).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 2 Operative blood loss (mls)
Study or subgroup Intramedullary nail Medoff plate Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Proximal femoral nail (PFN)
Ekstrom 2007 105 230 (185) 98 527 (565) -297.00 [ -414.33, -179.67 ]
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Analysis 8.3. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 3 Radiographic
screening time (minutes).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 3 Radiographic screening time (minutes)
Study or subgroup Intramedullary nail Medoff plate Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Proximal femoral nail (PFN)
Ekstrom 2007 105 7 (4) 98 5 (5) 2.00 [ 0.75, 3.25 ]
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Analysis 8.4. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 4 Operative
fracture of the femur.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 4 Operative fracture of the femur
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Miedel 2005 3/109 0/108 49.3 % 6.94 [ 0.36, 132.70 ]
Subtotal (95% CI) 109 108 49.3 % 6.94 [ 0.36, 132.70 ]
Total events: 3 (Intramedullary nail), 0 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 1.29 (P = 0.20)
2 Proximal femoral nail (PFN)
Ekstrom 2007 1/105 0/98 50.7 % 2.80 [ 0.12, 67.98 ]
Subtotal (95% CI) 105 98 50.7 % 2.80 [ 0.12, 67.98 ]
Total events: 1 (Intramedullary nail), 0 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 0.63 (P = 0.53)
Total (95% CI) 214 206 100.0 % 4.84 [ 0.57, 40.81 ]
Total events: 4 (Intramedullary nail), 0 (Medoff plate)
Heterogeneity: Chi2 = 0.17, df = 1 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 1.45 (P = 0.15)
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Analysis 8.5. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 5 Later fracture of
femur.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 5 Later fracture of femur
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Miedel 2005 0/109 0/108 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 109 108 0.0 [ 0.0, 0.0 ]
Total events: 0 (Intramedullary nail), 0 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
2 Proximal femoral nail (PFN)
Ekstrom 2007 0/105 0/98 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 105 98 0.0 [ 0.0, 0.0 ]
Total events: 0 (Intramedullary nail), 0 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Total (95% CI) 214 206 0.0 [ 0.0, 0.0 ]
Total events: 0 (Intramedullary nail), 0 (Medoff plate)
Heterogeneity: Chi2 = 0.0, df = 0 (P<0.00001); I2 =0.0%
Test for overall effect: Z = 0.0 (P < 0.00001)
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Analysis 8.6. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 6 Cut-out.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 6 Cut-out
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Miedel 2005 3/109 4/108 66.0 % 0.74 [ 0.17, 3.24 ]
Subtotal (95% CI) 109 108 66.0 % 0.74 [ 0.17, 3.24 ]
Total events: 3 (Intramedullary nail), 4 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 0.40 (P = 0.69)
2 Proximal femoral nail (PFN)
Ekstrom 2007 6/105 2/98 34.0 % 2.80 [ 0.58, 13.55 ]
Subtotal (95% CI) 105 98 34.0 % 2.80 [ 0.58, 13.55 ]
Total events: 6 (Intramedullary nail), 2 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 1.28 (P = 0.20)
Total (95% CI) 214 206 100.0 % 1.44 [ 0.52, 4.01 ]
Total events: 9 (Intramedullary nail), 6 (Medoff plate)
Heterogeneity: Chi2 = 1.46, df = 1 (P = 0.23); I2 =31%
Test for overall effect: Z = 0.70 (P = 0.48)
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Analysis 8.7. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 7 Non-union.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 7 Non-union
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN)
Ekstrom 2007 0/105 2/98 0.19 [ 0.01, 3.84 ]
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Analysis 8.8. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 8 All technical
complications of fixation.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 8 All technical complications of fixation
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Miedel 2005 6/109 7/108 63.0 % 0.85 [ 0.29, 2.45 ]
Subtotal (95% CI) 109 108 63.0 % 0.85 [ 0.29, 2.45 ]
Total events: 6 (Intramedullary nail), 7 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
2 Proximal femoral nail (PFN)
Ekstrom 2007 8/105 4/98 37.0 % 1.87 [ 0.58, 6.00 ]
Subtotal (95% CI) 105 98 37.0 % 1.87 [ 0.58, 6.00 ]
Total events: 8 (Intramedullary nail), 4 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 1.05 (P = 0.30)
Total (95% CI) 214 206 100.0 % 1.23 [ 0.57, 2.65 ]
Total events: 14 (Intramedullary nail), 11 (Medoff plate)
Heterogeneity: Chi2 = 0.96, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 0.52 (P = 0.60)
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Analysis 8.9. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 9 Reoperation.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 9 Reoperation
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Miedel 2005 3/109 9/108 100.0 % 0.33 [ 0.09, 1.19 ]
Subtotal (95% CI) 109 108 100.0 % 0.33 [ 0.09, 1.19 ]
Total events: 3 (Intramedullary nail), 9 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 1.70 (P = 0.090)
2 Proximal femoral nail (PFN)
Ekstrom 2007 9/105 1/98 100.0 % 8.40 [ 1.08, 65.09 ]
Subtotal (95% CI) 105 98 100.0 % 8.40 [ 1.08, 65.09 ]
Total events: 9 (Intramedullary nail), 1 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 2.04 (P = 0.042)
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Analysis 8.10. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 10 Wound
infection - any type.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 10 Wound infection - any type
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Miedel 2005 2/109 8/108 100.0 % 0.25 [ 0.05, 1.14 ]
Subtotal (95% CI) 109 108 100.0 % 0.25 [ 0.05, 1.14 ]
Total events: 2 (Intramedullary nail), 8 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 1.79 (P = 0.073)
2 Proximal femoral nail (PFN)
Ekstrom 2007 8/105 2/98 100.0 % 3.73 [ 0.81, 17.15 ]
Subtotal (95% CI) 105 98 100.0 % 3.73 [ 0.81, 17.15 ]
Total events: 8 (Intramedullary nail), 2 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 1.69 (P = 0.090)
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Analysis 8.11. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 11 Deep wound
infection.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 11 Deep wound infection
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Miedel 2005 0/109 2/108 0.20 [ 0.01, 4.08 ]
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Analysis 8.12. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 12 Wound
haematoma.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 12 Wound haematoma
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN)
Ekstrom 2007 1/105 0/98 2.80 [ 0.12, 67.98 ]
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Analysis 8.13. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 13 Severe medical
complications.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 13 Severe medical complications
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Miedel 2005 3/109 4/108 0.74 [ 0.17, 3.24 ]
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Analysis 8.14. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 14 Mortality at 1
year.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 14 Mortality at 1 year
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Gamma nail
Miedel 2005 24/109 31/108 62.6 % 0.77 [ 0.48, 1.22 ]
Subtotal (95% CI) 109 108 62.6 % 0.77 [ 0.48, 1.22 ]
Total events: 24 (Intramedullary nail), 31 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 1.13 (P = 0.26)
2 Proximal femoral nail (PFN)
Ekstrom 2007 15/105 18/98 37.4 % 0.78 [ 0.42, 1.46 ]
Subtotal (95% CI) 105 98 37.4 % 0.78 [ 0.42, 1.46 ]
Total events: 15 (Intramedullary nail), 18 (Medoff plate)
Heterogeneity: not applicable
Test for overall effect: Z = 0.78 (P = 0.43)
Total (95% CI) 214 206 100.0 % 0.77 [ 0.53, 1.12 ]
Total events: 39 (Intramedullary nail), 49 (Medoff plate)
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 1.37 (P = 0.17)
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Analysis 8.15. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 15 Inability to
walk 15 metres at one year.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 15 Inability to walk 15 metres at one year
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN)
Ekstrom 2007 6/64 7/56 0.75 [ 0.27, 2.10 ]
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Analysis 8.16. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 16 Inability to rise
from a chair at one year.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 16 Inability to rise from a chair at one year
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN)
Ekstrom 2007 31/64 26/56 1.04 [ 0.71, 1.52 ]
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Analysis 8.17. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 17 Inability to
climb a curb at one year.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 17 Inability to climb a curb at one year
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN)
Ekstrom 2007 50/64 38/56 1.15 [ 0.92, 1.44 ]
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Analysis 8.18. Comparison 8 Femoral nail (2 types) versus Medoff sliding plate, Outcome 18 Need to use
walking aids at one year.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 8 Femoral nail (2 types) versus Medoff sliding plate
Outcome: 18 Need to use walking aids at one year
Study or subgroup Intramedullary nail Medoff plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN)
Ekstrom 2007 38/64 35/56 0.95 [ 0.71, 1.27 ]
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Analysis 9.1. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 1 Length of
surgery (minutes).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 1 Length of surgery (minutes)
Study or subgroup Intramedullary nail Plate Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 20 82 (53) 19 166 (48) -84.00 [ -115.71, -52.29 ]
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Analysis 9.2. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 2 Number of
patients transfused.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 2 Number of patients transfused
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 11/20 18/19 0.58 [ 0.39, 0.88 ]
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Analysis 9.3. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 3 Radiographic
screening time (minutes).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 3 Radiographic screening time (minutes)
Study or subgroup Intramedullary nail Plate Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 20 4.2 (2.4) 19 4 (1.6) 0.20 [ -1.07, 1.47 ]
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Analysis 9.4. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 4 Operative
fracture of femur.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 4 Operative fracture of femur
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
2 Gamma nail versus 90 degree blade plate
Pelet 2001 1/13 0/13 3.00 [ 0.13, 67.51 ]
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Analysis 9.5. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 5 Cut-out.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 5 Cut-out
Study or subgroup Intramedullary nail fixation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 0/20 5/19 91.8 % 0.09 [ 0.01, 1.47 ]
Subtotal (95% CI) 20 19 91.8 % 0.09 [ 0.01, 1.47 ]
Total events: 0 (Intramedullary nail), 5 (fixation)
Heterogeneity: not applicable
Test for overall effect: Z = 1.69 (P = 0.090)
2 Gamma nail versus 90 degree blade plate
Pelet 2001 1/13 0/13 8.2 % 3.00 [ 0.13, 67.51 ]
Subtotal (95% CI) 13 13 8.2 % 3.00 [ 0.13, 67.51 ]
Total events: 1 (Intramedullary nail), 0 (fixation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
Total (95% CI) 33 32 100.0 % 0.32 [ 0.07, 1.53 ]
Total events: 1 (Intramedullary nail), 5 (fixation)
Heterogeneity: Chi2 = 2.80, df = 1 (P = 0.09); I2 =64%
Test for overall effect: Z = 1.43 (P = 0.15)
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Analysis 9.6. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 6 Non-union.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 6 Non-union
Study or subgroup Intramedullary nail Plate Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 1/18 1/17 29.1 % 0.94 [ 0.06, 13.93 ]
Subtotal (95% CI) 18 17 29.1 % 0.94 [ 0.06, 13.93 ]
Total events: 1 (Intramedullary nail), 1 (Plate)
Heterogeneity: not applicable
Test for overall effect: Z = 0.04 (P = 0.97)
2 Gamma nail versus 90 degree blade plate
Pelet 2001 0/13 2/13 70.9 % 0.20 [ 0.01, 3.80 ]
Subtotal (95% CI) 13 13 70.9 % 0.20 [ 0.01, 3.80 ]
Total events: 0 (Intramedullary nail), 2 (Plate)
Heterogeneity: not applicable
Test for overall effect: Z = 1.07 (P = 0.28)
Total (95% CI) 31 30 100.0 % 0.42 [ 0.06, 2.69 ]
Total events: 1 (Intramedullary nail), 3 (Plate)
Heterogeneity: Chi2 = 0.59, df = 1 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 0.92 (P = 0.36)
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Analysis 9.7. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 7 All technical
complications of fixation.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 7 All technical complications of fixation
Study or subgroup Intramedullary nail Plate Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 1/18 7/17 54.5 % 0.13 [ 0.02, 0.98 ]
Subtotal (95% CI) 18 17 54.5 % 0.13 [ 0.02, 0.98 ]
Total events: 1 (Intramedullary nail), 7 (Plate)
Heterogeneity: not applicable
Test for overall effect: Z = 1.98 (P = 0.048)
2 Gamma nail versus 90 degree blade plate
Pelet 2001 2/13 6/13 45.5 % 0.33 [ 0.08, 1.36 ]
Subtotal (95% CI) 13 13 45.5 % 0.33 [ 0.08, 1.36 ]
Total events: 2 (Intramedullary nail), 6 (Plate)
Heterogeneity: not applicable
Test for overall effect: Z = 1.53 (P = 0.12)
Total (95% CI) 31 30 100.0 % 0.23 [ 0.07, 0.71 ]
Total events: 3 (Intramedullary nail), 13 (Plate)
Heterogeneity: Chi2 = 0.56, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 2.56 (P = 0.011)
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Analysis 9.8. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 8 Reoperation.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 8 Reoperation
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 0/20 6/19 0.07 [ 0.00, 1.22 ]
Subtotal (95% CI) 20 19 0.07 [ 0.00, 1.22 ]
Total events: 0 (Intramedullary nail), 6 (Plate)
Heterogeneity: not applicable
Test for overall effect: Z = 1.82 (P = 0.068)
2 Gamma nail versus 90 degree blade plate
Pelet 2001 0/13 0/13 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 13 13 0.0 [ 0.0, 0.0 ]
Total events: 0 (Intramedullary nail), 0 (Plate)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Total (95% CI) 33 32 0.07 [ 0.00, 1.22 ]
Total events: 0 (Intramedullary nail), 6 (Plate)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 1.82 (P = 0.068)
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Analysis 9.9. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 9 Deep wound
infection.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 9 Deep wound infection
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 0/18 1/17 0.32 [ 0.01, 7.26 ]
2 Gamma nail versus 90 degree blade plate
Pelet 2001 0/13 0/13 0.0 [ 0.0, 0.0 ]
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Analysis 9.10. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 10 Pneumonia.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 10 Pneumonia
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 2/20 3/19 0.63 [ 0.12, 3.38 ]
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Analysis 9.11. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 11 Pressure
sores.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 11 Pressure sores
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 1/20 0/19 2.86 [ 0.12, 66.11 ]
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Analysis 9.12. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 12 Deep vein
thrombosis.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 12 Deep vein thrombosis
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 0/20 0/19 0.0 [ 0.0, 0.0 ]
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Analysis 9.13. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 13 Pulmonary
embolism.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 13 Pulmonary embolism
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 0/20 0/19 0.0 [ 0.0, 0.0 ]
2 Gamma nail versus 90 degree blade plate
Pelet 2001 1/13 0/13 3.00 [ 0.13, 67.51 ]
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Analysis 9.14. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 14 All medical
complications.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 14 All medical complications
Study or subgroup Intramedullary nail Plate Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 9/20 7/19 54.5 % 1.22 [ 0.57, 2.62 ]
Subtotal (95% CI) 20 19 54.5 % 1.22 [ 0.57, 2.62 ]
Total events: 9 (Intramedullary nail), 7 (Plate)
Heterogeneity: not applicable
Test for overall effect: Z = 0.51 (P = 0.61)
2 Gamma nail versus 90 degree blade plate
Pelet 2001 7/13 6/13 45.5 % 1.17 [ 0.54, 2.53 ]
Subtotal (95% CI) 13 13 45.5 % 1.17 [ 0.54, 2.53 ]
Total events: 7 (Intramedullary nail), 6 (Plate)
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
0.1 0.2 0.5 1 2 5 10
Favours nail Favours plate
(Continued . . . )
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(. . . Continued)
Study or subgroup Intramedullary nail Plate Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total (95% CI) 33 32 100.0 % 1.20 [ 0.69, 2.06 ]
Total events: 16 (Intramedullary nail), 13 (Plate)
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 0.65 (P = 0.52)
0.1 0.2 0.5 1 2 5 10
Favours nail Favours plate
Analysis 9.15. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 15 Length of
hospital stay (days).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 15 Length of hospital stay (days)
Study or subgroup Intramedullary nail Plate Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 20 13 (4) 19 18 (7) -5.00 [ -8.60, -1.40 ]
-10 -5 0 5 10
Favours nail Favours plate
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Analysis 9.16. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 16 Mortality (1
year).
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 16 Mortality (1 year)
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 2/20 1/19 1.90 [ 0.19, 19.27 ]
Subtotal (95% CI) 20 19 1.90 [ 0.19, 19.27 ]
Total events: 2 (Intramedullary nail), 1 (Plate)
Heterogeneity: not applicable
Test for overall effect: Z = 0.54 (P = 0.59)
2 Gamma nail versus 90 degree blade plate
Pelet 2001 0/13 0/13 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 13 13 0.0 [ 0.0, 0.0 ]
Total events: 0 (Intramedullary nail), 0 (Plate)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Total (95% CI) 33 32 1.90 [ 0.19, 19.27 ]
Total events: 2 (Intramedullary nail), 1 (Plate)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.54 (P = 0.59)
0.001 0.01 0.1 1 10 100 1000
Favours nail Favours plate
Analysis 9.17. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 17 Pain at
follow up.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 17 Pain at follow up
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
2 Gamma nail versus 90 degree blade plate
Pelet 2001 3/13 5/13 0.60 [ 0.18, 2.01 ]
0.01 0.1 1 10 100
Favours nail Favours plate
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Analysis 9.18. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 18 In nursing
home at one year from injury.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 18 In nursing home at one year from injury
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 9/18 10/17 0.85 [ 0.46, 1.56 ]
0.1 0.2 0.5 1 2 5 10
Favours nail Favours plate
Analysis 9.19. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 19 In nursing
home or dead at one year from injury.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 19 In nursing home or dead at one year from injury
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Proximal femoral nail (PFN) versus Dynamic Condylar Plate (DCP)
Sadowski 2002 11/20 11/19 0.95 [ 0.55, 1.65 ]
0.1 0.2 0.5 1 2 5 10
Favours nail Favours plate
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Analysis 9.20. Comparison 9 Femoral nail (2 types) versus condylar or blade plate, Outcome 20 Use of
walking aids.
Review: Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults
Comparison: 9 Femoral nail (2 types) versus condylar or blade plate
Outcome: 20 Use of walking aids
Study or subgroup Intramedullary nail Plate Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
2 Gamma nail versus 90 degree blade plate
Pelet 2001 6/13 10/13 0.60 [ 0.31, 1.16 ]
0.1 0.2 0.5 1 2 5 10
Favours nail Favours plate
A P P E N D I C E S
Appendix 1. Search strategies for The Cochrane Library and MEDLINE
The Cochrane Library MEDLINE (OVID-WEB)
#1 MeSH descriptor Hip Fractures explode all trees
#2 ((hip* or femur* or femoral* or trochant* or pertrochant* or
intertrochant* or subtrochant* or intracapsular* or extracapsular*)
NEAR fracture*):ti,ab,kw
#3 (#1 OR #2)
#4 4 (pin* or nail* or screw* or plate* or arthroplasty* or fix* or
prosthes*):ti,ab,kw
#5 MeSH descriptor Internal Fixators, this term only
#6 MeSH descriptor Bone Screws, this term only
#7 MeSH descriptor Fracture Fixation, Internal explode all trees
#8 MeSH descriptor Bone Plates, this term only
#9 MeSH descriptor Bone Nails, this term only
#10 MeSH descriptor Arthroplasty explode all trees
#11 (#4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10)
#12 (#3 AND #11)
1. exp Hip Fractures/
2. hip$ or femur$ or femoral$ or trochant$ or pertrochant$ or
intertrochant$ or subtrochant$ or intracapsular$ or extracapsu-
lar$)adj4 fracture$).tw.
3. or/1-2
4. (pin$1 or nail$ or screw$1 or plate$1 or arthroplast$ or fix$ or
prosthes$).tw.
5. Internal Fixators/ or Bone Screws/ or Fracture Fixation, Inter-
nal/ or Bone Plates/ or Bone Nails/
6. Arthroplasty/or Arthroplasty, Replacement, Hip/
7. or/4-6
8. and/3,7
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Appendix 2. Search strategy for EMBASE
EMBASE (OVID-WEB)
1. exp Hip Fracture/
2. ((hip$ or ((femur$ or femoral$) adj3 (neck or proximal))) adj4 fracture$).tw.
3. or/1-2
4. exp Randomized Controlled trial/
5. exp Double Blind Procedure/
6. exp Single Blind Procedure/
7. exp Crossover Procedure/
8. Controlled Study/
9. or/4-8
10. ((clinical or controlled or comparative or placebo or prospective$ or randomi#ed)adj3 (trial or study)).tw.
11. (random$ adj7 (allocat$ or allot$ or assign$ or basis$ or divid$ or order$)).tw.
12. ((singl$ or doubl$ or trebl$ or tripl$) adj7 (blind$ or mask$)).tw.
13. (cross?over$ or (cross adj1 over$)).tw.
14. ((allocat$ or allot$ or assign$ or divid$) adj3 (condition$ or experiment$ or intervention$ or treatment$ or therap$ or
control$ or group$)).tw.
15. or/10-14
16. or/9,15
17. limit 16 to human
18. and/3,17
Appendix 3. Searches prior to 2000
Search activity
Electronic searching of MEDLINE up to August 1999 with the following search terms: (Gamma and nail) and (screw and (dynamic
or compression or Ambi)).
Handsearches of the following journals from 1990 when the first reports of the use of the Gamma nail were published: Journal of
Bone and Joint Surgery - American Volume, Journal of Bone and Joint Surgery - British Volume, Acta Orthopaedica Scandinavica,
Journal of Trauma, Injury, Clinical Orthopaedics, Orthopaedic Clinics of North America, International Orthopaedics, and Journal
of Royal College of Surgeons (Edinburgh).
Handsearching of conference abstracts from 1990 reported within the Journal of Bone and Joint Surgery - American Volume, Journal
of Bone and Joint Surgery - British Volume, Acta Orthopaedica Scandinavica Supplementum, and Injury.
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WH A T ’ S N E W
Last assessed as up-to-date: 29 November 2007.
1 April 2008 Amended Converted to new review format.
4 March 2008 New citation required and conclusions have changed For the sixth substantive update, which first appeared in
Issue 3, 2008, the main changes were as follows.
(1) The search for trials was updated to June 2007.
(2) Four newly identified studies (Ekstrom 2007; Giraud
2005; Ovesen 2006; Papasimos 2005) were included.
(3) One new comparison was added (Targon PF nail versus
SHS) and one category extended to include the PFN versus
Medoff plate comparison.
(4) One previously ongoing study (Khaleel) was moved to
awaiting assessment and renamed Fernando 2006.
(5) One newly identified study (Harris 2005) was added to
awaiting assessment.
(6) Five newly identified studies (Azzoni 2004; Bienkowski
2006; Kafer 2005; Klinger 2005; Tarantino 2005) were ex-
cluded.
(7) Additional information and data for an already included
trial were added (Mehdi 2000).
(8) The ’Synopsis’ was rewritten as a ’Plain language sum-
mary’; and other changes made to comply with format and
methodological requirements.
(9) There were no substantial changes made to the conclu-
sions.
H I S T O R Y
Protocol first published: Issue 2, 1995
Review first published: Issue 3, 1996
15 August 2005 New citation required and conclusions have changed For details of this and previous updates please see Pub-
lished notes.
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C O N T R I B U T I O N S O F A U T H O R S
Martyn Parker initiated and designed the review, usually contacted trialists for further information and compiled the first drafts of all
versions. Helen Handoll located the review studies for most versions, occasionally contacted trialists for further information, always
checked data entry and critically rewrote all drafts for all versions. All other tasks, including independent data extraction and quality
assessment, were shared. Martyn Parker is the guarantor of the review.
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• University of Teesside, Middlesbrough, UK.
• Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, UK.
External sources
• No sources of support supplied
N O T E S
The first substantive update appearing in Issue 2, 1999 involved an expansion of the original review, “Gamma nail versus sliding hip
screw for extracapsular hip fractures”, to include other cephalocondylic nails. Four more studies on the Gamma nail (Haynes 1996;
Kukla 1997; Pahlpatz 1993; Park 1998), and two studies on the intramedullary hip screw (Baumgaertner 1998; Hardy 1998) were
included.
For the second substantive update, which first appeared in Issue 1, 2002, the main changes were as follows.
1. The update of the search for trials to August 2001.
2. The inclusion of three new Gamma nail trials (Adams 2001; Kuwabara 1998; Michos 2001) and three new intermedullary hip screw
trials (Harrington 1999; Hoffmann 1999; Mehdi 2000).
3. Two Gamma nail studies (Hogh 1992; Mott 1993) previously in studies awaiting assessment are now excluded as no further
information has been forthcoming.
4. The inclusion of two new comparisons, each represented by one study: proximal femoral nail versus the sliding hip screw (Saudan
2001a) and proximal femoral nail versus the dynamic condylar screw (Saudan 2001b).
5. The inclusion of one trial on a mini-invasive nail (Dujardin 2001).
6. Peto odds ratios changed to relative risks in accordance with Cochrane Review Group requirements.
7. The addition of a new outcome, ’All technical complications of fixation’ and the clarification of the outcome: ’operative fracture’.
8. Pooling of the results for key outcomes for three of the short proximal femoral nails (Gamma, IMHS and the PFN) versus the sliding
hip screw.
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9. Addition of a ’Synopsis’.
For the third substantive update, which first appeared in Issue 4, 2002, the main changes were as follows.
1. The update of the search for trials to August 2002.
2. Inclusion of newly identified study (Pelet 2001) comparing the Gamma nail with a blade plate.
3. Exclusion of another newly identified study (Dicicco 2000).
4. Incorporation of further details and results of three already included trials (Harrington 2002; Sadowski 2002; Saudan 2002),
previously Harrington 1999, Saudan 2001b and Saudan 2001a respectively, obtained from newly published full reports of these trials.
5. Some restructuring of the text and tables to give emphasis on overall results of short femoral nails and lessen the emphasis on the
outdated Kuntscher-Y nail.
6. Some adjustments to the ’Conclusions’ but no substantive changes in implications.
For the fourth substantive update, which first appeared in Issue 1, 2004, the main changes were as follows.
1. The update of the search for trials to May 2003.
2. Newly identified study of Marques Lopez 2002 included.
3. Though a further report of Ahrengart 1994 was identified giving results for more patients we kept the results from the previous
report, pending clarification.
4. Three newly identified studies (Hardy 2003; Herrera 2002; Nuber 2003) were excluded.
5. The studies of Davidson 1996 and Prinz 1996 were moved from ’Awaiting assessment’ to excluded.
6. Study of Moran 2000 moved from ongoing to excluded.
7. Reference to letter on study of Hardy 1998 added.
8. Details of newly identified onging study (Parker) added.
For the fifth substantive update, which first appeared in Issue 4, 2005, the main changes were as follows.
(1) The search for trials was updated to June 2005.
(2) The newly identified studies of Miedel 2005, Pajarinen 2005 and Utrilla 2005 were included.
(3) Study of Mott 1993 moved from excluded to included on receipt of additional information.
(4) Three newly identified studies (Bhatti 2004; Khan 2002; Schipper 2004) were excluded.
(5) One newly identified study (Khaleel) is listed as an ongoing trial and two other studies (Ahmad; White) await assessment.
(6) The length of the ’Abstract’ was reduced and other format changes undertaken to comply with the Cochrane StyleGuide (November
2004). Other changes, such as the consideration of the I-squared statistic were made to comply with the Cochrane Handbook for
Systematic Reviews of Interventions (March 2005).
(7) Graphical presentation of the results was revised and compressed to reduce the number of graphs.
(8) There were no substantial changes made to the conclusions.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Bone Nails; ∗Bone Screws; Fracture Fixation, Internal [adverse effects; ∗instrumentation]; Fracture Fixation, Intramedullary [adverse
effects; instrumentation]; Hip Fractures [mortality; ∗surgery]; Randomized Controlled Trials as Topic
MeSH check words
Adult; Humans
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